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1 Introduction 
1.1  The immune system of vertebrates 
Vertebrates have developed a highly complex system to combat pathogens that constantly aim to 
destroy the integrity of organisms, the immune system.  
Immunity against pathogenic attacks is generated by two different branches of the immune 
system, innate and adaptive immunity. Innate immunity serves as the first defense during the 
course of an infection and fights pathogens with unspecialized, but effective clearance of 
infections via the complement system and phagocytes. The complement system consists of 
soluble plasma proteins that target bacterial, viral and fungal structures and thereby tags these 
pathogens for phagocytosis. Furthermore, the assembly of certain complement factors can lead 
to a pore formation in the bacterial membrane for instance followed by destruction of the 
pathogen (Janeway and Medzhitov 2002). Phagocytes are another major component of the innate 
immune system. As a reaction to viral or bacterial infection a specialized group of cells from 
myeloid origin, e.g. macrophages, granulocytes, natural killer cells (NK cells) and dendritic cells 
(DCs) serve as sentinels and incorporate soluble antigens as well as virus, bacteria and already 
infected cells to clear the infection. Therefore, they express a set of surface receptors, the toll like 
receptors (TLR) as a member of PRR (pattern recognition receptors) which recognize conserved 
antigens of the microbial metabolism, e.g. LPS (lipopolysaccharides), proteogylcans, microbial 
DNA and double-stranded RNA (Takeda 2004; Beutler 2004).  
In addition, dendritic cells serve as a link between the innate and the adaptive immune system 
and therefore adopt the role of inducing an immune response that is able to specifically target the 
intruder and develop a memory for this pathogen that in turn leads to a stronger and faster 
defense the next time this pathogen threatens the organisms. Dendritic cells do therefore not 
only incorporate the pathogen but process it and present the antigenic peptides on specialized 
molecule receptors on the cell surface. The so called MHC II (major histocompatibility complex II) 
molecules (Snell 1948) also play a crucial role in the discrimination between self and foreign 
antigens, an important feature of the immune system in order to save the organism from self-
destruction by autoimmunity. MHC class I molecules are ubiquitously expressed in almost every 
cell of the organism. MHC class I receptors are loaded with antigens from the cytoplasm which 
include host peptides as well as particles from virus and other infectious antigens. Once loaded on 
the MHC receptor, the receptor is transported to the cell surface and is recognized by CD8+ T cells 
(CD, cluster of differentiation). If these cytotoxic T cells recognize the MHC molecule together 
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with the presented antigen, they degranulate and thereby destroy the infected cells. In contrast 
to that, antigen-loaded MHC class II molecules are recognized by CD4+ T cells, the so called helper 
cells. These CD4+ T cells are able to stimulate B lymphocytes that in turn develop to plasma cells. 
Plasma cells then produce antibodies that are specific for the presented antigen.  
During antigen uptake and presentation of antigen on MHC class II molecules, dendritic cells 
undergo certain changes in their morphology and receptor expression patterns on their cell 
surface, a process that is termed maturation. This in turn leads to the ability to efficiently activate 
the adaptive part of the immune system. Activated mature dendritic cells migrate towards the 
draining lymph nodes, where they enter the paracortex and present the processed antigens to 
T cells that are part of the adaptive immune system. This long lasting and more pathogen-specific 
branch of the immune system is mainly developed and maintained by lymphocytes. Two 
subclasses of lymphocytes can be separated from each other. B cells and T cells develop from a 
common progenitor in the bone marrow. Whereas B cells fully develop in the bone marrow, 
T cells leave the bone marrow in earlier steps of their development and undergo certain positive 
and negative selection steps in the thymus that avoid autoimmunity. The positive selection 
regulates the ability of TCR subsets to be able to interact with MHC class I and II molecules, 
respectively. T cells that fail to recognize MHC molecules presented by the thymus epithelial are 
deleted during T cell development. The negative selection leads to elimination of thymocytes that 
interact with MHC molecules that present self-antigens. Only if both selection mechanisms are 
successfully overcome, the T cells are leaving the thymus as naïve T cells, circulate through the 
blood stream and subsequently enter the lymph nodes to be activated by antigen presenting cells 
(APCs).  
After recognition of the foreign antigen that is presented by APCs in the lymph node, T cells 
become activated, proliferate and differentiate into effector or helper T cells. Effector CD8+ T cells 
migrate to infected tissues and clear the infection by release of cytotoxic granules which destroy 
the pathogen and infected apoptotic cells. CD4+ T helper cells are in turn able to activate B cells 
that differentiate into plasma cells which produce antigen specific antibodies and into memory 
cells that stay in the organism for an extended period and are able to secrete specific antibodies 
in the course of a new infection with the once recognized pathogen. The development of an 
immunological memory enables the organisms to clear a new infection with the same pathogen 
much faster and with higher efficacy. 
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1.1.1 Dendritic cells as cross-linkers of innate and adaptive immunity 
Dendritic cells (DCs) were first discovered by Steinman and Cohn in peripheral tissues in mice 
(Steinman and Cohn 1973). They are a particularly heterogeneous group of antigen presenting 
phagocytes that develop out of myeloid or lymphoid progenitors, respectively, specialized in the 
uptake of antigens, the processing and consecutive presentation of antigen to T cells in the lymph 
node. Both, myeloid and lymphoid progenitors reside in the bone marrow. Myeloid progenitors 
can develop into monocytes that are characterized by a defined subset of surface markers 
(CD14+and CD11c+) and are circulating in the blood. After development of monocytic precursors in 
the bone marrow, they migrate mainly via the blood stream to non-lymphatic tissues. M-CSF 
(macrophage colony-stimulating factor) alone induces the differentiation into macrophages. In 
contrast, monocytes can develop into immature DCs after encountering the cytokines GM-CSF 
(granulocyte-macrophage-colony stimulating factor) and IL-4 (interleukin-4) (Inaba 1992; Sallusto 
and Lanzavecchia 1994). In this immature state, dendritic cells have the ability to roam the tissue 
and search for pathogens, which they take up by phagocytosis (Sallusto 1995; Sallusto and 
Lanzavecchia 1994; Fanger et al. 1996; Slepnev and De 2000). The surface expression of MHC II 
and costimulatory B7 molecules is low and they have a characteristic cell shape with dendritic 
protrusions. 
Langerhans cells (LC) or Langerhans macrophages develop out of CD14+, CD11c+ and CD1+ 
progenitor cells by stimulation with the cytokines GM-CSF, IL-4 and TGF- or M-CSF alone, 
respectively. Langerhans cells and Langerhans macrophages reside in peripheral, mostly 
epidermal tissue and mature upon encountering CD40L, the CD40 ligand on T cells, or pathogenic 
DNA.  
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Figure 1: Life cycle of a dendritic cell. 
Progenitors of the Langerhans cell leave the bone marrow and enter the tissue via the blood stream. There, 
they develop into precursor cells and into immature dendritic cells. Upon antigen-uptake, DCs leave the 
tissue and enter the lymphatics, where they mature. Fully matured DCs reside in the lymph nodes and 
present the processed antigens to T cells (Shortman and Naik 2007). 
After encountering an antigen or sense inflammatory factors such as LPS, TNF- or CD40L, 
respectively, immature dendritic cells are able to produce proinflammatory factors, e.g. IL-12 and 
type I and II interferons that in turn stimulate the innate immunity (Mellman and Steinman 2001). 
Moreover, they undergo a dramatic change not only in their morphology but also in the 
expression pattern of surface receptors and actin rearrangement, a developmental program that 
is called maturation (cf. figure 1). Morphologically, this change is accompanied by rounder cell 
shape and the formation of migration-relevant lamellipodia. The maturation process enables 
dendritic cells to migrate through afferent vessels towards the lymph node and serve as effective 
antigen presenting cells. Therefore, reciprocal downregulation of the chemokine receptors CCR1 
and CCR3, respectively and upregulation of CCR7 occurs, a chemokine receptor that signals 
through stimulation via CCL19 and CCL21 (Dieu et al. 1998; Sozzani et al. 1998). These chemokines 
are expressed and secreted by lymphatic endothelial cells and stromal lymphoid tissue in the 
draining lymph nodes and serve as chemoattractants for the directed migration of DCs to the 
lymph node a process that is named chemotaxis (Martín-Fontecha et al. 2003; Saeki et al. 1999). 
Furthermore, adhesion molecules, e.g. ICAM-1 (intercellular adhesion molecule 1, CD54) and co-
stimulatory molecules such as CD80 and CD86 are upregulated in the course of maturation. This 
upregulation is a key feature of mature dendritic cells that enables them to successfully activate 
naïve T cells for clonal expansion and differentiation into T cell subsets. In addition, maturation of 
the professional APC is accompanied by the downregulation of endocytosis. After migration into 
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the paracortical T cell zone of the lymph node dendritic cells are attracted to T cells and form 
initial, however transient contacts with them. After recognition of the T cell-specific antigen 
presented by the MHC complex, a more stable interaction can occur, that leads to full activation 
of T cells and is accompanied by clonal expansion and differentiation followed by a phase of 
detachment (Mempel et al. 2004).  
1.1.2  T cell receptor signaling and T cell activation 
Naïve T cells that successfully passed positive and negative selection rounds in the thymus are 
released in the blood stream and enter lymph nodes, where they migrate along fibroblastic 
reticular cell (FC) and DC-networks, respectively (Bajenoff et al. 2006). In the paracortical T cell 
zone they encounter APCs. This contact serves as the starting point in T cell activation. If the T cell 
receptor (TCR) recognizes its specific antigen peptide presented by MHC molecules, a signaling 
cascade is initiated that finally leads to fully activated CD4+ or CD8+T cells, respectively. 
CD4+ T cells differentiate afterwards into T helper cells of the type 1 or type 2, respectively, 
dependent on cytokine stimulation. For TH1 helper cells the activated T cell is dependent on the 
presence of IL-12 that is mainly produced by macrophages and B cells. Activated inflammatory TH1 
cells in turn secrete interferon- (IFN ) and tumor necrosis factor-  (TNF-) for the activation of 
macrophages. Differentiation into TH2 helper cells is dependent on IL-4, secreted by T cells and 
mast cells. After stimulation, these cells secrete IL-4, IL-5, IL-10 and IL-13 and activate B cells for 
the effective production of antibodies for long-term immunity. CD8+ T cells differentiate into 
cytotoxic T cells that clear viral infections by destruction of infected cells. 
In order to establish this activation not only the TCR needs to be involved but furthermore the 
costimulatory molecule B7/CD28. Only if these two receptors are synchronously stimulated, 
T cells can be activated. Sole engagement of the TCR leads to anergy of T cells which is 
characterized by the unresponsiveness of T cells to further stimulation.  
The T cell receptor (TCR) consists of a heterodimer of an α- and a -chain of the immunoglobulin 
superfamily linked by a disulfide-bridge. α- and -chains exhibit a variable immunoglobulin region 
that is located at the extracellular N-terminus followed by a constant transmembrane region and 
a short cytoplasmic tail at the C-terminus. The variable region is responsible for the binding of the 
peptide/MHC complex. Moreover the TCR receptor complex harbors a homodimer of -chains 
and the CD3 complex. The CD3 complex consists of a -CD3 chain, a -CD3 chain and two -CD3 
chains. The latter components of the TCR complex are indispensable for the signal transduction 
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upon peptide/MHC complex recognition, since they possess intracellular signaling domains that 
bear ITAM-motifs (immunoreceptor tyrosine-based activation motifs) and serve as 
phosphorylation sites for kinases that transfer the signal from the outside into the cell. In the - , 
-, and -CD3 chain there is only one ITAM, whereas in the -chain, three ITAMs can be found. 
These motifs are phosphorylated upon TCR ligation and serve as interaction sites for 
phosphotyrosine kinases (PTK) (Chan et al. 1992). This initial phosphorylation of ITAMs is thought 
to occur after a conformational change in the CD3- chain upon TCR ligation which leads to an 
easier accessibility for the lymphocyte-specific protein tyrosine kinase Lck and Fyn (cf. figure 2). 
This in turn leads to the recruitment of ZAP-70 to the signaling complex. ZAP-70 has two major 
target proteins, LAT (linker for the activation of T cells) and SLP-76 (Src homology 2 (SH2) domain-
containing leukocyte phosphoprotein of 76 kDa). The nine tyrosines in LAT are phosphorylated 
after TCR engagement and bind PLC1 (phospholipase C) and PI3K (phosphatidylinositol 3-kinase) 
as well as GRB2 (growth factor receptor-bound protein 2) and Gads (GRB2-related adapter 
downstream of Shc). The latter recruits SLP-76 to phosphorylated LAT. A signaling network is 
formed by the attachment of Vav1, Nck and Itk to the complex.  
 
Figure 2: Signal transduction after TCR engagement. 
Clustering of the T cell receptor leads to intracellular phosphorylation events that initiate a signaling 
cascade ultimately leading to actin rearrangements and the activation of transcription factors (figure taken 
from Koretzky and Myung 2001) 
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The formation of this signaling complex leads to the activation of PLC1 by Itk. Phospholipase C is 
a crucial factor in T cell activation. It catalyzes the hydrolysis of PI(4,5)P2 to the second 
messengers DAG (diacylglycerol) and IP3 (inositol triphosphate). DAG activates two pathways in 
the course of T cell activation. On the one hand DAG activates protein kinase C theta (PKC) which 
regulates NF-B activation. In the course of activation NF-B translocates to the nucleus and 
activates several genes that are involved in homeostasis and survival of T cells. On the other hand, 
DAG activates Ras. Ras is a GTPase that activates Raf1, a MAPKKK (mitogen-activated protein 
kinase kinase kinase) that activates MAPK kinases (MAPKK) that ultimately activate the MAPK 
extracellular signal-regulated kinases ERK1 and ERK2. ERK1/2 activate the AP-1 complex, a 
transcription factor that positively regulates the IL-2 gene. IL-2 is the most important cytokine for 
the activation of T cells. IL-2 secretion leads in an autocrine feedback loop to sustained T cell 
activation and serves as a proliferation signal for the clonal expansion of T cells (Nelson et al. 
1994).  
IP3 signaling occurs mainly via Ca
2+ ions. IP3 receptors on the membrane of the endoplasmic 
reticulum (ER) are activated by the PLC1 product and release Ca2+ ions from the sarcoplasm into 
the cytosol. Increased calcium concentrations in the cytoplasm activate CRAC (calcium release 
activated calcium) channels which open for Ca2+ ion influx into the T cell. Elevated cytosolic 
calcium-ion levels activate calcineurin that dephosphorylates nuclear factor of activated T cells 
(NFAT), a transcription factor that subsequently translocates into the nucleus. Together with AP-1 
it is responsible for the transcription of the IL-2 gene and other genes important for T cell 
activation.  
 
1.2 Adhesion and migration of immune cells 
1.2.1 Integrins in adhesion and migration of immune cells 
Integrins are a family of proteins that serve as adhesion molecules and signal transmitters. They 
are heterodimeric transmembrane receptors that consist of an -chain and a -chain. Thus far, 8 
different - and 18 different -chains are known that can in combination build up to 24 different 
heterodimers. Integrins play a crucial role in the mediation of cell-cell and cell-matrix contacts and 
are therefore important proteins in cellular processes such as wound healing, embryogenesis and 
the extravasation of leukocytes and formation of the immunological synapse (Lauffenburger et al. 
1996; Dustin and Springer 1991; Springer and Dustin 2012).  
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The -chain consists of an I-domain at the N-terminal extracellular site (only nine of the 18 -
chains bear this motif), followed by a seven-bladed -propeller and additional three -sandwich 
domains (named Thigh, Calf1 and Calf2). Furthermore, they consist of a transmembrane region 
and a short cytoplasmic C-terminal tail.  
The -chains contain an N-terminal I-like domain, a -sandwich hybrid domain followed by a 
cystein-rich PSI (Plexin-semaphorin-integrin) domain, four integrin EGF-like domains and a -tail 
domain. Also -chain integrins are inserted in the plasma membrane and bear a short intracellular 
domain which serves as binding site for talin and -actinin (Stanley et al. 2007).  
The integrin signaling is bidirectional and consists of inside-out and outside-in signaling. Inside-out 
signaling refers to the conformational change in the integrin extracellular domain that leads to 
higher binding affinities often accompanied by clustering of the integrin receptors for higher 
binding avidity. Outside-in signaling means the signals that are transduced after binding of 
integrins in their high affinity conformation to its ligands (Abram and Lowell 2009).  
 
Figure 3: Integrin-inside-out signaling in immune cells. 
Before stimulation the integrins are bent in an inactive form with a closed conformation of the - and -
cytoplasmic integrin chains. Upon stimulation of immune cells with chemokine or TCR engagement, several 
kinases are activated that recruit Rap1-GTP and talin to the cytoplasmic tail of integrins, leading to a 
separation of the - and -chain. This in turn, changes the arrangement of the extracellular domains which 
are then in an active and opened conformation. (Abram and Lowell 2009)  
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Inside-out signaling occurs mainly after stimulation of the cell by chemokines or the cross-linking 
of extracellular receptors, e.g. the TCR (cf. figure 3). Engagement of the TCR leads to a signaling 
cascade that ultimately results in the activation of 2-integrins in T cells. Substrate-binding to 
chemokine receptors or TCR activates several signaling cascades that result in the recruitment of 
GTP-loaded Rap1 to the -chain of integrins and talin to the -chain. Talin connects the integrin 
with the actin cytoskeleton and therefore enables physical coupling for forward movement. 
Several other proteins bind to the cytoplasmic tails of integrins upon stimulation which leads to 
the separation of the integrin - and -chain. This cytoplasmic tail separation results in 
conformational changes in the integrin extracellular domain structure converting them into an 
opened and active conformation, that enables binding of adhesion molecules (Abram and Lowell 
2009). 
1.2.2 Cell Migration 
Cell migration serves an indispensable basis for many biological processes. In embryogenesis, 
migration of cells is required for gastrulation and neurulation. In adult organisms migratory 
processes are necessary for wound healing and for the proper functionality of the immune 
system. Furthermore, migration plays a major role in tumor development and cancer progression 
via metastasis (Lauffenburger et al. 1996 ).  
During cell migration, a tight regulation of spatial and temporal development of cell polarity and 
signal transduction is of crucial importance. Migration can be divided into several fundamental 
steps. Forward locomotion of cells is dependent on the formation of membrane protrusions at the 
leading edge (figure 4). Afterwards the cell prolaps attaches to the substrate, e.g. ECM 
(extracellular matrix) or adhesion molecules on cells. Firm adhesion to the substrate in turn serves 
as anchorage for the subsequent contraction of the cell body and nucleus and drives the 
delocalization. The last step in this concerted process is the detachment of the cell at the trailing 
edge (Sheetz 1994).  
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Figure 4: The fundamental steps of cell migration 
Step 1: formation of membrane protrusions and polymerization of actin at the cell front. Step 2: adhesion of 
the protrusion to the substrate by development of focal contacts. Step 3: tension of the cell cortex and 
movement of the cell body. Step 4: Detachment of the cell rear by mechanical force or proteolytic cleavage 
of the focal contacts 
Migration, especially in immune cells is not a random process, but often led by a gradient of 
chemokines which serve as guidance for the directionality of cell movement, a process known as 
chemotaxis. Chemokine sensing leads to the directed formation of membrane protrusions and to 
development of cell polarity (Van and Devreotes 2004).  
Development of cell polarity is mediated by heterotrimeric G protein coupled receptors (GPCR) 
that recognize chemokines and signaling of ECM receptors such as integrins subsequently lead to 
the activation of signaling cascades. These signaling pathways mainly depend on small GTPases of 
the Rho-family, e.g. Rho A, Rac1 and Cdc42. Their function is supported by two classes of proteins. 
GEF proteins (Guanine nucleotide exchange factors) activate Rho-family GTPases by the exchange 
of GDP for GTP. In contrast, GAPs (GTPase activating proteins) inactivate GTPases by facilitating 
the hydrolysis of GTP to GDP. RhoA acts on the leading and the trailing edge of migrating immune 
cells. In transmigrating T cells downregulation of RhoA by RNAi leads to unpolarized cells and 
defects in the retraction of the uropod (Heasman et al. 2010). Rac1 and Cdc42 can be found at the 
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leading edge of migrating cells. They activate the Arp2/3 complex which is necessary for actin 
polymerization and leads to the formation of membrane protrusions. Furthermore, Rac1 activates 
IRSp53 which leads to the formation of a branched actin network (Nakagawa et al. 2003). Cdc42 
and Rac1 positively regulate microtubule orientation and stabilization. Therefore, they interact 
with PAK that phosphorylates Stathmin, a negative regulator of microtubule formation which is 
inactivated upon phosphorylation (Wittmann et al. 2004). By targeting IQGAP1 that translocates 
the microtubule interacting protein CLIP-170 to actin filaments (Fukata et al. 2002), Rac1 and 
Cdc42 serve as providers of an anchorage site at the leading edge of migrating cells. Another 
important factor in the organization of cell polarity are the downstream target of Rho-GTPases of 
the ROCK family and Dia1. ROCK leads to the activation of the LIM-kinase that inhibits cofilin and 
thereby inhibiting actin depolymerization. Dia1 induces stress fibers mainly via interaction with 
src kinases and leads to activation of the Arp2/3 complex by interactions with IRSp53 (Ridley 
2006).  
Leukocytes are able to use integrin–dependent and –independent mechanisms for migration 
according to the surrounding environment (Friedl et al. 1998; Lämmermann et al. 2008). They 
move in an amoeboid manner which enables them to move very fast along the ECM by squeezing 
through it rather than by degrading ECM structures (Mandeville et al. 1997; Friedl and Wolf 2003). 
A further characteristic of amoeboid migration in leukocytes is the lack of strong adhesive 
contacts between the cells and the substrate (Wolf et al. 2003). At the leading edge, a network of 
filamentous actin is rapidly formed and membrane protrusions are probing the surrounding. This 
scanning is accompanied by a local concentration of diverse receptors involved in the 
establishment of signal transduction, e.g. TCR, 2-integrins, Fc- and chemokine receptors. The mid 
region of the migrating cell contains the nucleus and signs responsible for the maintenance of the 
front-rear axis. The trailing edge of the cells contains the uropod and shows a high concentration 
of adhesion receptors, e.g. ICAM-1, 1-integrins and ERM (ezrin radixin moesin)-adaptor proteins, 
which are responsible for the mediation of cell-cell and cell-matrix interaction and is postulated to 
have an anchoring function (Friedl and Weigelin 2008; Wolf et al. 2003). 
In contrast to migration on two-dimensional surfaces, the migration in a three-dimensional 
surrounding is independent of the engagement of integrins (Friedl et al. 1998; Friedl and Weigelin 
2008; Friedl and Wolf 2003; Lämmermann et al. 2008). Locomotion is provided by a dynamic 
actin-flow squeezing the cells through the ECM. The confinement of the ECM itself provides the 
anchorage for the cells to generate forward flow (Lämmermann et al. 2008).  
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1.3 Cytohesin and ARF proteins and their role in immune cell signaling 
In humans and mice there are four known members of the cytohesin-family, namely cytohesin-1, 
cytohesin-2 (ARNO), cytohesin-3 (Grp1) and cytohesin-4. For Drosophila only one homologue of 
this family is known, steppke. Cytohesins serve as guanine nucleotide exchange factors for ADP-
ribosylation factors (ARFs) (Chardin et al. 1996). In vitro, cytohesin-1 interacts with ARF1 and 
ARF6, respectively.  
Initially, ARF proteins were discovered as cofactors in the cholera-toxin mediated ADP-
ribosylation of heterotrimeric G-proteins (Kahn and Gilman 1986). Later on it became clear that 
they are important proteins in vesicular membrane trafficking (Moss and Vaughan 1995). Due to 
similarities in their sequence, ARF-proteins can be grouped in three classes. ARF1, ARF2 and ARF3 
belong to class I ARFs and regulate COPI-coat assembly and the budding of vesicles that are 
transported from the ER to compartments of the Golgi-network. Class II ARFs (ARF4 and ARF5), in 
particular ARF5 might be involved in recruitment of coat-particles to trans-Golgi membranes, 
however, the precise function of class II ARFs remains unclear. ARF6 is the only member of the 
class III ARFs. The protein is localized at the plasma membrane (Peters et al. 1995) and regulates 
clathrin–dependent and –independent endocytosis e.g. of MHC I molecules and integrin 1 
(Brown et al. 2001). ARF6 is capable of activating phosphatidyl 4-phosphate 5-kinase (PIP5K) and 
phospholipase D (PLD) and therefore has an impact on the phospholipid metabolism. It thereby 
leads to actin remodeling via Rac1 (D'Souza-Schorey et al. 1998; Radhakrishna and Donaldson 
1997).  
1.3.1 Structure of cytohesin proteins 
In the main, cytohesin proteins show a highly conserved modular domain structure (cf. figure 5). 
All members possess a coiled-coil domain at the N-terminus, that is responsible for protein 
interactions e.g. with CYTIP (Boehm et al. 2003) and possibly for dimerization of cytohesin 
proteins. The central Sec7 domain bears the catalytic activity responsible for GDP-/GTP-exchange 
on ARF-GTPases (Chardin et al. 1996; Meacci et al. 1997) and furthermore interacts with LFA-1 
(Chardin et al. 1996; Geiger et al. 2000; Kolanus et al. 1996). This interaction leads to an 
enhancement of TCR-mediated adhesion of T cells to the LFA-1 specific ligand ICAM-1 
(intercellular adhesion molecule-1) as part of the inside-out signaling. At the C-terminus, a PH-
domain is located, followed by a polybasic c-domain. The PH-domain is a regulatory element 
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important for the integration of the cytohesin proteins into the plasma membrane (Nagel et al. 
1998). All cytohesin family members have the possibility to be expressed in a diglycine and a 
triglycine variant (Cronin et al. 2004; Klarlund et al. 2000). The diglycine variant shows a high 
affinity to PIP3, which is a phosphorylation product of the PI3-kinase, and is responsible for the 
insertion of cytohesin proteins into the plasma membrane. The triglycine variant is not correlated 
with a high affinity to PIP3, however proteins of the ARF family might serve as regulators of 
membrane recruitment as it is proposed by Hofmann and Cohen. These authors reported, that 
ARL4 and ARF6 are able to translocate proteins of the cytohesin family to the plasma membrane 
independently from the expression of the diglycine or the triglycine variant (Cohen et al. 2007; 
Hofmann et al. 2007). 
 
 
Figure 5: Modular domain structure of cytohesin proteins. 
 
Furthermore, the polybasic C-terminal region in cytohesin-1 and cytohesin-2 contains 
phosphorylation sites. Cytohesin-2 phosphorylation leads to the removal from the plasma 
membrane (Santy et al. 1999). Cytohesin-1 bears phosphorylation sites at position Ser 393, 
Ser 394 and Thr 395 in contrast to cytohesin-3 that is lacking the amino acid sequence leading to 
phosphorylation events (Dierks et al. 2001; Kolanus 2007). Thus, phosphorylation events might 
play a crucial role in the regulation of cytohesin proteins especially regarding the localization and 
differential roles in cell signaling.  
1.3.2 Cytohesin proteins in immune cell signaling 
Cytohesin-1 is ubiquitously expressed in many tissues but very highly expressed in NK cells and 
activated T cells. It was first discovered as an interactor of LFA-1 (L2- integrin) in a yeast-two-
hybrid screen with LFA-1 serving as bait (Kolanus et al. 1996). Further investigation in the same 
study revealed that the interaction between LFA-1 and cytohesin-1 was provided by direct 
interaction of the Sec7 domain of cytohesin-1 and the 2-cytoplasmic tail of LFA-1. Cytohesin-1 is 
a positive regulator for the activation of LFA-1 mediated adhesion in activated T cells and in 
mature MoDCs (Kolanus et al. 1996; Quast et al. 2009). Mainly responsible for this activation is 
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the Sec7 domain of cytohesin-1 and its related GEF-activity since the dominant-negative point 
mutant cytohesin-1 E157K failed in the activation of T cell adhesion to ICAM-1 (Geiger et al. 2000). 
However, overexpression of the C-terminal PH domain of cytohesin-1 only, had a dominant-
negative effect on the activation of LFA-1 mediated adhesion, leading to the conclusion that the 
PH domain could serve as a regulatory element in this context (Kolanus 2007). 
LFA-1 activation is mediated via conformational changes in the integrin’s extracellular domain 
structure. Transition into the high-affinity conformation allowing leukocyte arrest on endothelial 
tissues is a very fast process in which cytohesin-1 is involved in T cells and mature dendritic cells 
(Quast et al. 2009; Weber et al. 2001). 
Correct localization of cytohesin-1 is important for the function of the protein and might be 
guided by the small GTPase ARF6 (Weber et al. 2001). In activated T cells and stimulated mature 
dendritic cells cytohesin-1 is recruited to the plasma membrane. In migrating T cells cytohesin-1 
and ARF6 show differential functions leading to the conclusion that they do not act in the same 
pathway (Weber et al. 2001).  
Another important regulator of cytohesin-1 function in immune cells is CYTIP (cytohesin-
interacting protein, cybr) (Boehm et al. 2003). CYTIP interacts with cytohesin-1 via its coiled-coil 
domain and leads to the removal of cytohesin-1 from the plasma membrane. In this respect, 
CYTIP serves as negative regulator of T cell adhesion by binding cytohesin-1 and therefore 
translocating the protein from the plasma membrane which ultimately results in the abrogation of 
LFA-1 activation (Boehm et al. 2003). 
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Figure 6: Cytohesin-1 in immune cell signaling. 
Cytohesin-1 interacts with the cytoplasmic tail of CD18 and leads to LFA-1 activation. Membrane 
recruitment of cytohesin-1 is mediated by ARF proteins which in turn are activated by the catalytic GTP-
exchange activity of the cytohesin Sec7 domain. Membrane recruitment is negatively regulated by CYTIP. It 
interacts with the coiled-coil domain of cytohesin and leads to its retraction from the plasma membrane. 
Cytohesin-1 activates RhoA and the MAPK cascade resulting in actin structural rearrangements and IL-2 
production, respectively.  
Cytohesin-1 is not only involved in inside-out signaling in T cells by activating LFA-1 after TCR 
engagement, but also important for outside-in mediated signals leading to T cell activation and 
proliferation. This can be concluded from experiments in which cell spreading was investigated 
(Geiger et al. 2000). Jurkat T cells that overexpress cytohesin-1 induced cell spreading when 
plated on ICAM-1 coated surfaces. In contrast to cells, that overexpressed the dominant-negative 
cytohesin-1 E157K mutant, which were unable to spread. This finding clearly underlines the role 
of the Sec7 domain as a central component of the outside-in signaling cascade. However, the 
cytohesin-1 E157K mutant does not influence the expression of the mAb24 activation epitope in 
LFA-1. Furthermore Perez could show that activation of LFA-1 resulted in the phosphorylation of 
cytohesin-1 and the activation of the c-Jun and ERK1/2 pathway (Perez et al. 2003). The 
cytohesin-1 dependent activation of the MAPK signaling cascade was also described by Kliche who 
further investigated in the involvement of the GEF-activity of cytohesin-1 in ERK1/2 activation 
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(Kliche et al. 2001). Overexpression of Kaposin A, a component of human Herpesvirus 8 (HHV8), 
was able to activate ERK1/2 signaling leading to activation of the AP-1 response element in 
293 cells. Activation of AP-1 only occurred when cytohesin-1 wildtype was overexpressed but not 
when the GEF-inactive E157K mutant was overexpressed. Activation of the MAPK signaling 
cascade is ultimately linked to genetic programs as cell survival and proliferation.  
AP-1 is part of the promoter region of the IL-2 gene and IL-2 production is a hallmark of T cell 
activation. Cytohesin-1 is a positive regulator of IL-2 gene transcription and therefore of T cell 
activation, most likely via the ERK1/2 signaling route. It could be demonstrated that cytohesin-1 
positively regulates ERK1/2 phosphorylation and activates AP-1 (Paul 2007). Furthermore, 
cytohesin-3, which is upregulated in anergic T cells (Korthauer et al. 2000), inhibits AP-1 and 
therefore, IL-2 gene transcription ultimately enhancing the unresponsive state of anergic T cells 
(Paul 2007).  
Another involvement of cytohesin-1 in immune cell signaling was recently demonstrated by Quast 
et al. (cf. figure 6). Cytohesin-1 is a positive regulator of RhoA activity in dendritic cells as well as 
in HeLa cells (Quast et al. 2009). This activation is PI3-kinase-dependent and can be blocked by the 
employment of the PI3-kinase inhibitor LY-294002 (Quast et al. 2009). PI3-kinase is activated in 
the course of events after TCR-engagement in T cell activation. PI3-kinase phosphorylates its 
target PIP2 and increases thereby the PIP3-content of the plasma membrane leading to plasma 
membrane recruitment of proteins via their PH domains. Especially the diglycine variant of 
cytohesin proteins has a high affinity for PIP3 and can be regulated by PI3-kinase. Furthermore, 
PI3-kinase negatively regulates the expression of cytohesin-3 in peripheral blood lymphocytes 
(PBL) (Paul 2007). Interestingly, in insulin signaling cytohesin-3 and its homologue steppke is 
located upstream of PI3-kinase in Drosophila as well as in murine and human insulin signaling, 
respectively (Hafner et al. 2006; Fuss et al. 2006) 
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1.4 Specific inhibition of protein function 
Proteomics is the science concerned with the identification of protein functions in biological 
processes. This field emerged and gained further importance as a consequence of unraveling the 
human genome. Proteins are the key players in almost every cellular process, including signal 
transduction, transport of ions and second messengers and building structures in the cell.  
Investigating protein function and their interplay in a physiological background is challenging, and 
different approaches that aim to target inhibition of protein expression or function are available 
at the present time.  
A complete exclusion of the protein of interest can be achieved by knockout technology. In this 
approach the genetic information of a protein is eliminated from the genome by deleting an exon 
of the gene of interest or by creating a frame shift in the gene locus that leads to a stop signal and 
therefore the genetic information is not or only partially translated. Gene knockout is created by 
recombining a reporter gene into the gene locus of interest in embryonic stem cells. After 
successful recombination the embryonic stem cells can be transferred into a murine blastocyst of 
pseudopregnant surrogate mothers. This leads to the development of a chimera with a 
homozygous manipulated gene locus. For full gene knockout, the chimeric animals have to be 
crossed to produce a homozygous animal. The phenotype of the desired knockout or knock-in is 
then investigated in the organism in whole or in some tissues or cell types. Creating a knockout or 
knock-in organism, respectively, can be very time consuming and costly, especially in higher 
developed organisms since breeding periods are long and the genetic manipulation has to be 
germline transmissive. Furthermore, the outcome is uncertain since there is the possibility that 
the deletion of a gene could lead to lethality in early steps in development. This can be overcome 
by creating conditional knockout animals by tissue- or cell-type specific recombination into CRE-
mice. These mice express CRE-recombinase in a tissue-specific manner. Injection of tamoxifen 
then leads to recombination in the selected tissue and creates a partial knockout. A further 
drawback in this approach is, that multifunctional proteins which possess binding sides for more 
than one interacting protein, are completely removed so that there is no facile way to investigate 
a separable function of the protein without leaving other functions untouched.  
Another technology used for the analysis of protein function is the employment of short 
interfering RNA (siRNA technology). This method takes advantage of a common mechanism within 
the cell: After the transcription of the gene into mRNA, this single stranded ribonucleic acid can be 
degraded when bound within the RISC (RNA-induced silencing complex) to its complementary 
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sequence. Thereby a downregulation of protein expression is achieved. Introduction of RNA 
complementary to the mRNA of the protein of interest can therefore lead to a downregulation of 
the desired protein content in the organism.  
RNAi technology provides a very useful tool in the investigation of protein function, because the 
gene of interest can be specifically targeted and this method is applicable to almost every 
transfectable cell type in vitro. Furthermore, in comparison to knockout strategies, this technique 
is faster and less cost intensive. Nevertheless, there are some disadvantages in this method. The 
use of RNAi is not suitable for proteins that have a long-time turnover, because the protein is 
targeted indirectly and in order to gain sufficient knockdown efficiencies, the proteins that are 
already produced, have to be degraded first. Furthermore, siRNA transfections are only transient 
and knockdown efficiency is only of short duration especially in fast dividing cells. Sometimes the 
downregulation of the protein is incomplete and therefore the loss of function cannot be 
observed, because even small amounts of the protein are sufficient to remain the functionality in 
the investigated context. Furthermore, particularly in immune cells, transfection can lead to cell 
activation as a side effect by the activation of TLRs (Toll-like receptors) (Hornung et al. 2005; Heil 
2004; Diebold 2004), mainly TLR 3, 7 and 8. This hurdle can be overcome by substitution of the 2’-
hydroxyl-group with a 2’-O-methyl-group (Judge et al. 2006). The modification has an 
immunosuppressive activity leading to both, downregulation of the desired gene product and 
avoidance of undesired upregulation of inflammatory responses. Another obstacle in the 
employment of siRNA technology is the absence of a reliable delivery system in vivo. To date 
there is no possibility to introduce small interfering RNAs into whole mammalian organisms or 
deliver it for long-term application. 
Another opportunity to effectively inhibit protein function in vitro and in vivo is provided by the 
use of small molecules as inhibitors of cellular processes. Small molecules play a major role as 
second messenger molecules, e.g. cAMP.  
The approach to selectively target a protein of interest by means of the addition of organic 
molecular probes is termed “chemical genetics” (O' Connor et al. 2011). This method is applicable 
in whole organisms, cell types and single cells. Advantages of the use of small molecules as 
inhibitors of protein function are versatile. During the last decade a plethora of small organic 
molecules has been developed and applied to investigate protein functions in vivo and in vitro. 
Small compounds are easy to apply to organisms by injection or to cultured cells and enter the 
cells quickly due to their hydrophobicity. Small molecule compounds can also easily be removed 
from cell culture by washing it out. This can provide the opportunity to investigate kinetics of 
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protein turnover. Furthermore, specific sites of protein function can be targeted while other 
functions of the protein are left untouched. This offers the advantage of focusing on separate 
pathways the protein might be involved in. Another advantage of the system is that different 
concentrations can be used. In comparison, a knock-out of a complete gene or even gene family 
can result in impacts on several pathways. If the concentration of the inhibitor is chosen carefully, 
it can result in phenotypes comparable to a partial gene knockout and might provide information 
about dose response relations.  
The biggest benefit from using small molecules as tools for inhibition of protein function however 
might arise from the opportunity to use it as drugs in the treatment of diseases. Since it is possible 
to design small molecules for almost all kinds of proteins, specific disease resulting from 
overproduction or overfunctionality of proteins might be targeted. In contrast to therapeutic 
antibodies that are also very specific for the abrogation of protein-protein interaction and hence 
provide a versatile tool for the cure of specific diseases, small molecules are cell-permeable and 
therefore not only restricted to targeting cell surface receptors. However, also in the use of small 
molecules some disadvantages have to be taken into account. On one hand there is always the 
risk of toxicity of the compound itself or by products that develop during metabolism of these 
compounds. On the other hand the solubility of compounds can cause problems in the 
bioavailability, because organic molecules tend to build aggregates in hydrophilic surrounding. 
These major disadvantages might be overcome in parts by adding functional groups to the 
molecule that lead to higher solubility of the compound without affecting target specificity and 
functionality. Adding reporter groups to the molecule can be also very useful for the in vitro and 
in vivo investigation of protein function. For example, using compounds with fluorophores could 
provide information about spatio-temporal distribution of the target protein in the living cell if the 
protein of interest cannot be targeted directly by overexpression of a fusion protein or if 
overexpression in this context leads to undesired side effects.  
In summary, all these techniques have their merits and demerits notwithstanding small molecules 
have some key advantages especially regarding their potential as starting points for the 
development of therapeutics. 
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Secin H3, a novel small molecule inhibitor for cytohesin function 
Inhibition of the ARF-GEFs of the cytohesin family was impossible for a long time. The ARF-
inhibitor Brefeldin A was known and its mode of action was investigated and unraveled 
(Mossessova et al. 2003; Nebenfuhr et al. 2002), however, it was ineffective in the inhibition of 
cytohesins. Recently Hafner et al. identified a small organic molecule effective in the inhibition of 
cytohesin GEF function towards ARF-GTPases (Hafner et al. 2006). In a very elegant approach, an 
aptamer, namely M69, that binds to cytohesins was fluorescently labeled and several compound 
libraries were screened for their ability to displace this aptamer, revealing a better and specific 
binding to cytohesin proteins, resulting in an increase of fluorescence by the released aptamer. 
With the help of this aptamer-displacement assay, the novel small molecule inhibitor Secin H3 
(Sec7 inhibitor H3, inhibitor of cytohesin function) could be identified. Secin H3 was able to inhibit 
GTP-exchange towards ARF1 and ARF6 for cytohesin-1, -2 and -3 without affecting Golgi-network 
structures (Hafner et al. 2006). Furthermore, with the help of this small molecule inhibitor, 
cytohesin proteins could be linked to non-immune insulin signaling in humans and in Drosophila 
(Fuss et al. 2006; Hafner et al. 2006), and to Erb receptor signaling (Bill et al. 2010).  
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2 Materials and Methods 
2.1 Materials 
2.1.1 Equipment 
Autoclave Model 135T H+P (Oberschleißheim) 
Avanti J‐20XP Beckman Coulter (München) 
Biofuge fresco Heraeus instrument GmbH (München) 
Biofuge pico Heraeus instrument GmbH (München) 
Centrifuges Multifuge 4KR Heraeus instrument GmbH (München) 
CO2‐Incubator  Binder (Great River, USA) 
Dual channel SPR 7600DC Reichert Technologies (Depew, USA) 
Electronic balance College MettlerToledo (Greifensee, Switzerland) 
Electrophoresis chambers perfect blue gel 
system  
Peqlab (Erlangen) 
Electroporation device GenePulser Xcell + CE 
module 
Biorad (München) 
FACS Canto II BD (Heidelberg) 
Fluorescence‐ and absorption analyzer Synergy 
HT 
MWG (Ebersberg) 
Fluorescence microscope Eclipse TE2000- NIKON (Tokyo, Japan) 
Gel dryer Model 583 BioRad (München) 
Heat block Thermo mixer compact Eppendorf (Hamburg) 
Horizontal shaker Rocky Fröbel Labortechnik GmbH (Lindau) 
Laminar flow hood type 2 for cell culture 
Euroflow  
Thermolife (Woerden, Netherlands) 
Luminometer Microlumat plus LB 96V  Berthold (Bad Wildbad) 
Magnetic stirrer ARE VELP scientific (Milan, Italy) 
MicroPorator, MP‐100 system  Peqlab (Erlangen) 
Light microscope DMIL  Leica (Wetzlar) 
Nucleofector Amaxa (Köln) 
Oligonucleotide purification columns Quant 96 
G‐50 micro columns 
GE Healthcare (München) 
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Optima LE‐80K Ultracentrifuge Beckman Coulter (München) 
pH meter MP220  Mettler Toledo (Greifensee, Switzerland) 
Photometer Biophotometer Eppendorf (Hamburg) 
Pipette controller Pipetus‐Akku  Hirschmann Laborgeräte (Eberstadt) 
Pipettes Pipetman P2, P20, P100, P200, P100  Gilson (Middleton, WI, USA) 
Power supplies for electrophoresis Elite300Plus Schütt Labortechnik (Göttingen) 
Precision balance  Mettler Toledo (Greifensee, Switzerland) 
Protein‐Minigel‐Apparature  BioRad(München) 
Protein‐Transfer‐Apparature  BioRad (München) 
Sonifier GM300 Bandelin (Berlin) 
Vortex Zx3 VELP scientifica (Mailand, Italy) 
Water bath Type 1004  GFL (Burgwedel) 
WS 5 rocker Edmund Bühler (Hechingen) 
2.1.2 Consumables 
Cell culture dishes (10 cm)  Greiner Bio‐one (Frickenhausen) 
Cell culture flasks (175/75/25 cm2) Greiner Bio‐one (Frickenhausen) 
Cell culture plates (6‐well, 12‐well, 24‐well)  Greiner Bio‐one (Frickenhausen) 
Cell scraper  Sarstedt (Nümbrecht) 
Cellophane membrane  BioRad (München) 
Chip SPR HC1500m Xantec bioanalytics GmbH (Düsseldorf) 
Disposable hypodermic needle, (0.4x20 mm) 
Sterican 
 Braun (Melsungen) 
Electroporation cuvettes (4 mm)  BioRad (München) 
FACS tubes  BD Falcon (Heidelberg) 
Filter paper Whatman Nr. 4  Schleicher & Schuell (Dassel) 
Filter paper used for EMSA (gel drying) BioRad (München) 
Filter tips (10 μL, 200 μL, 1000 μL) Starlab (Ahrensburg) 
Microtiter plates (96‐well)  Nunc (Roskilde, Denmark) 
Nitrocellulose membrane PROTRAN  Schleicher & Schuell (Dassel) 
Nylon cell strainer (40 μm pore)  BD Biosciences (Heidelberg) 
Polypropylene reaction tubes (0.5/1.5/2.0 mL)  Starlab (Ahrensburg) 
Radiographic film HyperfilmTM MP,  GE Healthcare (München) 
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Sterile filters (0.2 μm/0.45 μm)  Schleicher & Schuell (Dassel) 
Syringe, 10 mL  Braun (Melsungen) 
2.1.3 Reagents 
Acrylamide, 40%  Roth (Karlsruhe) 
Acrylamide/Bisacrylamide‐Mix, 30%  Roth (Karlsruhe) 
Adenosine 5`‐triphosphate, [γ-32P], 10 mCi/mL  Perkin Elmer (Massachusetts, USA) 
Ammonium peroxodisulfate (APS)  Roth (Karlsruhe) 
Anhydrotetracyline  IBA-technologies (Göttingen) 
BCA‐Reagent solutions  Pierce (Rockford, USA) 
Bovine serum albumin (BSA)  Roth (Karlsruhe) 
Bromophenol blue  Roth (Karlsruhe) 
Dimethyl sulfoxide (DMSO)  Roth (Karlsruhe) 
Dithiothreitol (DTT)  Roth (Karlsruhe) 
DNA loading buffer with ficoll, 6x  Roth (Karlsruhe) 
ethylene diamine tetraacetic acid (EDTA)  Roth (Karlsruhe) 
ethylene glycol tetraacetic acid (EGTA)  Roth (Karlsruhe) 
Ethanol  Roth (Karlsruhe) 
Ethidium bromide  Roth (Karlsruhe) 
Ficoll, human (Pancoll)  PAN Biotech GmbH (Aidenbach) 
Fibrinogen Sigma (Taufkirchen) 
G418 sulfate  PAA (Pasching) 
Gentamicin  Gibco (Eggenstein) 
Glucose  Roth (Karlsruhe) 
Glycine  VWR (Darmstadt) 
Glycerin  Roth (Karlsruhe) 
Glycerolphosphate  Sigma (Taufkirchen) 
GM‐CSF, murine (recombinant) R&D Systems (Wiesbaden), Immunotools 
(Friesoythe) 
Guanosine 5’‐triphosphate sodium salt (GTP) Sigma (Taufkirchen) 
4‐(2‐hydroxyethyl)‐1‐piperazine-ethanesulfonic 
acid (HEPES) 
Roth (Karlsruhe) 
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HRP detection system ECL Western Blotting 
Analysis  
Thermo Scientific (Rockford, IL, USA) 
Hydrochloric acid (HCl)  Roth (Karlsruhe) 
ICAM‐1‐Fc supernatant from CV‐1 cells over-
expressing ICAM‐1‐Fc fusion protein 
 
Igepal  
Sigma (Taufkirchen) 
Imidazole Roth (Karlsruhe) 
Lipopolysaccharide (LPS)  Sigma (Taufkirchen) 
L‐Glutamine  Gibco (Eggenstein) 
Luciferase substrate  Promega (Mannheim) 
Magnesium chloride (MgCl2)  Roth (Karlsruhe) 
2‐Mercaptoethanol  Roth (Karlsruhe) 
Methanol  Roth (Karlsruhe) 
Milk powder  Roth (Karlsruhe) 
Non essential amino acids  Sigma (Taufkirchen) 
Ni-NTA QIAGEN, Hilden 
Penicillin/Streptomycin  GIBCO (Eggenstein) 
Phenylmethanesulphonylfluoride (PMSF)  Sigma (Taufkirchen) 
12‐O‐Tetradecanoylphorbol‐13‐acetate (PMA)  Sigma (Taufkirchen) 
Potassium chloride (KCl)  Roth (Karlsruhe) 
2‐Propanol  Roth (Karlsruhe) 
Protease inhibitors Antipain, Aprotinin, 
Benzamidine, Leupeptin, PMSF 
Sigma (Taufkirchen) 
Protein A‐SepharoseTM 6MB  GE Healthcare (München) 
Precision Plus Protein All Blue Standard BioRad (München) 
Secin 16, ZINC ID 00843734 ASINEX (Moscow, Russia) 
Secin 144, ZINC ID 08188318 Vitas-M Laboratory (Moscow, Russia) 
Secin H3  Calbiochem (Darmstadt) 
Sodium dodecyl sulfate (SDS)  Roth (Karlsruhe) 
Sodium fluoride (NaF)  Sigma (Taufkirchen) 
Sodium hydroxide (NaOH)  Roth (Karlsruhe) 
Sodium orthovanadate (Na3VO4)  Sigma (Taufkirchen) 
Sodium pyrophosphate (Na4P2O7)  Sigma (Taufkirchen) 
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Sucrose  Roth (Karlsruhe) 
TBE‐buffer, 10x  Roth (Karlsruhe) 
TEMED  Roth (Karlsruhe) 
Tetra‐sodium‐diphosphate decahydrate  Roth (Karlsruhe) 
Tris‐[hydroxymethyl]aminomethane (Tris)  Roth (Karlsruhe) 
Triton X‐100  Roth (Karlsruhe) 
Trypan blue solution, 0.4%  Sigma (Taufkirchen) 
VCAM‐1‐Fc supernatant from HEK293T cells 
over-expressing VCAM‐1‐Fc fusion protein 
 
 
2.1.4 Kits 
MidiMACS Separator Kit  Miltenyi Biotec GmbH (Bergisch Gladbach) 
CD4+ T Cell Isolation Kit II, human Miltenyi Biotec GmbH (Bergisch Gladbach) 
CD8a+ T Cell Isolation Kit II, mouse Miltenyi Biotec GmbH (Bergisch Gladbach) 
CD11c MicroBeads, mouse Miltenyi Biotec GmbH (Bergisch Gladbach) 
 
2.1.5 Media, sera and buffers 
DMEM, high glucose  PAA (Pasching) 
HBSS  PAA (Pasching) 
PBS  PAA (Pasching) 
RPMI 1640  Gibco (Eggenstein) 
VLE‐RPMI 1640  Biochrom (Berlin) 
 
2.1.6  Enzymes 
T4 DNA ligase  MBI Fermentas (St. Leon‐Rot) 
Shrimp Alkaline Phosphatase (SAP)  Roche (Mannheim) 
Restriction enzymes  MBI Fermentas (St. Leon‐Rot), 
RNase A Roche (Mannheim) 
Phusion Polymerase Thermo Scientific (Rockford, IL, USA) 
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2.1.7 Antibodies 
The following primary antibodies were used against human antigens: 
Primary Antibody  Dilution Supplier 
Goat anti‐human IgG  1:100 (coating)  Dianova (Hamburg) 
Rabbit anti‐human actin  1:1000 (WB)  Sigma (Taufkirchen) 
Rabbit anti‐human phosho ERK1/2  1:1000 (WB)  Cell Signaling (Danvers, USA) 
Rabbit anti‐human ERK1/2  1:1000 (WB)  Cell Signaling (Danvers, USA) 
Mouse anti‐human CD3 (clone OKT3)  5 μg/mL  LGC Promochem, ATCC (Wesel) 
Mouse anti‐human CD28  1 μg/mL (stimulation)  BD Biosciences PharMingen 
(Heidelberg) 
 
The following secondary antibodies were used for flow cytometry analysis of human cells and for 
western blot analysis: 
Secondary Antibody  Dilution  Supplier 
HRP‐Donkey‐anti‐Rat‐IgG  1:5000 (WB)  Santa Cruz (St. Cruz, USA) 
HRP‐Goat‐anti‐Rabbit‐IgG  1:5000 (WB)  Santa Cruz (St. Cruz, USA) 
HRP‐Goat‐anti‐Mouse‐IgG  1:5000 (WB)  Santa Cruz (St. Cruz, USA) 
FITC‐Sheep‐anti‐Mouse  1:200 (FACS)  Dianova (Hamburg) 
2.1.8 Oligonucleotides and plasmids 
2.1.8.1 DNA oligonucleotides 
All oligonucleotides were synthesized by Eurofins MWG Operon (Ebersberg). 
primer sequence  5’ – 3’   
pASK_C1Sec7_for GCGGGGCTCGAGATGGAAAACCTGGGATCCACA 
pASK_C1Sec7_rev GCGGGGAAGCTTTTTAAGTGTGAGTGAGGTCATT 
pASK_C2Sec7_Mlu_f GCGGGGACGCGTATGGTGGAGGGGCTGGAGGCCAATGAGGGC 
pASK_C2Sec7_Not_r GCGGGGGCGGCCGCTTTAGGTGTGGGTCAGGTCATTCCCGTC 
pASK_C3Sec7_Mlu_f GCGGGGACGCGTATGATCGACAATCTAACTTCCGTAGAGGAG 
pASK_C3Sec7_not_r GCGGGGGCGGCCGCTTTAGGTGTGGGTCAGGTCGTTCCCGTC 
pASK_C4Sec7_Mlu_f GCGGGGACGCGTATGATCGACTGCTTCGAGAGTGCGGAGGAG 
pASK_C3Sec7_not_r GCGGGGGCGGCCGCTTTAGGTGTGAGTGAGGTCATTGCCGTC 
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Arf1(17N)_Nde_f GCGGGGCATATGCGCATCCTCATGGTGGGCCTG 
Arf1_XhoI_r GCGGGGCTCGAGTTTACTTCTGGTTCCGGAGCTGATT 
 
2.1.8.2 Plasmids 
Expression constructs were cloned into the pASK IBA43 plus vector and commonly bear an 
amino‐terminal hexahistidine‐tag. The Sec7 domain (amino acids 49-249) of human cytohesin-1 
and 17N ARF1 (amino acids 18 - 181) were inserted into the MCS using the restriction enzymes 
XhoI and HindIII which leads to the deletion of the C-terminal strep-tag.  
2.1.9 Bacteria strains 
Strain Genotype Application Reference 
BL21  B F- ompT hsdSB (r
-
B m
-
B) gal dcm (DE3) 
(Camr) 
 
Expression of 6xHIS 
fusion proteins 
Studier and 
Moffat, 1986 
MC1061  araD139, Δ(ara‐leu)7696, galE15, galK16, 
Δ(lac)χ74, rpsL(Str
I), hsdR2 (mκ
−mκ
−), mcrA, 
mcrB (P3)additional with yeast plasmid p3: 
kann, bla(amp)-am, tet-am 
 
Amplification of 
plasmids  
(p3): CDM constructs 
Casadaban and 
Cohen, 1980 
DH5α  endA1, hsdR17(rκ
−mκ
+), supE44,thi1, recA1, 
gyrA, (Nalγ), relA1 
Amplification of 
plasmids 
Hanahan, 1983 
2.1.10 Primary cells 
Human peripheral blood lymphocytes (PBL) were isolated from buffy coats of healthy blood 
donors. The Institute of Experimental Hematology and Transfusion Medicine of the University of 
Bonn kindly provided the buffy coats. 
Murine bone marrow-derived dendritic cells (BmDC) were prepared from bone marrow of six to 
eight weeks old WT C57BL/6 mice. 
HUVECs were a kind gift from George Whitesides. 
Isolation of primary cells was approved by the local Ethics Committee. 
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2.1.11 Cell lines 
Cell type  Description 
Jurkat E6.1  human T cell‐line from patients with acute leukemia (ATCC) 
TAg Jurkats  stable transfectant line expressing SV40 large T‐antigen 
CV-1 monkey kidney cell line 
HEK293T Human embryonic kidney cell line expressing the SV40 large T-antigen 
 
2.1.12 Mice 
WT C57BL/6 inbred mouse strain expressing the MHC class I haplotype H2Kb were purchased 
from Charles river laboratories. Animal care and experiments were done in compliance with 
institutional guidelines and the German law for Welfare of Laboratory Animals. For all 
experiments mice between six to eight weeks of age were used. 
2.2 Methods 
2.2.1 Molecular Cloning 
2.2.1.1 PCR 
In order to amplify DNA fragments, polymerase chain reaction (PCR) was used. This is the 
standard method for the enzymatic amplification of DNA. The chain reaction is divided into three 
parts characterized by different temperatures. First, the desired DNA fragment is reversely 
denatured by applying temperatures of 95°C. Oligonucleotides (primers) subsequently anneal to 
the sequence specific complement region of single-stranded DNA. The temperature for this step is 
dependent on the nature of the oligonucleotide and usually is between 55 and 65°C. In a final 
step the polymerase elongates the complement strand by adding free nucleotides to the 3’ end of 
the primer at a temperature of 72°C. In each cycle the DNA template is theoretically duplicated. 
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A 50 µL reaction mix for PCR contained the following ingredients: 
DNA template  200 ng 
5 x Buffer  10 μl 
dNTP Mix (2.5 mM) 5 µL 
10 pmol forward primer  1 μl 
10 pmol reverse primer  1 μl 
Taq Polymerase  0.5 μl 
Ad 50 µL H20 bidest.  
2.2.1.2 DNA precipitation 
In order to clear the DNA from enzymes and unbound nucleotides, the PCR reaction mix was 
phenol-chloroform extracted by adjusting the volume to 400 µL with A. bidest. 300 µL 1:1 phenol-
chloroform mix was added. The solution was vortexed and spun down to separate the aqueous 
phase from the organic phase. DNA was precipitated with 40 µL 4 M lithium chloride and 1 mL 
100% ethanol at -20°C for 20 minutes. The mix was then centrifuged for 12 minutes at 4°C in a 
micro centrifuge at 13000 rpm. The pellet was washed carefully with 70% ethanol and dried. 
Finally, the DNA was dissolved in a 40 µL of A. bidest.  
2.2.1.3 Analysis of DNA by restriction digest 
In order to obtain cut products ready for the ligation in the desired vector and to prepare the 
vector backbone for ligation the DNA has to be digested by restriction endonucleases. Therefore 
40 µL of cleaned PCR product or 3 µg plasmid DNA, respectively were mixed with 5 µL of the 
adequate 10x restriction buffer suitable for the chosen enzyme and 1 µL of the enzyme. The final 
volume was adjusted to 50 µL and the digest mix was incubated at 37°C for one hour.  
2.2.1.4 Removal of 5’phosphate ends in plasmid vectors 
To avoid self-ligation of the plasmid backbone the 5’phosphate was removed by incubating the 
digestion mix with 1 U of shrimp alkaline phosphatase (SAP) and 5.7 µL of 10x SAP-buffer for 
additional 10 minutes at 37°C. 
2.2.1.5 Purification of DNA fragments 
For the removal of proteins and undesired DNA fragments after the restriction digest, the DNA 
was loaded onto a low melting agarose gel and separated by electrophoresis. After separation the 
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desired fragments were excised under UV-light and the gel block was melted and diluted with 
40 µL H2O bidest to set the DNA free from the agarose. 
2.2.1.6 Ligation and transformation 
The ligation of the vector backbone and the insert generates a new plasmid which contains the 
information for the expression of proteins. The complementary ends of plasmid and DNA-insert 
are fused to each other with the help of T4 DNA ligase which links the 3’OH group of the vector to 
the 5’phosphate group of the insert. Vector and insert were used at a ratio of 1:3. The reaction 
contained additionally 1 µL T4 DNA ligase and 2 µL 10x ligation buffer the final volume was 
adjusted to 20 µL with H20 bidest. The reaction was performed at room temperature for 2 hours. 
2.2.1.7 Transformation of chemo-competent E. coli cells 
E. coli are used to amplify the plasmid DNA or to recombinantly express protein encoded by the 
transformed plasmid. For the transformation chemo-competent bacteria were carefully thawed 
on ice and 70 µL of the cell suspension was mixed with either 1 µL of plasmid DNA or 10 µL of 
ligation mix and incubated for 10 minutes on ice. Cells were then heat-shocked for 3 minutes at 
37°C and subsequently incubated on ice for 5 minutes. The transformed bacteria were incubated 
with 1 mL LB-medium without antibiotics for 30 minutes at 37°C and plated on LB-agar containing 
the appropriate antibiotic for the selection of the plasmid. 
2.2.1.8 Isolation of plasmid DNA 
Minipreparation 
The mini preparation is a method for isolation of plasmid DNA from bacteria from a small volume 
of bacterial culture. 2 mL of an overnight culture in LB‐medium containing the corresponding 
selective antibiotic were pelleted at 20000 x g and resuspended in 250 μL solution I. Then, 250 μL 
of solution II were added in order to lyse the bacteria. Precipitation of the chromosomal DNA 
occurs when 350 μL solution III were added to the sample. Afterwards, the sample was 
centrifuged at 20000 x g for 15 minutes in order to separate chromosomal DNA, RNA and proteins 
from plasmid DNA. 700 μl of supernatant were mixed with phenol and aqueous and organic phase 
were separated by centrifugation at 20000 x g for 5 minutes for extraction of remaining proteins. 
By adding 0.7 volumes of isopropanol and incubating the mix at – 20°C for 20 minutes, plasmid 
DNA was precipitated. The DNA was pelleted by centrifugation at 20000 x g for 10 minutes. The 
pellet was subsequently washed with 70% ethanol and 100% ethanol, respectively dried and 
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resuspended in 50μl A. bidest. The remaining RNA was hydrolyzed by adding 10 μg RNase A to the 
sample. 
Solution I  Solution II Solution III 
10 mM EDTA 2 M NaOH 2.5 M KOAc 
25 mM Tris-Cl (pH 8.0) 1% (w/v) SDS 2.5 M HOAc (pH 4.7) 
 
Maxipreparation 
To gain high amounts of very pure plasmid DNA, maxipreparations were performed. A 
maxipreparation follows initially the same procedure as a minipreparation, followed by an 
additional purification of the DNA by a CsCl density gradient centrifugation. Bacteria from 1 liter 
overnight culture in LB-medium with the respective selective antibiotics were pelleted at 5000 x g 
for 20 minutes. The pellet was resuspended in 40 mL solution I. Alkaline lysis was achieved by 
adding 80 mL solution II. 40 mL solution III was added subsequently to neutralize the mix and the 
precipitate was pelleted at 5000 x g for 10 minutes. The supernatant was filtered and DNA was 
precipitated by adding 100 mL isopropanol and centrifuging for 10min at 5000 x g and 4°C. The 
pellet was then dried and solved in 4 mL solution I containing 5.5 g CsCl and 500 µL ethidium 
bromide. The solution was centrifuged for 5min and 5000 x g and the supernatant was then 
loaded into an ultracentrifugation tube. The mix was centrifuged for 4 hours at 50000 x g in an 
ultracentrifuge. The DNA band was isolated and contaminating ethidium bromide was removed 
by for consecutive extracting steps with n-butyl-alcohol. DNA was precipitated by adding an equal 
volume of 1 M ammonium acetate and two volumes of ethanol. Precipitated DNA was pelleted by 
a centrifugation at 5000 x g at 4°C. The pellet was washed with 70% ethanol and 100% ethanol 
and dried overnight. It was resuspended in 500 – 1000 µL A. bidest depending on the size of the 
pellet.  
2.2.1.9 Quantification of plasmid DNA 
The concentration of DNA solutions was determined, by measuring the absorbance at 260 nm, 
using an Eppendorf photometer. 
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2.2.2 Cell culture 
2.2.2.1 Cell counting 
10 μL cell suspension were mixed with an adequate amount of trypan blue staining solution to 
detect dead cells and applied to a Neubauer counting chamber. Determination of total cell 
number was performed by counting four large squares. The total cell number was calculated by 
the formula: 
No. of cells counted  / 4· dilution factor ·10
4
= cell number/mL 
2.2.2.2 Cell cultivation 
Jurkat T‐cells were grown in RPMI 1640 supplemented with 10% heat‐inactivated FCS and 
10 μg/mL gentamicin at 37°C in an incubator, containing 5% CO2 and were splitted three times per 
week to a titer of 2 x 105 cells/mL.  
2.2.2.3  Generation of human PBL 
PBL were prepared from standard buffy coat preparations of healthy blood donors by Ficoll 
density gradient centrifugation. Hence, the buffy coat was diluted with prewarmed 2 mM 
EDTA/PBS in a 1:1 ratio and 30 mL of diluted blood were then overlaid on 15 mL Ficoll in a 
50 mL-tube. Cells were then centrifuged at 800 x g for 30 minutes at RT in a swinging‐bucket rotor 
without brake. After centrifugation a ring of PBMCs (peripheral blood mononuclear cells) became 
visible in the interphase between Ficoll and serum. The PBMC fraction, containing monocytes and 
lymphocytes, was carefully transferred into a fresh 50 mL tube. The cells were diluted with 2 mM 
EDTA/PBS to a volume of 50 mL and centrifuged at 640 x g for 7 minutes at room temperature. 
The cells were washed until the pellet became white, decreasing the centrifugation speed 
successively from 640 x g to 200 x g, in order to clear the cells from contaminating erythrocytes 
and platelets. The pellet was then resuspended in 5 mL VLE‐RPMI supplemented with 10% 
heat‐inactivated FCS and 1% Penicillin/Streptomycin for cell counting. A concentration of 5x106 
cells per mL was adjusted with supplemented medium. Isolated PBMCs were seeded in 6‐well 
plates (5 mL cell suspension /6‐well) and allowed to adhere for 1‐2 hours at 37°C in an incubator 
with 5% CO2-atmosphere. Afterwards, the supernatant, containing the non‐adherent lymphocytes 
(peripheral blood lymphocytes, PBL) was collected and further cultivated. PBLs were transferred 
into a fresh flask the next day in order to further remove adherent monocytes. 
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2.2.2.4 Generation of murine bone marrow-derived dendritic cells 
BM‐DC were prepared from bone marrow of six to eight week old C57BL/6 WT mice. Bone 
marrow was isolated from hind legs of mice. Therefore legs were disinfected with ethanol, before 
tibia and femur were isolated. Bone marrow was then flushed out of the bone with PBS using a 
syringe. Total bone marrow was filtered with 40 μm pore nylon cell strainers and plated in 10 cm 
non-treated petri‐dishes at 5 x 106 cells in 10 mL VLE-RPMI supplemented with 10% heat-
inactivated FCS, 2 mM L‐Glutamine, 100 U/mL Penicillin, 0.1 mg/mL Streptomycin and 10 ng/mL 
murine recombinant GM-CSF. The culture medium was half‐renewed every three days. At day 
8‐10 of culture, BM‐DC were stimulated to mature by adding 200 ng/mL LPS for 48 hours. 
2.2.2.5 Isolation of murine splenic CD8+ T cells and dendritic cells 
Murine splenic CD8+ T‐cells were derived from NK-depleted OT-I mice and wild type DC were 
obtained from WT C57BL/6 mice by magnetic activated cell sorting (MACS), using CD11c micro 
beads or CD8a+ T Cell Isolation Kit (Miltenyi), respectively. The latter kit is an indirect magnetic 
labeling system for the isolation of “untouched” T cells from single‐cell suspensions of mouse 
spleen. Highly pure “untouched” T cells were obtained by depletion of non T cells. Non T cells e.g. 
B‐cells, NK cells, dendritic cells, macrophages, granulocytes and erythrocytes were indirectly 
magnetically labeled by using a cocktail of biotin‐conjugated antibodies against CD45R (B220), 
CD49b (DX5), CD11b (Mac‐1), and Ter‐119, as well as anti‐Biotin microBeads. The magnetically 
labeled non T cells were depleted by retaining them on a MACS column in the magnetic field of a 
MACS separator, while the unlabeled T cells passed through the column. This negative isolation 
method was used to avoid possible interfering effects, which are due to antibody‐mediated 
cross‐linking of surface molecules on the T cell. For DC and T cell isolation spleens were passed 
through a metal filter with a pore size of 250 µm, to remove cell aggregates and connective tissue 
and to obtain a single cell suspension. T cells were additionally loaded onto a column filled with 
medium equilibrated nylon wool and incubated for 1 hour at 37°C. Column was washed with 
twice the column volume of medium and flow-through, containing the T cells was collected. 
T cells and DC were counted, pelleted and taken up in an appropriate volume of MACS‐buffer and 
micro beads. Cells were incubated for 15 minutes at 4°C. Afterwards two consecutive washing 
steps were performed to remove unbound antibodies. The cell pellet was then resuspended in 
500 μL MACS‐buffer per 108 total cells and applied to an AutoMACS automate which performed 
the magnetic separation. T cells and DCs were taken up in RPMI-medium supplemented with 
10% heat inactivated FCS,100 U/mL Penicillin and 0.1 mg/mL Streptomycin and used for 
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functional assays 3‐4 hours after isolation. DCs were pulsed with OVA-peptide at a concentration 
of 1 mg/mL for one hour prior to cocultivation with OT-1 T cells. 
MACS buffer 
PBS 
2 mM EDTA 
0.5% BSA 
2.2.2.6 Generation of ICAM-1-Fc and VCAM-1-Fc supernatants 
Production of supernatant containing ICAM-1-Fc 
CV-1 cell were grown to confluency in a 15 cm petri-dish in DMEM supplemented with 2 mM L-
Glutamine, 10% heat-inactivated FCS and 10 μg/mL gentamicin. Cells were rinsed with PBS and 
5 mL of DMEM without supplements was added. 50 µL of Vaccinia virus stock bearing the ICAM-1-
Fc DNA (for details see Kolanus et al. 1996) was added to the medium for one hour and 25 mL 
DMEM medium was added afterwards. Cells were grown for two more days or until the cell shape 
was rounded. The supernatant was collected and sterile-filtered (pore size 0.2 µm) to clean the 
supernatant from contaminating cells and virus. Supernatant was used in cell adhesion assays. 
Production of supernatant containing VCAM-1-Fc 
HEK293 T cells were grown to 50 – 60 % confluency and transfected with the CDM8 VCAM-1 
plasmid via standard Calcium-phosphate method (Graham and van der Eb 1973). Cells were 
further grown in DMEM medium supplemented with 2 mM L-Glutamine, 10% heat-inactivated 
FCS and 10 μg/mL gentamicin for four to five days and supernatant containing VCAM-1-Fc fusion 
protein was collected and sterile filtered.  
2.2.3 Protein Biochemistry 
2.2.3.1 Isolation and purification of recombinantly expressed proteins 
BL21 (DE3) bacteria transformed with the plasmid pASK-IBA-43plus cytohesin-1 Sec7 were seeded 
in 1 liter LB-medium at an optical density at 600 nm (OD 600) of 0.1 and shaken at 150 rpm at 37°C. 
At an OD600 between 0.6 and 0.8 protein expression was induced by adding 200 µg/L 
anhydrotetracyline and bacteria were grown at 37°C for 6 more hours. Anhydrotetracycline binds 
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to the tetracycline promoter/operator and leads to the transcription and bacterial recombinant 
expression of the desired plasmid information.  
Bacteria were pelleted by centrifugation at 5000 x g for 20 minutes and pellet was immediately 
used for purification or stored at -80°C.  
For purification affinity chromatography technique was applied. The expressed hexahistidine-tag 
of the protein binds to a Ni-NTA (nickel nitrilotriacetic acid) sepharose. Ni-NTA is a chelating agent 
that binds Ni2+ ions. The histamine tag of the protein coordinates Ni-ions by the nucleophilic 
imidazole in the histidine side chain and hence binds to the immobilized Ni-NTA. Untagged 
proteins and proteins with lower histidine content do not bind and can be removed by intensive 
washing. Afterwards the protein can be eluted from the sepharose by adding high concentrations 
of imidazole. 
The bacterial pellet from 1 liter of culture was lysed in 20 mL lysis buffer and the bacteria were 
sonicated (Sonifier GM300) for 15 minutes at an intensity of 70% for complete disrupture of 
bacterial membranes. Cell debris and insoluble protein was removed by centrifugation at 6000 x g 
at 4°C. Supernatant was incubated with 1 mL Ni-NTA sepharose slurry and incubated for one hour 
at 4°C under gentle agitation. Unbound protein was removed by four consecutive washing steps 
with washing buffer and protein was eluted by two elution steps adding 1 mL of elution buffer 
and incubating for 5 minutes on ice. Imidazole was removed by gel filtration, loading the eluate 
on a PD-10 column and the protein was eluted by 8 consecutive elution steps with 500 µL dialysis 
buffer, each.  
 
Buffers for the purification of cytohesin proteins: 
Lysis buffer: Wash buffer: Dialysis buffer: Elution buffer: 
100 mM Tris/HCL, pH 7.8 50 mM Tris/HCl, pH 7.8 PBS 50 mM Tris/HCl, pH 7.8 
300 mM NaCl 300 mM NaCl  300 mM NaCl 
3 mM MgCl2 3 mM MgCl2  3 mM MgCl2 
proteinase inhibitors: 25 mM imidazole  500 mM imidazol 
Aprotinin (20 mg/mL) 
1:2000 
   
Leupeptin (20 mg/mL) 
1:2000 
   
PMSF (1 M) 1:1000    
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Buffers for the purification of (17N)ARF1: 
Lysis buffer/Wash buffer: Elution buffer: Dialysis buffer: 
50 mM Tris/HCl (pH 8.0) 50 mM Tris/HCl (pH 7.4) 50 mM Tris/HCl (pH 7.4) 
150 mM KCl 150 mM KCl 150 mM KCl 
10 mM imidazole 100 µM GDP 3 mM MgCl2 
100 µM GDP 1 M imidazole 100 µM GDP 
proteinase inhibitors (only in 
lysisbuffer): 
  
Aprotinin (20 mg/mL) 1:2000   
Leupeptin (20 mg/mL) 1:2000   
PMSF (1 M) 1:1000   
 
2.2.3.2 GTP-exchange assay  
In order to investigate the cytohesin-mediated replacement of GDP with GTP on ARF1 a special 
characteristic of the ARF1 protein was exploited. Under normal circumstances ARF1 is expressed 
with a myristoylation site which is responsible for plasma membrane insertion in vivo. However 
expression lacking the first 17 N-terminal amino acids of the protein leads to better solubility 
coupled with higher activity of the protein (Ahmadian et al. 2002; Antonny et al. 1997; Northup et 
al. 1982). Secondly tryptophans within ARF1 display autofluorescence that can be detected at a 
wavelength of 280 nm and 340 nm for excitation and emission, respectively. Upon binding of GTP 
and replacement of GDP this fluorescence increases dramatically and can be measured in a plate 
reader. The increase in fluorescence is proportional to the amount of GTP loaded on the ARF1 
protein and thus represents therefore for the activity of the used cytohesin protein.  
To this end cytohesin Sec7 domain was diluted in PBS buffer to a final concentration of 160 – 
200 nM supplemented with 3 mM MgCl2 and various concentrations of Secin inhibitors and 
incubated at 37°C for 10 minutes. ARF1(17N) protein (final concentration 500 nM) was 
preincubated with 3 mM MgCl2, 500 µM EDTA and 20 µM GDP in PBS at 37°C for 15 minutes. The 
proteins were mixed and incubated in a 96-well plate at 37°C. Exchange reaction was started by 
adding GTP at a final concentration of 50 µM to the protein mix. Changes in fluorescence were 
followed by measuring at wavelength of 280 nm and 340 nm for excitation and emission, 
respectively every 5 seconds until saturation was reached. The velocity of the reaction was 
calculated from the linear fluorescence increase area by determining the slope printed against the 
logarithm of the used concentrations of inhibitor.  
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2.2.3.3 Interaction studies of cytohesin protein with small organic molecules 
SPR (surface plasmon resonance) is a versatile tool for studying molecular interactions. From 
whole cells down to small molecules interactions can be followed with this technique. The 
mechanism underlying this optometric method is based on changes in the angle of total reflection 
on a gold surface. In this study protein was loaded on one half of a gold-chip surface, the other 
half was left blank. Previously, the gold-chip was coated with a hydroxycarboxylate-hydrogel. This 
gel improves the resolution of interaction measurement since it increases the thickness of the 
layer in which interactions influence the angle of total reflection. Change of this angle occurs after 
mass increase on top of the gold surface and displays dependent on the curve of association and 
dissociation of the analyte interaction. Small molecules were loaded on the chip surface. If 
interaction occurred, an increase in the response was observable. The blank half of the chip 
served as a reference for unspecific interactions of the analyte with the chip itself.  
SPR experiments were performed using a dual-channel SR7000DC system (Reichert Inc., USA). 
Recombinant Cytohesin-1 Sec7 domain was covalently immobilized on an HC1500m chip. The 
surface was activated with activation buffer (0.1 M NHS, 0.7% EDC, 0.05 M MES, pH 5.0) and the 
protein was applied at a concentration of 50 µg/mL in 5 mM acetic acid, pH 4.5 to sample 
channel, only. Unreacted residues on the chip surface were quenched with 1 M ethanolamine, 
pH 8.5 (see detailed protocol below). Binding and dissociation were performed in 1% DMSO 
containing PBS at a flow rate of 50 µL/min. Regeneration of the chip surface was achieved by 
injection of 10 mM glycine-HCl, pH 3.0. The netto sample channel response (which was calculated 
by subtracting the response from the reference channel from that of the sample channel) was 
corrected for blank buffer injection and DMSO injection. Data processing and curve fitting was 
done using SPR V4.0.17 (Reichert Inc., USA) and Scrubber2 software (BioLogic Software, 
Australia). 
Detailed immobilization protocol 
Sensorchip: NHS activated HC1500m 
 System flushed with H2O 
 Elution buffer (1 M NaCl/0.01 M NaOH, pH 9.0) for 3 minutes, flow rate 50 µL/min 
 H20 2-5 min 
 Injection of activation buffer (freshly prepared: 0.1 M NHS, 0.05M MES, pH 5.0 and 0.7% 
EDC) for 10 minutes (flow rate 10 µL/min) 
 2 minutes H20 50 µL/min 
 Unhook reference channel 
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 Purge line with H2O 100 µL/min 
 Injection of ligand (50 µg/mL) for 15 minutes (3 µL/min) 
 H2O 15 min 3 µL/min + 120 s 50 µL/min 
 Put reference channel in line again (flow rate 50 µL/min) 
 1 M Ethanolamine 10 µL/minute for 15 minutes 
 Flush system with H2O flow rate 50 µL/min 
 Switch system to PBS/ 1% DMSO 
2.2.3.4 Preparation of cell lysates 
For the preparation of cell lysates, 2 x 106 cells were harvested and washed with cold PBS. The cell 
pellet was subsequently resuspended in 60 - 100 μL Igepal lysis buffer with freshly added protease 
inhibitors and incubated for 20 minutes on ice. Cell debris was pelleted by centrifugation at 
13000 x g at 4°C for 10 minutes. The cell lysate was transferred to a new tube and the pellet was 
discarded. The protein amount was quantified by using a standard BCA assay. For experiments in 
which ERK phosphorylation levels were analyzed, unstimulated or stimulated cells were lysed in 
Triton lysisbuffer, containing phosphatase inhibitors and freshly added protease inhibitors. To this 
end, the cell pellet was resuspended in 60‐100 μL Triton lysisbuffer and immediately frozen in 
liquid nitrogen. Cell lysate was stored at ‐80°C until use. When cell lysates were needed, it was 
thawed on ice, before cellular debris was pelleted by centrifugation at 13000 x g at 4°C for 
10 minutes. The supernatant was transferred to a new tube and protein content was determined 
by a standard BCA assay  
Igepal lysis buffer Triton lysis buffer Protease inhibitor dilution 
10 mM HEPES, pH 7.5 10 mM Tris HCl, pH 7.5 Antipain (2 mg/mL) 1:1000 
10 mM KCl 1 mM EGTA Aprotinin (20 mg/mL) 1:2000 
10 mM MgCl 1 mM EDTA Benzamidine (1 M) 1:1000 
150 mM NaCl 10 mM Glycerol phosphate Leupeptin (20 mg/mL) 1:2000 
1% Igepal 50 mM Sodium Fluoride PMSF (1 M) 1:1000 
 5 mM Sodium Pyrophosphate  
 1 mM Sodium Vanadate  
 0.27 M Sucrose  
 1% Triton X‐100  
2.2.3.5 Determination of protein concentration by BCA assay 
Protein amount of cell lysates were quantified using the BCA assay (Pierce). The BCA assay 
(bicinchoninic acid assay) is a biochemical assay for determining the total level of protein in a 
solution, similar to Lowry protein assay, Bradford protein assay or biuret reagent. First, a serial 
dilution for standard curve was performed using bovine serum albumin ranging from 2 mg/mL to 
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0 mg/mL. 3 μL of each standard and each sample were added to a 96‐well microplate. Samples 
were added in two replicates. The detection reagent was prepared using a ratio of one part 
reagent A : 50 parts reagent B). 200 μL of working reagent was added to each well. The 96-well 
plate was placed in an incubator for 10 minutes at 65°C. Absorbance of each well was read at 
562 nm using a microplate reader. Standard 0 mg/mL was used as the blank control. Amount of 
protein in each well was calculated afterwards from linear regression of the standard’s 
absorption. 
2.2.3.6 SDS-PAGE 
SDS‐PAGE is the standard method for separating proteins according to their size. SDS binds to the 
protein in a constant ratio (1.4 g SDS/g protein), giving a uniform mass-to-charge-ratio to all 
proteins, so that the distance of migration through the gel is directly related to only the size of the 
protein. In this study discontinuous SDS polyacrylamide gel electrophoresis was employed, in 
which gels are constructed of two different acrylamide gels, one on top of the other. The upper 
stacking gel contained 5% acrylamide and the lower resolving gel, contained a higher acrylamide 
concentration. The large pore stacking gel concentrated the SDS‐coated proteins, whereas the 
small pore resolving gel afterwards effectively separated proteins due to a shift in pH. 
Polyacrylamide gels were prepared according to standard protocol. 10 µg of protein were mixed 
with 3x loading buffer and boiled for 5 minutes at 99°C. The gel was clamped in the 
electrophoresis chamber and buffer chambers were filled with gel running buffer. The boiled 
sample was loaded onto the gel, including one lane with 6 µL of molecular weight protein 
standard. The gel was run at 80 V (stacking gel) and at 120 V (resolving gel), until the blue dye 
front reaches the bottom. Afterwards the aperture was removed from the power supply and 
proteins were visualized using Coomassie Brilliant Blue stain or blotted on a nitrocellulose 
membrane.  
1x stacking gel solution (5%) 1 x resolving gel solution (10%) 
2.05 mL A. bidest. 2 mL A. bidest.  
375 µL 1 M Tris/HCl (pH 6.8) 1.25 mL 1 M Tris/HCl (pH 8.8)  
30 µL 10% SDS  50 µL 10% SDS  
30 µL 10% APS 50 µL 10% APS  
3 µL TEMED 2 µL TEMED  
0.5 mL 30% acrylamide/bisacrylamide-Mix 1.515 mL 30% acrylamide/bisacrylamide-Mix  
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1 x Laemmli running buffer 3 x loading buffer 
192 mM glycine 150 mM Tris HCl, pH 6.8 
25 mM Tris 6% (w/v) SDS 
0.1% SDS 30% (v/v) Glycerin 
ad 1 L A. bidest 300 mM DTT 
 0.3% (w/v) bromophenol blue 
2.2.3.7 Western Blot analysis 
Western Blot was performed to immobilize proteins separated by SDS-PAGE on a nitrocellulose 
membrane for immunostaining. Placed on the black site of the western blot cassette were: a 
sponge, three whatman filter papers, the gel, the nitrocellulose membrane, another three 
whatman filter papers and a second sponge. This was done in fresh 1x transfer buffer. The 
cassette was then closed and placed in the western transfer chamber, filled with cold 1x transfer 
buffer. The proteins were then transferred from the gel to the nitrocellulose membrane at 
300 mA per chamber for one hour at 4°C. Unoccupied spaces on the nitrocellulose membrane 
were blocked overnight with 5% milk powder in TBS-T at 4 °C under gentle agitation. Protein 
detection was achieved by a specific primary antibody in 10 mL TBS-T, containing 5% BSA. The 
membrane was incubated for one hour with primary antibody solution at room temperature (with 
gentle agitation), and then washed 4 times for 5 minutes with TBS-T. The primary antibody was 
then detected with a secondary antibody, conjugated to horseradish peroxidase (HRP). 
Membrane was washed again 4 times for 5min with TBS-T, before incubating it for 1 minute with 
ECL solution (1 mL of solution A and 1 mL of solution B, Pierce). Chemiluminescence was detected 
by autoradiography. To demonstrate loading of equal amounts of proteins, membranes were 
“stripped” of antibody, using a “stripping” buffer (20 minutes, 55°C) and were stained for a 
ubiquitous protein, e.g. actin. 
 
1x Transfer buffer TBS buffer 
192 mM glycine 50 mM Tris, pH 7.5 
25 mM Tris 140 mM NaCl 
20% methanol  
0.002% SDS “Stripping” buffer 
 2% (w/v) SDS 
TBS-T buffer 62.5 mM Tris/HCl, pH 6.7 
0.05% (v/v) Tween‐20 in TBS buffer 100 mM 2‐mercaptoethanol 
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2.2.4 Cell stimulation and functional assays 
2.2.4.1 Inhibitor treatment 
The small molecule SecinH3 (Sec7 inhibitor H3), is a Sec7 inhibitor which has been recently 
identified in an aptamer displacement screen (Hafner et al. 2006). SecinH3 preferentially inhibits 
the GEF activity of cytohesins 1‐3 and the Drosophila cytohesin‐3 homolog steppke, whereas the 
GEF function of other Sec7 domain containing proteins (e.g. the yeast protein Gea2 or the 
mammalian ARF6 GEF EFA6) is only weakly affected by SecinH3 (Hafner et al. 2006). It has been 
demonstrated that SecinH3 potently inhibits cytohesin‐catalyzed GDP/GTP exchange on ARF1, as 
well as cytohesin‐3‐dependent insulin signal transduction of Drosophila, mouse and human cells 
in vitro and in vivo (Fuss et al. 2006; Hafner et al. 2006). 
Secin 16 and Secin 144 are novel potent cytohesin family GEF inhibitors identified by 
chemoinformatic methods to improve target affinity and selectivity of SecinH3 (Stumpfe et al. 
2010). Both inhibitors were dissolved in 0.5% DMSO. Immune cells were incubated with SecinH3, 
Secin 16 or Secin 144 for 1h at 37°C. Equal amounts of DMSO were used as a control. Inhibited 
cells were afterwards used in assays as indicated. 
2.2.4.2 Cell stimulation  
Stimulation of murine splenic T cells 
Murine splenic T‐cells were stimulated 3‐4h after cell isolation by cocultivation with OVA-pulsed 
murine DC. 
Stimulation of Jurkat T cells 
For adhesion assays Jurkat T cells were stimulated with 5 µg anti-CD3 (OKT3) or 50 ng/mL PMA for 
15 – 20 minutes at 37°C. 
Stimulation of PBLs 
To induce the phosphorylation of ERK PBLs were stimulated with aAPC at a ratio of 1 cell : 1 bead. 
The aAPCs were coated with anti-CD3 (OKT3), anti-CD28 and MHC I in a ratio of 5% : 1 : 7. In all 
experiments, cells were stimulated in 200‐500 μL VLE-RPMI, containing 0.5% FCS. 1 ‐ 2 mL cold 
PBS was added in order to terminate stimulation. 
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Maturation of dendritic cells 
see 2.2.2.4 
Stimulation of Jurkat T cells and PBL for cell adhesion assays 
see 2.2.4.6 
2.2.4.3 CBA assay and ELISA 
The production of cytokines is a hallmark for the activation of T cells and the development of 
different T cell subsets. After engagement of the TCR and costimulation of CD28 T cells undergo 
changes that finally lead to differentiation into T cell subsets and clonal expansion. In order to 
investigate the activation and differentiation status of T cells, they were isolated and stimulated in 
the presence of either aAPCs (human system) or OVA-pulsed DC (murine system) and incubated 
for several days. The supernatant, containing cytokines released from the cells was collected and 
frozen at -80°C. Cytokine production was measured by CBA or IL-2- and Interferon-γ-ELISA 
according to the manufacturer’s instruction. 
2.2.4.4 Proliferation assay 
The measurement of proliferation is an important tool to investigate the influence of inhibitors on 
T cell activation. To this end, cells are stained with a viability dye (in this case CFSE) which is 
resides in the cytosol of the cells and is diluted by every cell division. Therefore a decrease in 
fluorescence with every cell division can easily be measured by flow cytometry. 
CD4+ untouched T cells were stained with 0.5 µM CFSE dye in PBS for eight minutes. Reaction was 
stopped by adding FCS to the reaction mix which quenches unincorporated CFSE. Excessive dye 
was removed by two consecutive washing steps and cells were resuspended in VLE-RPMI 
supplemented with 10% heat-inactivated FCS and 100 U/mL Penicillin, 0.1 mg/mL Streptomycin at 
a concentration of 1 x 106 cells/mL. T cells were preincubated with the respective inhibitor (at 
concentrations indicated) for one hour at 37°C in medium. Stimulation was achieved by mixing 
cells and aAPCs at a final ratio of 1:1 and the cells were incubated at 37°C and 5% CO2. After three 
– four days CFSE fluorescence was measured by flowcytometry. Therefore cells were washed in 
PBS and the mean fluorescence intensity of the samples was measured in the FITC-channel. 
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2.2.4.5 Viability assay 
In order to find out if the application of inhibitors for cytohesin functions have an impact on the 
viability of T cells, Annexin V staining in combination with propidium iodide staining was 
performed. Annexin V is a protein that binds to phosphatidylserin (PS). PS is located in the inner 
plasma membrane. Upon induction of apoptosis, PS translocates to the outer leaflet of the plasma 
membrane and can be detected by fluorescently labeled Annexin V. In contrast, propidium iodide 
stains dead cells by entering the cell, because of missing plasma membrane integrity. Hence, a 
combination of both dyes gives information about necrosis and apoptosis induction.  
In the viability assays 1 x 106 cells were incubated with cytohesin-inhibitors at different concen-
trations in 0.5% DMSO or DMSO alone as control and cultivated in media at 37°C and 5% CO2. 
After three days the cells were collected and washed with PBS. The staining with Annexin V and 
propidium iodide was performed according to the manufacturer’s protocol. Annexin V positive 
and propidium iodide positive cells were quantified by flow cytometry.  
2.2.4.6 Static cell adhesion assays 
Static cell adhesion assays on ICAM‐1‐Fc or VCAM-1-Fc were carried out as described previously 
(Boehm et al. 2003; Kolanus et al. 1996) with following modifications. 2x105 Jurkat/well in HBSS 
were preincubated with inhibitors diluted in 0.5% DMSO/HBSS for one hour at 37°C and 5% CO2 
and stained with H33342 bisbenzimide (6 µg/mL) 30 minutes prior to stimulation. Cells were then 
placed on ICAM‐1‐Fc/VCAM-1-Fc coated 96‐well plates and stimulated with either 5 µg/mL anti-
CD3 (OKT3) antibody or 50 ng/mL PMA for 15 minutes at 37°C and 5% CO2 to adhere. Unbound 
cells were washed off carefully with HBSS and the adherent cells were quantified by measuring 
bisbenzimide fluorescence at a wavelength of 360 nm and 485 nm for excitation and emission, 
respectively. The number of adherent cells was calculated by comparison with an unwashed 
control. All samples were measured in triplicates. 
Adhesion assays with PBL were carried out in the same fashion, except that a concentration of 1 x 
106 cells/mL were used and the stimulation time was increased to 30 minutes. 
2.2.4.7 Adhesion under flow conditions 
In order to investigate early events in the activation of integrins, adhesion assays were performed 
in which PBLs were drawn over a confluent layer of endothelial cells. After a short period of rolling 
some PBLs attach firmly to the endothelial cells and can be counted (Weber et al. 2001).  
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HUVEC cells were grown to confluency in 35 mm Petri-dishes and stimulated with 10 ng/mL TNF-
alpha over night. Two hours prior to experiment cells were loaded with human CXCL12 
(500 ng/mL). HUVECs were assembled in a parallel flow-chamber. PBL (1x106 cells/mL in HH-
buffer) were incubated with 10 µM Secin 16 in 0.5% DMSO or DMSO alone as control prior to 
experiment. PBL were drawn through the chamber with a laminar flow at a shear rate of 
1.5 dyn/cm2. The cells that were attached to HUVEC after 6 minutes of wash with HH-buffer were 
counted. 
HH-buffer: 
HBSS w/o Mg2+ and Ca2+ 
0.5% BSA 
10 mM HEPES pH 7.4 
1 mM MgCl2 
1 mM CaCl2 
2.2.4.8 Transwell migration assays 
One method for the quantification of chemotaxis is a transwell migration assay. To this end 
polycarbonate filters of a pore size of 5 µm in a modified Boyden chamber were used. Cells are 
loaded on top of the filter and are attracted by a chemokine gradient that is applied to the lower 
chamber and squeeze through the mesh of the polycarbonate filter. Migrated cells can then be 
easily quantified by counting the cells in the lower compartment of the chamber. 
2 x 105 cells (Jurkat or BmDCs) were preincubated with inhibitors in 0.5% DMSO or DMSO alone as 
control in VLE-RPMI containing additionally 10% heat-inactivated FCS and 100 U/mL penicillin, 
0.1 mg/mL streptomycin. Cells were loaded on top of the filter and incubated for one hour at 37°C 
and 5% CO2 to adhere. Afterwards, cells were stimulated with 200 ng/mL human CXCL12 or 
murine CCL19, respectively. After three hours (Jurkat T cells) or 24 hours (BmDC) cells in the lower 
compartment of the chamber were counted and compared to the total number of cells in the 
assay to determine the migration rate. 
2.2.4.9 2D migration assays 
Ibidi slides (15 µ-slideVI) were coated with either 5 µg/cm2 fibronectin, 50 µg/mL fibrinogen or 
12.5 µg/mL murine ICAM-1-Fc for 1 hour at room temperature and washed with PBS. For human 
ICAM-1-Fc coating, slides were preincubated with goat anti-human antibody (16 µg/mL) at pH 9.5 
for 90 minutes followed by two washing steps in 50 mM Tris pH 9.5. To avoid unspecific binding to 
the plastic surface slides were subsequently coated with 1% BSA/PBS for 60 minutes at room 
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temperature or overnight at 4°C. ICAM-1-Fc supernatants from vaccinia infected CV-1 cells were 
then applied for 90 minutes at room temperature. Unbound ICAM-1 was removed by two 
washing steps with HBSS. 
1.5 x 105 cells were preincubated with the respective inhibitor or DMSO as control in 30 µL growth 
medium supplemented with 0.5% FCS and seeded on the slides. After one hour 10 µL chemokine 
(200 µg/mL) was applied to one side of the slide. Cell migration was recorded with a fully 
automated inverted phase-contrast TE Eclipse microscope with a 10x objective, motorized xyz-
stage (Marzhäuser, Wetzlar) and a CCD-1300 Vosskühler camera at 37°C. In every sample 30 cells 
were tracked and their motility, y- forward migration index and velocity was analyzed with ImageJ 
software and the manual tracking and chemotaxis (ibidi) tool. The y-forward migration index is 
determined by dividing the y-value of a given track by its respective accumulated track length. It is 
a factor for the directionality of movement towards a chemokine. 
2.2.4.10 3D collagen gel chemotaxis assay 
2 x 105 BmDCs or PBL per assay in 50 µL VLE-RPMI with 0.5% FCS were mixed with 100 µL of 
collagen mix (kept strictly on ice to avoid polymerization of the collagen) and the respective 
inhibitor at a final concentration of 10 µM in 0.5% DMSO or DMSO alone as control. The mixture 
was loaded into a custom made chemotaxis chamber and incubated for 1 hour at 37°C and 5% 
CO2. After the collagen was polymerized, 600 ng/mL murine CCL19 or human CXCL12, respectively 
were applied on top of the gel which creates a chemokine gradient throughout the collagen. The 
chambers were sealed with liquid wax and the chambers were adjusted on a microscope in a 
climate chamber with 37°C. Time-lapse phase-contrast series were recorded using a fully 
automated microscope. For every experiment pictures were taken at a rate of 2 min/ frame for 
four hours. Chemotactic mobility was determined by manual tracking of cells over the complete 
period of the assay using ImageJ’s manual tracking plug-in tool. FMI and velocity were calculated 
in ImageJ using the ibidi chemotaxis plug-in. 
Collagen mix: 
50 µL NaHCO3 (7.5%) 
100 µL 10x MEM 
750 µL Collagen I  
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3 Results 
Cytohesins are a family of guanine nucleotide exchange factors (GEFs) for small ARF-GTPases. The 
family consists of four known members in mammals, termed cytohesin-1 (Kolanus et al. 1996), 
cytohesin-2 (ARNO) (Chardin et al. 1996), cytohesin-3 (also Grp1 in humans and steppke in 
Drosophila, respectively) (Fuss et al. 2006; Klarlund et al. 1997) and cytohesin-4 (Ogasawara et al. 
2000). Cytohesins are reported to serve as important regulators in cellular processes, e.g. cell 
adhesion and migration of immune cells, in non-immune insulin signaling and EGF receptor 
signaling (Kolanus et al. 1996; Quast et al. 2009; Fuss et al. 2006; Bill et al. 2010). The GEF-activity 
however seems to be dispensable for at least some of these signal transduction pathways (Geiger 
et al. 2000; Bill et al. 2010). 
In contrast to other ARF-GEF proteins, e.g. BIG1/2 and GBF, cytohesins are insensitive to inhibition 
with Brefeldin A (Mossessova et al. 2003; Renault et al. 2003). However, recently the small 
molecule inhibitor Secin H3 (Sec7 inhibitor H3, inhibitor of cytohesin function, cf. figure 7), 
1-,2-,4-substituted triazole, was discovered. In the course of a small molecule screening for GEF 
activity inhibitors, Secin H3 was found to be able to replace the cytohesin specific aptamer M69 
(Mayer et al. 2001) bound to the Sec7 domain of cytohesin-2. It inhibits the GEF-activity of 
cytohesin-proteins towards ARF1 selectively, and binds to their respective Sec7 domains. In 
contrast, only minor effects on other Sec7 domain bearing GEF proteins (e.g. EFA6) can be 
observed (Hafner et al. 2006).  
 
Figure 7: Molecular structure of Secin H3 (Hafner et al. 2006). 
 
With the help of Secin H3, it was possible to identify cytohesin-2 and -3 in humans and the 
Drosophila homolog steppke as regulators of insulin signaling upstream of PI3-kinase (Fuss et al. 
2006; Hafner et al. 2006). Furthermore, very recently cytohesin-2 was reported to act in Erb 
signaling (Bill et al. 2010). 
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Despite the efficacy of Secin H3 in inhibiting cytohesin activity in insulin and EGFR signaling, 
cytohesin functions in immune cells were only poorly inhibited as compared to cytohesin 
knockdown experiments. Hence, there was a need for more potent inhibitors for this class of 
enzymes. To this end, Secin H3 was used to serve as the lead structure for a similarity based 
virtual compound screen (Hafner et al. 2006; Stumpfe et al. 2010). This bioinformatic approach 
combined two virtual screening (VS) methods. Both methodologies were target-structure based, 
that means, Secin H3 was used as reference compound in the search of novel compounds. Both 
approaches used two-dimensional representations of Secin H3, so called 2D fingerprints as the 
basis for virtual search. Yet, one approach, termed “similarity search”, focused on similar 
structures to the lead compound Secin H3. Starting from a reference compound, virtual molecule 
libraries are screened for divergent but similar molecular structures (Stumpfe et al. 2010). The 
other approach, termed “diversity search” was focusing on finding structures with different 
structural scaffolds compared to the lead-structure Secin H3 (Stumpfe et al. 2010). 
Using these criteria, 145 compounds were selected as potential interactors and further 
investigated in various in vitro and in vivo assays regarding their efficacy in inhibiting reported 
cytohesin functions.  
As depicted in figure 8, these assays included a gene expression assay for d4EB-P1 in S2 cells after 
insulin stimulation, an in vitro GTP-exchange assay with isolated ARF1 and cytohesin-2 (ARNO) 
Sec7, and a cell adhesion assay using Jurkat T cells on ICAM-1 coated surfaces. 
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Figure 8: Pathways influenced through Secin H3-mediated inhibition of steppke and cytohesin, 
respectively. 
Full arrows indicate the signaling pathways without inhibition by SecinH3, dashed arrows indicate the 
consequences of inhibiting steppke or cytohesin, respectively. The effects of inhibition displayed in the 
green boxes served as read out for the three assays performed in the screening (modified from Stumpfe et 
al. 2010) 
 
The compounds were screened for their ability to interfere with cytohesin-dependent insulin-
signaling in Drosophila S2 tissue cells. Inhibition of the Drosophila cytohesin steppke leads to 
elevated levels of dFOXO target genes, e.g. d4EB-P1, since their transcription is reduced after 
phosphorylation of dFOXO under normal conditions. The mRNA levels of d4EB-P1 served as read 
out for the functionality of the compounds (Stumpfe et al. 2010).  
In the second screening assay the compounds were tested for their inhibitory capacity of the 
catalytic GEF-activity of ARNO Sec7 protein towards ARF1 GTPase. Cytohesin GEF-activity was 
therefore measured in vitro with isolated proteins (Stumpfe et al. 2010). 
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In the third screening, the compounds were assayed for their ability to inhibit cytohesin-1 
mediated adhesion of Jurkat T cells to ICAM-1 after TCR engagement or PMA-stimulation 
(Stumpfe et al. 2010). 
As a result, two compounds showed interesting inhibition profiles which were further 
investigated. These compounds were Secin 16 (cf. figure 9), a small molecule comprising a phenyl 
diamide core and Secin 144 (cf. figure 12), a 5-oxa-1,2-diazole with aromatic appendices. The aim 
of this study was to investigate the inhibitory profile of these compounds and consequences for 
cytohesin-related processes in immune cells. 
3.1 The cytohesin inhibitor Secin 16 is a potent pan-cytohesin inhibitor 
 
Figure 9: Molecular structure of Secin 16 (molecular structure from ASINEX). 
3.1.1 Secin 16 inhibits cytohesin-dependent GTP-exchange, insulin signaling in 
Drosophila and adhesion of Jurkat T cells to ICAM-1 
The in silico identified small molecule compounds had to be investigated in cytohesin-regulated 
processes in order to determine their inhibitory efficacy. These assays included the guanine-
nucleotide exchange of ARNO-Sec7 towards the ADP ribosylation factor 1 (ARF1) (Chardin et al. 
1996), for their ability to increase mRNA levels of d4E-BP1, a downstream target of the 
transcription factor dFOXO (Fuss et al. 2006; Southgate et al. 2007), and for inhibiting adhesion of 
Jurkat T cells to ICAM-1 coated surfaces (Kolanus et al. 1996).  
Results 
50 
 
Figure 10: Secin 16 is a more potent inhibitor of cytohesin-2-mediated guanine nucleotide 
exchange towards ARF1, steppke-mediated insulin-signaling and cytohesin-1 regulated T cell 
adhesion to ICAM-1 as compared to Secin H3. 
A: Shown is the GTP-exchange rate of ARNO towards ARF1 normalized to the activity of Secin H3. GTP-
exchange rate was determined by measuring the tryptophan fluorescence of 250 nM ARF1 (17N) (amino 
acids 18 - 181) after addition of 50 µM GTP in the presence of 10 nM ARNO-Sec7 (amino acids 50 - 255) and 
3 mM magnesium ions. The concentration of the compounds was 5 µM. The average of five independent 
experiments is displayed. B: Shown is the expression of d4E-BP1 mRNA in Drosophila S2 cells after 18 hour 
preincubation with the respective inhibitor at a concentration of 10 µM and insulin stimulation. mRNA 
levels were quantified via qRT-PCR. The average of three independent experiments normalized to Secin H3 
is shown. (A and B modified from Stumpfe et al. 2010). C: Adhesion of Jurkat T cells to ICAM-1 coated 
surfaces. Cells were preincubated with 25 µM Secin H3, Secin 16 or DMSO as vehicle control, respectively, 
stained with H33342 and placed on ICAM-1. Jurkat T cells were stimulated with anti-CD3 (OKT3) or phorbol 
ester (PMA), respectively for 15 minutes. Unattached cells were removed by 5 consecutive washing steps 
and adherent cells were determined by measuring H33342 fluorescence at 485 nm. Shown is the average of 
three independent experiments as percentage of adherent cells compared to an unwashed control (100%). 
Asterisks indicate significant deviation from the vehicle control with respective stimulation calculated by 
Student’s t-test (* = P < 0.05, ** = P < 0.01; *** = P < 0.001). 
ARNO-Sec7 and ARF1(17N) were overexpressed in E. coli and purified. ARF1(17N) lacks the first 
17 amino-terminal amino acids which contain a myristoylation site, hence deletion of this site 
leads to better activity and solubility of the protein (Franco et al. 1993). The GTP-exchange was 
measured by tryptophan fluorescence of ARF1(17N) which changes due to significant 
conformational shifts in the protein after loading of ARF1 with GTP (Antonny et al. 1997; Northup 
et al. 1982). ARF1 was pre-incubated with GDP. ARNO-Sec7 and the respective inhibitor were then 
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mixed with the ARF1 protein and the reaction was started by addition of GTP. The fluorescence 
was measured. Figure 10A shows the relative GTP-exchange rate of ARNO Sec7 towards ARF1 
after inhibition with Secin 16 compared to Secin H3. Secin 16 was able to inhibit the GTP-
exchange 33% stronger as compared to Secin H3 at a concentration of 5 µM (Stumpfe et al. 2010).  
Inhibition of steppke in insulin-mediated signaling reduces Akt-dependent dFOXO1 
phosphorylation (Fuss et al. 2006). This in turn, leads to the exclusion from the nucleus, where 
dFOXO1 can no longer act as a repressor of d4EB-P1 gene expression (Brownawell et al. 2001). 
Elevated levels of d4EB-P1 mRNA hence serve as positive read out for inhibition of steppke. For 
the quantification of d4E-BP1 mRNA levels Drosophila S2 cells were preincubated with the 
inhibitors in a concentration of 10 µM for 18 hours. mRNA was isolated after insulin stimulation 
(5 µg/mL) and d4E-BP1 levels were quantified via quantitative RT-PCR after cDNA synthesis. The 
mRNA expression of d4E-BP1 (cf. figure 10B) following incubation with Secin 16 is 20-fold 
increased compared to the one for Secin H3 (Stumpfe et al. 2010).  
It is known that cytohesin-1 is an important regulator for adhesion of immune cells to ICAM-1 
(Geiger et al. 2000; Kolanus et al. 1996; Quast et al. 2009). However, Secin H3, a pan-cytohesin 
inhibitor did not lead to an adhesion phenotype to the same extend than knock-down of 
cytohesin proteins by RNAi did. In order to investigate, if Secin 16 is able to inhibit this cytohesin 
function more efficiently than Secin H3, adhesion assays with Jurkat T E6.1 cells were performed. 
Hence, Jurkat T cells were preincubated with 25 µM of the respective inhibitor for one hour, 
stained with Hoechst H33342 and subsequently placed onto ICAM-1 coated surfaces. After 15 
minutes of stimulation with 5 µg/mL OKT3 or 50 ng/mL PMA, respectively, unattached cells were 
carefully removed and the remaining cells were quantified by measuring the H33342-
fluorescence. 
Adhesion of Jurkat E6.1 T cells to ICAM-1 coated surfaces is strongly reduced following inhibition 
with Secin 16. Cells preincubated with Secin 16 show a reduction in adhesion of 59% after PMA 
stimulation and of 71% after TCR stimulation with anti-CD3 (OKT3) antibody, respectively, 
compared to the vehicle-treated control. In contrast, Secin H3 reduces the amount of adherent 
cells only by 15% after PMA stimulation and of 21% after TCR stimulation compared to the DMSO 
control. This effect is much weaker than that of inhibition by Secin 16. These results indicate that 
Secin 16 inhibits cytohesin-1 regulated cell adhesion more efficiently as compared to Secin H3. 
Taken together, these data suggest that compared to Secin H3, Secin 16 was much more effective 
in inhibiting multiple cytohesin-functions, e.g. ARNO-dependent guanine nucleotide exchange 
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towards ARF-GTPase 1, steppke-dependent insulin-signaling and cytohesin-1-dependent 
regulation of Jurkat T cell adhesion (Stumpfe et al. 2010). Therefore, the cytohesin-inhibitor 
Secin 16 was chosen for further investigation.  
3.1.2 Secin 16 binds to the Sec7 domain of cytohesin-1 
The diversity of the subsequently employed screening assay was a first attempt to address the 
question of specificity of the novel small molecules for cytohesin proteins. Therefore, known 
cytohesin functions are exploited for the Grp-1 homologue steppke in Drosophila, for guanine-
nucleotide exchange in ARNO and for cytohesin-1-mediated cell adhesion of Jurkat T cells. 
Since all these cytohesin-mediated processes were inhibited by the use of Secin 16, it can be 
assumed that Secin 16 is a specific compound for the inhibition of all cytohesin proteins. 
Furthermore, the observed inhibition of the in vitro GTP-exchange only involved the isolated Sec7 
domain of ARNO and the ARF1(17N) proteins therefore, interaction with the cytohesin Sec7 
domain can be concluded. 
Nevertheless, it was necessary to show that Secin 16 is able to bind its target protein. Hence, SPR 
(surface plasmon resonance) was used to ascertain that Secin 16 specifically binds to the Sec7 
domain of cytohesin-1. 
In a dual-channel SPR setup the Sec7 domain of cytohesin-1 purified from E. coli was covalently 
linked to the sample channel of an HC1500m chip. Binding of Secin 16 was measured as the net 
channel response (displayed as difference between sample channel response and reference 
channel response) corrected for blank buffer injections (1% DMSO, PBS) and for DMSO injections 
in different concentrations in 1% DMSO/PBS.  
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Figure 11: Secin 16 interacts with cytohesin-1 Sec7 domain. 
Secin 16 shows dose-response dependence in the binding to Sec7-domain of cytohesin-1. Shown are the 
fitted binding and dissociation curves of Secin 16 interaction with the Sec7 domain of cytohesin-1 
immobilized to an HC1500m polycarboxylate hydrogel chip at the indicated concentrations in 
1% DMSO/PBS. The data are corrected for blank buffer and solvent injections. Each line is calculated from at 
least three independent injections.  
Secin 16 binds in a concentration-dependent manner to cytohesin-1 Sec7 domain as displayed in 
figure 11. At concentrations of 10 µM the binding of the protein already reaches saturation after 
200 seconds of injection. Coating of the chip surface with ARF1(17N) or BSA, respectively did not 
lead to binding of the compound even after elongating the incubation time with the proteins. This 
clearly indicates that Secin 16 binds specifically to the Sec7 domain of cytohesin proteins and can 
be used in concentrations of 10 µM for further experiments. 
3.2 The cytohesin inhibitor Secin 144 is a partial inhibitor of cytohesin 
function 
The virtual screen performed to find novel inhibitors for cytohesin function, led to the discovery 
of 145 potential novel molecules that could serve for this purpose. In the consecutive functional 
screen these compounds were evaluated for their potential to inhibit cytohesin-related functions, 
e.g. guanine nucleotide exchange of cytohesin-2 towards ARF1, steppke-dependent regulation of 
insulin signaling and cytohesin-1-regulated adhesion of Jurkat T cells to ICAM-1. Amongst others, 
Secin 144 showed an interesting inhibition profile (Stumpfe et al. 2010).  
Results 
54 
 
Figure 12: Molecular structure of Secin 144 (molecule structure from VitasM laboratories). 
 
3.2.1 Secin 144 does not influence cytohesin-2-mediated GTP-exchange towards 
ARF1 and steppke-dependent Foxo signaling, but abrogates adhesion of Jurkat T 
cells to ICAM-1 
In order to verify the inhibitory potential of compounds that were found in a virtual screen, based 
on Secin H3 as lead compound, the novel Secin molecules were subjected to functional screening 
assays (Stumpfe et al. 2010). 
Cytohesin proteins are known GEFs for the ADP-ribosylation factors, e.g. ARF1 and ARF6 (Chardin 
et al. 1996; Meacci et al. 1997). Inhibition of this primary cytohesin function leads to a decreased 
exchange of GTP towards ARF1 as it can be measured by tryptophan autofluorescence (Ahmadian 
et al. 2002).  
As depicted in figure 13A, Secin 144 was tested for the ability to inhibit GTP-exchange. In order to 
compare the inhibitory capacity with the small molecule Secin H3, in vitro GTP-exchange assays 
with ARNO Sec7 towards ARF1 were performed. To this end, cytohesin-2 was preincubated with 
5 µM Secin 144 or Secin H3 in DMSO, respectively, and ARF1(17N) was added to the reaction. 
GTP-exchange was measured after injection of GTP by following the increase of the intrinsic ARF1 
tryptophan fluorescence (Antonny et al. 1997; Northup et al. 1982).  
The addition of Secin 144 did not lead to an improved inhibition of GTP-exchange activity of 
cytohesin-2 towards ARF1. As depicted in figure 13A, the relative exchange rate was even 
increased about 35% compared to Secin H3 treatment.  
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Figure 13: Secin 144 shows no significant inhibition of Drosophila insulin signaling and 
cytohesin-2 GTP-exchange towards ARF1 as compared to Secin H3, however it is a potent 
inhibitor of cytohesin-1-mediated adhesion of Jurkat T cells to ICAM-1. 
A: Shown is the GTP-exchange rate normalized to the activity of Secin H3. Secin 144 leads to elevated 
exchange rates compared to Secin H3 thus cannot be considered as an improved inhibitor of GTP-exchange 
towards ARF1. Secin 144 exchange rate was determined by measuring the tryptophan fluorescence at 
250 nM ARF1(17N) (amino acids 18 - 181) after addition of 50 µM GTP in the presence of 10 nM ARNO-
Sec7 (amino acids 50 - 255) and 3 mM magnesium ions. The concentration of the compounds was 5 µM. 
Secin 16 shows a relative increase of exchange activity of 1.35. The average of five independent 
experiments is shown. (modified from Stumpfe et al. 2010) B: Shown is the expression of d4E-BP1 mRNA in 
Drosophila S2 cells after 18 hour preincubation with the respective inhibitor at a concentration of 10 µM 
and insulin stimulation. mRNA levels were quantified via RT-PCR. The average of three independent 
experiments is shown. The level of d4E-BP1 mRNA is decreased compared to the mRNA level that is 
expressed after incubation with Secin H3. (modified from Stumpfe et al. 2010) C: Adhesion of Jurkat E6.1 T 
cells to ICAM-1. Cells were preincubated with 0.5% DMSO (vehicle control) or 25 µM of the indicated 
compound in 0.5% DMSO for one hour and placed in 96-well plates coated with ICAM-1-Fc. Cells were then 
stimulated for 15 minutes and unattached cells were carefully removed by 5 consecutive washing steps. 
Shown is the average of three independent experiments as percentage of adherent cells compared to an 
unwashed control (100%). Asterisks indicate the significance to the comparably stimulated vehicle control 
determined via Student‘s t-test (* P< 0.05, *** P< 0.001). 
The Drosophila cytohesin-3 homologue steppke was reported to act in insulin signaling leading to 
the phosphorylation of dFOXO1. After phosphorylation FOXO1 is retained in the cytosol and 
hence, fails to act as a transcription factor for d4EB-P1 (Fuss et al. 2006). Thus, elevated d4EB-P1 
mRNA levels served as readout for cytohesin inhibition. In order to test the effects of the novel 
small molecules in cytohesin function they were applied to well-established and robust functional 
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assays. For the determination of d4EB-P1 mRNA levels, S2 cells were starved and preincubated 
with the inhibitors 18 hours prior to stimulation with insulin. Cells were lysed and cDNA was 
produced out of isolated mRNA via reverse transcription. cDNA levels were determined by 
qRT-PCR. 
Secin 144 leads to a decreased level of d4EB-P1 mRNA of about 20% compared to Secin H3, 
equivalent to ineffective inhibition of steppke function (cf. figure 13B ).  
Interestingly, Secin 144 was found to be a strong inhibitor of T cell adhesion to ICAM-1 as 
depicted in figure 13C. Jurkat T cells were preincubated with 25 µM Secin 144 and placed onto 
ICAM-1-Fc-coated surfaces. For stimulation 5 µg/mL anti-CD3 (OKT3) or 50 ng/mL PMA were used, 
respectively.  
Application of Secin 144 in Jurkat T cells results in a strong reduction of T cell adhesion. Adhesion 
to ICAM-1 was abrogated irrespective of the kind of stimulation. This inhibitory effect on T cell 
adhesion was much stronger as compared to T cells that were treated with Secin H3. 
3.2.2 Secin 144 binds to the Sec7 domain of cytohesin-1 
Secin 144 proved to be only a partial inhibitor of cytohesin function as shown by the functional 
screening assays (cf. figure 13). In GTP-exchange assays and Foxo1-activation assays, Secin 144 
had no effect on the inhibition of cytohesin functions. In stark contrast to that, Secin 144 was one 
of the most potent inhibitors of T cell adhesion to ICAM-1 in vitro. Since adhesion is a cellular 
process which involves a plethora of signaling cascades and therefore protein components, it was 
also possible that Secin 144 did not affect cytohesin-1 but other proteins responsible for proper 
adhesion in T cells. To this end, it was tested, whether Secin 144 interacts with the Sec7 domain of 
cytohesin-1 responsible for the mediation of T cell adhesion (Kolanus et al. 1996; Geiger et al. 
2000). 
A dual-channel SPR setup was used to investigate the interaction of Secin 144 with the Sec7 
domain of cytohesin-1. Sec7 domain of cytohesin-1 purified from E. coli was covalently linked to 
the sample channel of an HC1500m chip. The reference channel was left unloaded. Binding of 
Secin 144 was measured at various concentrations as the net channel response (difference 
between sample channel and unloaded reference channel). Therefore, Secin 144 was freshly 
dissolved in water-free DMSO and subjected to ultrasound treatment for 15 minutes. Undissolved 
particles were pelleted by centrifugation at 13,000 x g for 15 minutes. The stock solution was then 
diluted in 1% DMSO/PBS at suitable concentrations immediately before injection. The resulting 
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response was corrected for blank buffer injections and DMSO as vehicle control and association 
and dissociation was depicted as a function of response versus time.  
 
Figure 14: SPR sensorgram of Secin 144 interaction with cytohesin-1 Sec7 domain. 
Shown are the fitted binding and dissociation curves of Secin 144 interaction with the Sec7 domain of 
cytohesin-1 immobilized to an HC 1500m polycarboxylate hydrogel chip at the indicated concentrations in 
1% DMSO/PBS. The data are corrected for blank buffer and solvent injections. Each line is calculated from at 
least three independent injections. 
As depicted in figure 14 the interaction of Secin 144 with the Sec7 domain of cytohesin-1 can be 
clearly proven with this method. Association of Secin 144 is concentration-dependent and its 
saturation occurs already at a concentration of 10 µM after 400 seconds. Hence, it can be 
concluded that Secin 144 binds specifically to cytohesin-1. This implies that the inhibitory effects 
observed upon use of Secin 144 in Jurkat T cell adhesion on ICAM-1, are due to the fact that 
Secin 144 is able to inhibit specifically cytohesin-1 function. 
3.3 Dissecting GEF-dependent and GEF-independent functions of cytohesin-1 
3.3.1 GTP-exchange of cytohesin-1 Sec7 domain towards ARF1 GTPase is only 
inhibited by Secin 16 but not by Secin 144 
Secin 16 was shown to be a potent small molecule compound for the inhibition of GTP exchange 
towards ARF1 mediated by cytohesin-2 (figure 10A). To investigate a possible inhibition of 
Secin 16 in the cytohesin-1 mediated GTP-exchange, assays were performed in the same manner 
for the isolated Sec7 domain of cytohesin-1 and ARF1(17N).  
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Figure 15: Secin 16 inhibits cytohesin-1 guanine nucleotide exchange towards ARF1 dose-
dependent. 
ARF1(17N) (final concentration 500 nM) was loaded with GDP in the presence of 2 mM EDTA. Stabilizing 
magnesium was added at a final concentration of 3 mM. Cytohesin-1 Sec7 domain (amino acids 49 – 249) at 
a final concentration of 80 nM preincubated with DMSO as vehicle control or the compound at the 
indicated concentrations was added and the reaction was started by injection of GTP at a final 
concentration of 50 µM. The reaction was followed by measuring the tryptophan fluorescence of ARF1 
protein at excitation and emission wavelengths of 280 nm and 340 nm, respectively. A: The linear region of 
fluorescence increase is displayed versus the time. Lines show the fitted linear regression. B: Calculated 
slope of the fluorescence increase is displayed versus Secin 16 concentration. Only the linear region of the 
fluorescence increase was used to determine the slope. Asterisks indicate significance compared to the 
vehicle control as calculated via Student’s t-test (* P< 0.05, *** P< 0.001). C: IC50 of Secin 16 in the GTP-
exchange assay. Shown is the slope versus the log of Secin 16 concentration. IC50 was calculated as 9.7 µM 
via GraphPad software. The graphs are the averaged result of 14 independent experiments.  
Secin 16 was used in concentrations from 2.5 µM to 50 µM in the GTP-exchange reaction of 
cytohesin-1 Sec7 domain towards the ARF1 protein. ARF1(17N) and cytohesin-1 Sec7 domain 
were overexpressed in E. coli and purified by Ni-NTA affinity chromatography. ARF1 was loaded 
with GDP in the presence of magnesium ions prior to the assay and the Sec7 domain of 
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cytohesin-1 was preincubated with DMSO as control or Secin 16 at concentrations indicated. Both 
proteins were then mixed and the reaction was initiated by injection of GTP at a final 
concentration of 50 µM. GTP-exchange was determined by measuring the tryptophan 
fluorescence of ARF1 protein (Antonny et al. 1997; Northup et al. 1982). As displayed in figure 
15A, significant inhibition of the reaction can be observed already at concentrations of 2.5 µM. 
The calculated IC50 from the in vitro GTP-exchange assay is 9.7 µM and thus corresponds to the 
concentration used in the other assays to inhibit cytohesin function. These results show that not 
only the GEF-function of ARNO, but also of cytohesin-1 Sec7 domain is effectively inhibited by 
Secin 16 in vitro.  
Secin 144 failed to inhibit GTP-exchange functions of cytohesin-2 towards ARF1 GTPase. However, 
in adhesion experiments Secin 144 proved to be a very potent inhibitor of adhesion to ICAM-1 
mediated by cytohesin-1 in Jurkat T cells. Furthermore, SPR experiments showed a specific 
interaction of Secin 144 with its target cytohesin-1. 
The virtual ligand-based screen for the identification of novel inhibitors for cytohesin proteins was 
based on the fact that Secin H3 specifically interacts with the Sec7 domain of cytohesin proteins. 
The family of cytohesin proteins shows a highly conserved domain structure. It was therefore 
unlikely that the failure of Secin 144 to inhibit GTP-exchange of cytohesin-2 Sec7 domain towards 
ARF1 was due to the fact that it is a specific inhibitor for cytohesin-1 functions. However, to 
exclude this possibility, GTP-exchange experiments with the Sec7 domain of cytohesin-1 have 
been performed.  
Hence, both ARF1(17N) or cytohesin-1 Sec7 domain were overexpressed in E. coli and purified 
by Ni-NTA affinity chromatography. Cytohesin-1 was preincubated with Secin 144 at 
concentrations between 1 µM and 20 µM. ARF1 was preincubated with GDP, EDTA and MgCl2 and 
mixed with cytohesin-1. Reaction was monitored following addition of GTP by measuring the 
tryptophan fluorescence of ARF1 protein (Antonny et al. 1997; Northup et al. 1982).  
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Figure 16: Secin 144 fails in inhibiting cytohesin-1-mediated GTP-exchange towards ARF1 in 
vitro. 
ARF1(17N) (final concentration 500 nM) was loaded with GDP in the presence of 2 mM EDTA. Stabilizing 
magnesium was added at a final concentration of 3 mM. Cytohesin-1 Sec7 domain (amino acids 49 – 249) at 
a final concentration of 80 nM preincubated with DMSO as control or the compound at the indicated 
concentrations was added and the reaction was started by injection of GTP at a final concentration of 
50 µM. The reaction was followed by measuring the tryptophan fluorescence of ARF1 protein at excitation 
and emission wavelengths of 280 nm and 340 nm, respectively. A: The linear region of fluorescence 
increase is displayed versus the time. Lines show the baseline corrected linear regression, error bars 
depict ±SD. B: Calculated slope of the fluorescence increase is displayed versus Secin 144 concentration. 
Only the linear region of the fluorescence increase was used to determine the slope. Asterisks indicate 
significance compared to the DMSO control as calculated via Student’s t-test (*** P< 0.001). C: 
Concentration-activity plot of Secin 144 in GTP-exchange assay. Shown is the slope versus the log of Secin 
144 concentration. The graphs are the averaged result of up to nine independent experiments.  
 
As displayed in figure 16, no inhibition of the cytohesin-1-mediated GTP-exchange reaction 
towards ARF1 can be observed after addition of Secin 144. In contrast, an increase in the GTP-
exchange activity of cytohesin-1 towards ARF1 is visible. However, the half-maximal effective 
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concentration, EC50, for the GTP-exchange was calculated to be more than 310 mM (GraphPad 
Prism). Especially since the GTP-exchange was observed in an in vitro system in the sole presence 
of the two interacting proteins, cytohesin-1 and ARF1, the effect is likely even smaller in a 
cytosolic surrounding. Therefore, it can be concluded, that the applied concentrations of Secin 
144 have no enhancing effect on the GTP-exchange activity of cytohesin-1 proteins in vivo.  
Furthermore, it can be concluded that the observed inhibition effects of Secin 144 in Jurkat T cell 
adhesion are not due to a specific inhibition of only cytohesin-1 in contrast to other cytohesins, 
since there is also no inhibition of GTP-exchange activity of cytohesin-1 towards ARF1.  
This result indicates that the inhibitory function of Secin 144 on cytohesin is limited to the 
adhesion-related branch of cytohesin-functions. Since the GEF function of cytohesin is not 
inhibited, it can be postulated that Secin 144 only inhibits the regulation of 2-integrin activation. 
This qualifies Secin 144 as a potent tool for dissecting GEF-dependent and -independent functions 
of cytohesin for the first time. 
3.3.2 The influence of cytohesin-1 on the activation of 2-integrins 
The activation of LFA-1 is a key function of cytohesin-1 (Kolanus et al. 1996; Geiger et al. 2000). 
Cytohesin-1 is recruited to the plasma membrane after T cell activation and interacts with the 
cytoplasmic tail of 2-integrin thus, leading to conformational changes that result in higher affinity 
of LFA-1 for its corresponding ligand ICAM-1. 
It was reported that cytohesin-1 directly interacts with the 2-integrin CD18 (Geiger et al. 2000; 
Kolanus et al. 1996). The novel small molecule inhibitor Secin 144 specifically inhibits the 
activation of cytohesin mediated 2-integrin activation which could be due to loss of interaction 
between cytohesin-1 and LFA-1. Unfortunately, several attempts to co-immunoprecipitate 
cytohesin-1 with CD18 and in vitro interaction studies with purified cytohesin Sec7 domain and 
cell lysates were unsuccessful regarding the detection of direct interaction between these two 
proteins in the course of this study.  
3.3.2.1 Novel inhibitors for cytohesin function abrogate primary T cell adhesion to 
ICAM-1 and VCAM-1 
Secin 16 and Secin 144 proved to be potent inhibitors of Jurkat T cell adhesion to ICAM-1. The 
small molecule inhibitor Secin 16 does not only inhibit the cytohesin-mediated activation of LFA-1, 
but is also able to abrogate GEF-activity of cytohesin proteins towards ARF-GTPases. Moreover, 
cytohesin-mediated regulation of GEF-activity was reported to be important for T cell adhesion 
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(Geiger et al. 2000; Kolanus et al. 1996). Thus, it was of great interest to test, whether sole 
inhibition of LFA-1 activation could be sufficient to abrogate adhesion in PBL. Furthermore, the 
influence of the inhibitors on activation of other integrins was tested by adhesion assays on 
VCAM-1, a ligand for 1-integrins. To this end, PBL were preincubated with 10 µM Secin 16 or 
Secin 144, stained with H33342 (bisbenzimide) and placed on ICAM-1-Fc or VCAM-1-Fc coated 96-
well plates, respectively. After one hour cells were stimulated with anti-CD3 (OKT3, 5 µg/mL) or 
PMA (50 ng/mL) to induce adhesion for 30 minutes. Unattached cells were carefully removed by 
several washing steps and adherent cells were quantified by measuring incorporated 
bisbenzimide fluorescence at 485 nm. 
 
 
Figure 17: Adhesion of PBL to ICAM-1 and VCAM-1 is strongly reduced after inhibition of 
cytohesin proteins with Secin 144 and Secin 16. 
PBL were preincubated with 10 µM Secin 144 in 0.5% DMSO or DMSO alone, respectively, and 6 µg/mL 
H33342 for one hour in HBSS. Cells were seeded onto ICAM-1 or VCAM-1 coated 96-well plates in triplicates 
and stimulated with OKT3 or PMA, respectively for 15 minutes. 5 consecutive washing steps removed not 
attached cells. Adherent cells were quantified by measuring the fluorescence of incorporated H33342. 
Depicted is the percentage of adherent cells compared to an unwashed control (100%). The average of 4 
and 3 independent experiments is shown. Error bars represent ± SD. Asterisks indicate significant deviation 
from the corresponding DMSO control as calculated by Student’s t-test (** = P< 0.01; *** = P< 0.001) 
As depicted in figure 17, Secin 16 is able to reduce adhesion of PBL to ICAM-1. This effect is milder 
than in Jurkat T cells, however a significant reduction can be observed. Furthermore, the adhesion 
to VCAM-1 is also impaired after Secin 16 inhibited cytohesin-function. PBL seeded on VCAM-1 
are not as responsive to stimulation by anti-CD3 (OKT3) and phorbol ester as compared to cells 
seeded on ICAM-1. However a reduction in the number of adherent cells can still be observed 
indicating that other integrins are also influenced by cytohesin function.  
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Adhesion to both, ICAM-1 and VCAM-1 coated surfaces, is abrogated after incubating PBL with 
Secin 144. Adhesion of PBL to VCAM-1 is not as strong as to ICAM-1 and stimulation does not 
increase the adherence of PBL to the same extent than in PBL seeded on ICAM-1. Secin 144 
treatment leads to inhibition of PBL attachment below unstimulated baseline levels after TCR 
stimulation in both experimental setups. The inhibitory effect of Secin 144 on the adhesion of PBL 
to VCAM-1 might be due to the fact that Secin 144 does not only inhibit cytohesin-1. Cytohesin-2 
and -3 are reported to be important regulators of 1-integrin recycling (Oh and Santy 2010). It is 
therefore possible that the inhibition of other proteins of the cytohesin family might have an 
influence on the adhesion to 1-integrin ligands as VCAM-1. 
3.3.2.2 Adhesion under flow is reduced in Secin 144 treated PBL 
T cells need to firmly attach to endothelial vessels under shear flow of the blood stream for their 
extravasation into inflamed tissues. Therefore, a rapid conformational change of integrins is 
necessary to respond to chemokines, released from the center of infection (Shamri et al. 2005). 
Quast et al. reported that BmDCs were diminished in their ability to firmly attach to endothelial 
cells under flow conditions when cytohesin expression was downregulated by RNAi (Quast et al. 
2009).  
In order to find out the role of cytohesin-1 in the development of activated LFA-1 conformations 
in human PBL, the small molecule inhibitors Secin 16 and Secin 144 were used in adhesion assays 
under flow conditions. 
PBL were preincubated with Secin 16 or Secin 144 in 0.5% DMSO or DMSO alone as vehicle 
control, respectively, for one hour and subsequently perfused in a chamber with a confluent layer 
of HUVECs stimulated with TNF-α to induce ICAM-1 surface expression and loaded with human 
CXCL12 for the induction of LFA-1 high affinity conformation. Adherent cells were quantified.  
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Figure 18: Adhesion of PBL to HUVECs is unaffected under flow-conditions by the inhibition with 
Secin 16 but reduced after inhibition with Secin 144. 
HUVECs were grown to confluency and stimulated with 10 ng/mL TNF- over night. Two hours prior to 
experiment, cells were stimulated with human CXCL12 (500 ng/mL). The HUVECs containing petri dish was 
assembled in a parallel flow-chamber. PBL (1 x 10
6
 cells/mL in HH-buffer) were incubated with 10 µM 
Secin 16 in 0.5% DMSO or DMSO alone (control) prior to experiment. PBL were drawn through the chamber 
with a laminar flow at a shear rate of 1.5 dyn/cm
2
. The cells that were attached to HUVECs after 6 minutes 
of wash were counted. Shown is the average of the adhesion rate from four independent experiments. 
(n.s. = not significant; ** = P < 0.01).  
As it can be seen in figure 18 the inhibition of cytohesin-1 function with Secin 144 reduces the 
ability of PBL to develop LFA-1 high-affinity conformation. In contrast, Secin 16 treatment did not 
lead to alterations in the development of the high affinity state of LFA-1 as depicted by unaltered 
numbers of attached cells to HUVECs.  
A possible explanation for this is, that the compound uses a different site for the inhibition of 
cytohesin-1 therefore inhibition of LFA-1 activation only occurs when Secin 144 is used, because 
Secin 144 is able to fully inhibit the interaction of cytohesin-1 with LFA-1.  
3.3.3 Cytohesin-mediated activation of T cells is not exclusively GEF-dependent 
Cytohesins, especially cytohesin-2 are reported to play an important role in cell signaling, e.g. 
insulin signaling in mice, humans and Drosophila via the PI3K/Akt pathway (Fuss et al. 2006; 
Hafner et al. 2006) and Erb signaling (Bill et al. 2010), connecting cytohesin proteins to very 
important metabolic cell functions and the development of cancer. Since cytohesin-1 is the most 
abundantly expressed cytohesin protein in leukocytes (Moss and Vaughan 2002) it is likely, that 
this protein also plays an important role in immune cell signaling since common signaling cascades 
are involved. Cytohesin-1 was shown to have an important role in T cell activation after TCR 
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engagement (Paul 2007; Grell 2009). The complete role of cytohesin-1 in T cell activation remains 
elusive, however. Especially the dual role of cytohesin proteins as GEFs for ARF-GTPases and LFA-1 
activators was inseparable in the investigation of cytohesin-1 function. The comparison of 
inhibition profiles of Secin 16 in combination with Secin 144 could help to give further insights 
into this question. Therefore, these compounds were used to investigate the role of cytohesins in 
T cell activation and cell signaling. 
3.3.3.1 In murine T cells, IL-2 and interferon- cytokine production is abrogated after 
inhibition with Secin 16  
A major read out for the activation of T cells is the production of the interleukin IL-2. This cytokine 
is produced after engagement of the TCR complex and CD28 and regulates via a positive feedback 
loop the proliferation and clonal expansion of T cells (Serfling et al. 1995; Malek 2008). To 
measure, whether the inhibition of cytohesins has an impact on the production of IL-2, murine 
CD8+ T cells were isolated from spleens of OT-1 mice and preincubated with Secin 16 for one hour. 
Stimulation of the T cells was performed by co-cultivation with OVA-pulsed spleen dendritic cells 
for up to 4 days. IL-2 and interferon- production were quantified by ELISA.  
 
Figure 19: IL-2 and interferon-γ production in murine T cells is abrogated after incubation with 
Secin 16  
Murine CD8+ T cells were isolated from OT-1 mice spleens by MACS separation and pre-incubated with the 
indicated concentrations of Secin 16 in 0.5% DMSO or DMSO alone (control) in RPMI-medium for one hour. 
DC from b/6 wild-type mice were isolated from spleen via MACS-separation and pulsed with 1 mg/mL OVA-
peptide. After one hour cells were mixed and the compound concentration was adjusted to the increased 
volume. After indicated time points, supernatant was collected and cytokine concentration was determined 
by ELISA. Shown results are the average of four experiments. Asterisks indicate significant deviation from 
the corresponding control at the indicated time points as determined by Student’s t-test (* = P < 0.05; ** = 
P< 0.01; *** = P< 0.001)(results in collaboration with Dr. Rike Schulte, IMMEI, Bonn). 
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As shown in figure 19, IL-2 and Interferon- production in murine T cells is abrogated after 
inhibition of cytohesin by Secin 16. 5 µM Secin 16 inhibit the production of IL-2 by more than 70% 
as compared to the corresponding vehicle control, the use of 2.5 µM Secin 16 inhibits the 
Interleukin-2 production by 30 - 64%, depending on the time point. Interferon- production is 
even more inhibited by the use of Secin 16 as compared to DMSO control. At a concentration of 
2.5 µM Secin 16 the interferon- production is reduced by 60 – 80% whereas at a concentration of 
5 µM Secin 16 a reduction of 80-90% can be observed. Thus the inhibitor shows a dose-response 
dependency and significantly inhibits the production of activating cytokines. This corroborates 
findings of Grell and Paul that cytohesin plays an important role in T cell signaling upon activation, 
who could show that cytohesin-1 is an upstream-regulator of IL-2 gene transcription (Grell 2009; 
Paul 2007). 
3.3.3.2 Secin 144 treatment of CD4+ T cells leads to reduced cytokine production 
Cytokine production is an important readout for the activation status of T cells. Cytokines 
determine differentiation of T cell subsets and lead to autocrine activation and clonal expansion 
of T cells. In order to investigate the role of cytohesin-1 for the activation of human T cells, 
cytokine production was measured in human CD4+ T cells. Therefore, CD4+ T cells were isolated by 
magnetic-activated cell sorting and incubated with Secin 16 or Secin 144, respectively, for one 
hour prior to stimulation. T cells were stimulated by the use of artificial antigen presenting cells 
(aAPC, a bead that is coated with anti-CD3 and anti-CD28, for full T cell activation) for two days. 
Supernatants were collected and the cytokines were quantified by a cytometric bead array via 
flow cytometry. 
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Figure 20: CD4+ T cell cytokine production is inhibited by Secin 16 and Secin 144. 
Human CD4+ T cells were isolated by magnetic-activated cellsorting, preincubated with 10 µM Secin 16 or 
Secin144, respectively, in 0.5% DMSO or DMSO alone (vehicle control) and stimulated with anti-CD3/anti-
CD28 beads for 24 and 60 hours. Supernatants were collected at the indicated time points and the cytokine 
concentration was quantified by CBA (cytometric bead array). Shown is a representative out of three 
independent experiments.  
IL-2 is the most important cytokine for the activation of T cells. After TCR engagement together 
with its costimulatory factor CD28, IL-2 is produced in large amounts to stimulate proliferation 
and differentiation of naïve T cells into effector cells. As shown in figure 20A the inhibition of 
cytohesin-1 by Secin 16 and Secin 144 leads to a strong reduction of IL-2 synthesis. The amount of 
IL-2 is 3 – 6 times lower than in the stimulated control. Treatment of CD4+ T cells with Secin 144 
prior to aAPC-stimulation also reduces IL-2 levels after 24 and 60 hours, however, to a lower 
extent as compared to Secin 16 treated cells indicating that both, cytohesin GEF-function as well 
as regulation of LFA-1 activation are important factors in the development of activated T cells. 
Interleukin-4 is an important cytokine for the differentiation of naïve T cells into TH2 cells. It is 
secreted at the site of T cell-APC contact and leads to differentiation and antibody synthesis in 
B cells (Leavy 2010). Inhibition of cytohesin-1 with Secin 16 leads to a reduction of IL-4 synthesis 
down to 30% compared to the stimulated vehicle control. Preincubation of CD4+ T cells with 
Secin144 does not significantly alter the produced amounts of IL-4. 
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Furthermore, incubation of T cells with Secin 16 leads to a strong reduction of TNF- production 
(about 30% of the stimulated vehicle control). TNF- is a cytokine that is produced as acute phase 
response of infectious processes and leads to apoptosis of infected cells. Secin 144 treatment also 
reduces TNF- production, however to a lower extent than inhibition with Secin 16. 
Interferon- is an important cytokine for the differentiation of naïve T cells into TH1 cells, that 
finally leads to an upregulation of cell based immunity. The interferon- level after Secin 16 
treatment is decreased to 75% of the level for the stimulated control. In this context, inhibition of 
cytohesin function by Secin 144 also leads to a decreased level of cytokine production. However, 
the reduction is milder as compared to Secin 16 treatment and therefore indicates that not only 
cytohesin-regulated activation of LFA-1 is of importance in T cell activation but also GEF-
dependent processes.  
These results suggest, that cytohesin-1 is a crucial factor in the activation and differentiation of 
T cells. Furthermore, since the synthesis of major cytokines is relevant in the differentiation of 
T cells to various T cell subsets is reduced after the inhibition of cytohesin-function, cytohesin-1 
appears to be involved in early signaling events after TCR engagement.  
Cytohesin-1 plays an important role in the activation of T cells (Grell 2009; Paul 2007) and the 
novel cytohesin inhibitors Secin 16 and Secin 144 corroborate these findings by the abrogation of 
cytokine production of IL-2, IL-4, TNF- and interferon-.  
Production of several cytokines is reduced after treatment of CD4+ T cells with Secin 144. This 
reduction however, is lower than in Secin 16-treated T cells (cf. figure 20) indicating that on one 
hand LFA-1 activation plays a role in cytokine production and on the other hand it also shows that 
the GEF activity of cytohesin-1 is the main factor for full T cell activation and therefore cytokine 
production. 
3.3.3.3 Proliferation of CD4+ T cells is impaired after inhibition of cytohesin function 
Cytokine production, especially secretion of IL-2, is a hallmark of activated T cells. Furthermore, 
activated T cells expand clonally and divide. Clonal expansion of T cells is a process that involves 
cytokine signaling, TCR- and LFA-1-engagement (Varga et al. 2010; Li et al. 2009; Smith-Garvin et 
al. 2009). Cytohesin proteins are reported to play an important role in signaling events, that are 
initiated by T cell receptor clustering or LFA-1 activation (Geiger et al. 2000; Kolanus et al. 1996). It 
is likely, that the signaling events, mediated by cytohesin proteins, are not solely dependent on 
GEF-activity, but that other functions of the protein are of importance. To further address the 
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question, if proliferation of T cells is regulated by cytohesin-1 and if this regulation is caused by 
the GEF-activity of cytohesins, Secin 16 and Secin 144 were used as differential inhibitors of 
cytohesin function in proliferation assays. CD4+ T cells were stained with CFSE and were 
preincubated with inhibitor or DMSO as vehicle control for one hour. Subsequently, cells were 
cultivated in the presence of aAPCs and the compound for several days. Cell proliferation was 
followed by measuring the average fluorescence of every cell generation by flow cytometry, since 
the CSFE-dye dilutes with every cell division, leading to populations with distinct lower 
fluorescence intensity as compared to undivided cells. 
 
 
Figure 21: Proliferation of PBL is inhibited by Secin 16. 
CD4
+
 T cells were isolated from buffy coats, stained with CFSE and incubated with 5 µM or 10 µM Secin 16, 
respectively in 0.5% DMSO or DMSO alone for one hour prior to stimulation with aAPC for 5 days. Cells 
were analyzed by flow cytometry. The shown histograms are a representative of five independent 
experiments. Secin 16 strongly inhibits the proliferation of primary T cells.  
As shown in figure 21, proliferation of CD4+ T cells is strongly reduced after inhibiting the 
cytohesin protein with Secin 16. In contrast to the stimulated DMSO control, T cells, preincubated 
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with Secin 16, show almost no proliferation and the main fraction of the population remains in an 
undivided state. This result shows that not only the production of cytokines but also the clonal 
expansion of activated T cells is disturbed after inhibiting cytohesin proteins. 
 
 
Figure 22: Proliferation is marginally influenced by inhibition of cytohesin-1 with Secin 144. 
T cell proliferation is reduced after treatment of CD4
+
 T cells with Secin 144 in a concentration-dependent 
manner. Proliferation inhibition is low compared to the effects induced by use of Secin 16. CD4
+
 T cells were 
isolated, stained with CFSE and incubated with 5 µM or 10 µM Secin 144, respectively in 0.5% DMSO or 
DMSO alone for one hour prior to stimulation with aAPC for 3 days. Cells were analyzed by flow cytometry. 
The shown histograms are a representative of five independent experiments.  
As it is depicted in figure 22, inhibition of cytohesin function with Secin 144 leads to a marginal 
decrease in proliferation of T cells after TCR engagement. These mild effects in T cell proliferation 
are indicating that mainly the GEF-function of cytohesin is of importance in the clonal expansion 
of T cells, especially in comparison with Secin 16 treated cells (cf. figure 21). These findings are in 
good accordance to earlier results in which it was observed, that IL-2 production is reduced in 
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Secin 144-treated cells, however to a smaller extend than cells in which cytohesin function was 
inhibited by the use of Secin 16. The reduction of proliferation is likely to be caused by inhibition 
of LFA-1 activation by Secin 144.  
3.3.3.4 Novel inhibitors for cytohesin function do not cause cell death in primary T cells 
Secin 16 proved to be a potent inhibitor of T cell proliferation and cytokine production. To 
ascertain that these effects are not caused by increased cell death due to toxic side effects of the 
compound, cells were incubated with increasing concentrations of Secin 16 and cell death was 
quantified by Annexin V and propidium iodide staining.  
 
Figure 23: Secin 16 does not alter the viability of PBL. 
Cells were incubated with Secin 16 at concentrations indicated and stimulated with aAPC for three days. 
Cells were subsequently stained with anti-Annexin V-FITC for the detection of apoptosis and propidium 
iodide for the detection of dead cells. The amount of living, apoptotic and dead cells was quantified by flow 
cytometry. Shown is the average of two independent experiments. Error bars indicate ±SD.  
As depicted in figure 23 Secin 16 has no significant impact on the viability of human PBL. The 
amount of living cells in the aAPC-stimulated DMSO control is 71 %. Comparable results are 
derived for the Secin 16-incubated samples. The changes in the number of living, apoptotic and 
dead cells proved to be not significant and a dose-response dependency cannot be observed. This 
indicates that the reduction in cytokine production and proliferation after incubating T cells with 
Secin 16 is not caused by toxicity of the small molecule inhibitor but dependent on the inhibition 
of cytohesin function. 
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Figure 24: Viability of human PBL is not affected by the use of Secin 144 as inhibitor for 
cytohesin-function. 
Cells were incubated with Secin 144 at concentrations indicated and stimulated with aAPC for three days. 
Cells were subsequently stained with anti-Annexin V-FITC for the detection of apoptosis and propidium 
iodide for the detection of dead cells. The amount of living, apoptotic and dead cells was quantified by flow 
cytometry. Shown is the average of two independent experiments. Error bars indicate ±SD. 
In order to show that effects observed in T cell activation, cytokine production and T cell 
proliferation are not caused by enhanced cell death due to the application of the compound, 
viability stains were also performed for Secin 144 treated cells. Figure 24 displays the results of 
the viability stain. Treatment of primary T cells with Secin 144 does not lead to increased 
apoptosis or necrosis as displayed by unaltered levels of dead and apoptotic cells, respectively 
compared to vehicle control treated cells.  
3.3.3.5 Ca2+-flux in Jurkat T cells is not affected by Secin 16 treatment 
T cell signaling consists of a complex network of signaling cascades influencing and signaling back 
to each other. Since it is reported, that cytohesin plays no role in the mobilization of intracellular 
calcium (Paul 2007; El Azreq et al. 2010) and to further examine the specificity of the inhibitory 
compounds for cytohesin-mediated signaling events, Ca2+-flux experiments were performed. To 
this end, Jurkat T cells were preincubated with Secin 16 for one hour and stained with Fluo-3, a 
calcium-sensitive dye. Fluorescence of Fluo-3 was quantified by flow cytometry and stimulation of 
Ca2+-flux was induced by adding 2 µg of anti-CD3 (OKT3) antibody.  
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Figure 25: Ca2+-flux is unaltered in Jurkat T cells after inhibition with Secin 16. 
Jurkat T cells were incubated with 10 µM Secin 16 in 0.5% DMSO or DMSO alone for one hour prior to 
experiment and stained with the Ca
2+
-ion sensitive dye Fluo-3. Ca
2+
-flux was measured with a flow 
cytometer. The baseline was recorded and Ca
2+
-flux was induced by addition of 2 µg anti-CD3 antibody 
OKT3. The increase of fluorescence indicates an increase in free Ca
2+
-ions released into the cytosol. Left site 
depicts Ca
2+
-flux histogram for the DMSO control, right site shows histogram for 10 µM Secin 16. 
As depicted in figure 25, no differences in the calcium-release profile between Secin 16-treated 
Jurkat T cells and DMSO-treated cells can be observed. The fluorescence increase in DMSO vehicle 
control and Secin 16 treated Jurkat T cells is about 10-fold higher after TCR-stimulation. Thus, the 
use of Secin 16 for inhibition of cytohesin has no impact on the signaling cascade responsible for 
calcium release. This observation is in full agreement with earlier results of Paul, who showed that 
transfection of Jurkat T cells with siRNA targeting cytohesin-1 did not alter calcium-levels within 
the cell as compared to control cells (Paul 2007). 
3.3.3.6 Secin 144 does not inhibit the phosphorylation of MAPK ERK1/2 
MAP kinases play an important role in signal transduction during T cell proliferation, eventually 
leading to the production of IL-2 (Serfling et al. 1995). The phosphorylation of the MAPK ERK1/2 is 
reported to be positively regulated by cytohesin function in T cells after LFA-1 engagement (Perez 
et al. 2003). To investigate, how cytohesin-1 mediates the activation and phosphorylation of 
ERK1/2 and, if LFA-1 engagement is a prerequisite for this phosphorylation, CD4+ T cells were 
stimulated with aAPCs after preincubation with Secin 16 or Secin 144, respectively. The 
phosphorylation of ERK1/2 was investigated by the use of western blot analysis.  
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Figure 26: ERK1/2 phosphorylation is diminished by Secin 16 and enhanced by Secin 144 
CD4
+
 T cells were incubated with 10 µM Secin 16 or Secin 144 in 0.5% DMSO, respectively or 0.5% DMSO 
alone (control) for one hour prior to stimulation. Cells were stimulated by aAPC for the indicated times. 
After stimulation cells were lysed and 10 µg of total protein were separated by SDS-PAGE and analyzed for 
phospho-ERK1/2 content via western blot. (unpublished data from Dr. Jessica Grell) 
As depicted in figure 26, phosphorylation of ERK1/2 is abrogated in Secin 16 pretreated CD4+ 
T cells. Total ERK1/2 expression is unaltered. This underlines the importance of cytohesin-1 in the 
activation of T cells. Cytohesin-1 overexpression leads to a strong upregulation of AP-1 expression 
in AP-1 promoter experiments (Paul 2007). The result indicates that this activation is mediated by 
the MAP kinase ERK1/2 underlining the importance of cytohesin-1 mediated signal transduction in 
T cells. 
Secin 144 inhibits the cytohesin-regulated activation of LFA-1 in adhesion however, GTP-exchange 
activity of cytohesin-1 is not inhibited. Figure 26 shows that the phosphorylation of ERK1/2 is not 
inhibited in CD4+ T cells after inhibition of LFA-1 activation via cytohesin-1 with Secin 144. In 
contrast, Secin 144 treatment leads to an increased level of ERK1/2 phosphorylation. This 
activation occurs only after stimulation with aAPCs and not in unstimulated T cells. This indicates 
that not only the catalytic GEF-activity of cytohesin proteins, but also that signaling after TCR 
engagement is necessary for proper signal propagation during T cell activation.  
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3.3.4 Influence of cytohesin-1 on the chemotaxis of immune cells 
Cytohesin-1 is reported to be an important regulator of dendritic cell migration (Quast et al. 
2009). Secin H3 failed to inhibit these complex processes at reasonable concentrations. Due to the 
fact that Secin 16 and Secin 144 were able to inhibit cytohesin-1 dependent adhesion more 
efficiently as compared to Secin H3, it was tested, whether these compounds are also able to 
inhibit cytohesin-dependent functions in immune cell migration. 
Furthermore, Secin 16 and Secin 144 show a differential inhibitory profile dissecting GEF-
dependent and -independent cytohesin functions. It was therefore interesting to investigate into 
the influence of these cytohesin functions in immune cell chemotaxis. 
3.3.4.1 Secin 16 but not Secin 144 inhibits migration of Jurkat T cells and mature 
BmDCs 
Cytohesin-1 is reported to be important for the migration of mature dendritic cells (Quast et al. 
2009). To further characterize Secin 16 and Secin 144, the inhibitors were utilized to inhibit 
cytohesin-1 function in transwell migration assays. Therefore, mature BmDCs were preincubated 
with Secin 16 or Secin 144, respectively at a concentration of 10 µM for one hour and placed on 
top of a modified Boyden chamber. Cells were stimulated with 200 ng/mL murine CCL19 or 
human CXCL12, respectively for 3 hours. Migrated cells were quantified by counting the cells in 
the lower compartment of the chamber and displayed as percent of migrated cells compared to 
the vehicle control (DMSO). 
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Figure 27: Transwell migration of mature BmDCs is inhibited by Secin 16 but not by Secin 144.  
Mature BmDCs were preincubated with 0.5% DMSO (vehicle control), 10 µM Secin 16 or 10 µM Secin144 in 
0.5% DMSO, respectively, for one hour and seeded in a modified Boyden chamber. Cells were stimulated 
with 200 ng/mL murine CCL19. Migrated cells were quantified after three hours of incubation at 37°C by 
counting the cells in the lower compartment of the chamber. The average of three independent 
experiments is shown normalized to the migration rate of the stimulated vehicle control. Asterisks indicate 
significant deviation from the stimulated control as determined by Student‘s t-test (**= P < 0.01; *** = P < 
0.001)  
It is depicted in figure 27 that migration of LPS-stimulated mature BmDCs after the inhibition of 
cytohesin function with the inhibitor Secin 16 is reduced by more than 25% as compared to the 
CCL19-stimulated vehicle control. This inhibition is in concordance with the findings, that RNAi of 
cytohesin-1 strongly reduced CCL19-induced chemotaxis of LPS-stimulated mature DCs (Quast et 
al. 2009). 
Interestingly, transwell migration of mature BmDCs is unaffected by Secin 144 employment. 
Secin 144 does not abrogate chemokine-induced migration as compared to cells that are treated 
with vehicle control.  
To ascertain if the involvement of cytohesin-1 in migration is also important for T cells, transwell 
migration assays were employed and compound-treated Jurkat T cells were examined. 
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Figure 28: Jurkat T cells migration is abrogated by inhibition of cytohesin-1 function with 
Secin16, but not with Secin 144. 
Jurkat T cells were preincubated with 0.5% DMSO (vehicle control), 10 µM Secin 16 or Secin 144 in 0.5% 
DMSO, respectively, for one hour and seeded in a modified Boyden chamber. Cells were stimulated with 
200 ng/mL human CXCL12 for three hours. Migrated cells were quantified after three hours of incubation at 
37°C by counting the cells in the lower compartment of the chamber. The average of three independent 
experiments is shown normalized to the migration rate of the stimulated DMSO control. Asterisks indicate 
significant deviation from the stimulated control as determined by Student‘s t-test (***=P< 0.001, n.s. = not 
significant) 
In human T cells, Secin 16 inhibits chemokine-induced transwell migration even more efficiently 
than compared to murine, mature BmDCs. As depicted in figure 28, transwell migration ability of 
Jurkat T cells is reduced about 50% in the presence of Secin 16. Thus, Secin 16 is also a potent 
inhibitor of human immune cell migration mediated by cytohesin-1. 
However, transwell migration of mature BmDCs and Jurkat T cells is unaffected by Secin 144 
employment (cf. figure 27 and figure 28). The compound does not alter chemokine-induced 
migration as compared to cells that are incubated with DMSO as control. Since Secin 144 mainly 
inhibits the cytohesin-mediated activation of LFA-1 this result is explainable, because in this 
experimental setup no specific ligand for LFA-1 was present.  
Transwell migration seems to be mainly influenced by GEF-activity of cytohesin proteins as it can 
be concluded from the results comparing effects of Secin 16 and Secin 144 if no specific ligand is 
present. 
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3.3.4.2 The role of cytohesin-1 in immune cell migration on two-dimensional substrates  
On two-dimensional surfaces dendritic cells use integrins as a force generator for forward 
locomotion (Johnson et al. 2006; Alon and Dustin 2007). It is known, that cytohesin interacts 
specifically with LFA-1 and therefore leads to an activation of this integrin (Geiger et al. 2000; 
Kolanus et al. 1996). Furthermore, cytohesin-2 and cytohesin-3 are reported to act in a 
complementary fashion in the recycling of 1-integrins and, as a consequence, influence their 
activity as well (Oh and Santy 2010). To further characterize Secin 16 and Secin 144, respectively, 
and therefore the role of cytohesin proteins in immune cell migration, the chemotaxis of immune 
cells on two-dimensional substrates was investigated.  
Cell migration on two-dimensional surfaces is strongly integrin-dependent (Alon and Dustin 2007; 
Johnson et al. 2006) and inhibition of the cytohesin-1-mediated activation of 2-integrins should 
lead to an alteration of chemotaxis in immune cells. Since Secin 144 does not have an influence on 
the GEF-function of cytohesin-1 it is interesting to investigate, which impact the sole inhibition of 
cytohesin-regulated LFA-1 activation has on the chemotaxis of immune cells.  
To this end, two-dimensional migration assays were performed. Cells were seeded on fibronectin, 
fibrinogen or ICAM-1 coated surfaces, respectively, and stimulated with 600 ng/mL chemokine 
(for immature BmDCs CCL3, for PBL CXCL12, respectively). Motility of the cells was monitored by 
live cell imaging.  
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Figure 29: Inhibition of cytohesin leads to diminished migration of immature BmDCs on 
fibronectin mediated by cytohesin-dependent GEF-activity. 
Cells were preincubated with 10 µM Secin16 or Secin 144 in 0.5% DMSO or DMSO alone as control, 
respectively, in minimal medium and seeded on ibidi slides coated with 50 µg/cm
2
 fibronectin for one hour. 
A chemokine gradient was applied from the upper side of the slide (CCL3 200 ng/mL as indicated by the 
arrow) and cells were followed via live cell imaging. For each sample 30 cells were tracked using ImageJ 
manual tracking tool and chemotaxis plots, y-forward migration and velocity were determined using ibidi’s 
chemotaxis plugin tool in Image J. Error bars depict ± SD, asterisks indicate significant deviation compared 
to the stimulated DMSO control (n.s. = not significant; ** = P < 0.01; *** = P< 0.001 determined by 
student’s t-test) 
Results 
80 
Immature BmDCs show an impairment in chemotaxis, when they migrate towards a CCL3 gradient 
on the extracellular matrix protein fibronectin (cf. figure 29) only after Secin 16 treatment. The 
velocity is strongly reduced when cytohesin-1 is inhibited by Secin 16. Furthermore, the distance 
covered by immature BmDCs, when migrating towards CCL3 is reduced after Secin 16 treatment. 
This supports findings of Quast et al. who could show that chemotaxis is impaired when mature 
BmDCs migrate through fibronectin coated transwell filters after RNAi of cytohesin-1. Treatment 
of immature BmDCs with Secin 144 does not lead to alterations in chemokine-induced migration 
on fibronectin.  
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Figure 30: Immature BmDCs show no significant reduction in chemotaxis on fibrinogen after 
inhibition of cytohesin functions. 
Cells were preincubated with 10 µM Secin16 or Secin 144 in 0.5% DMSO or DMSO alone as vehicle control, 
respectively in minimal medium and seeded on ibidi slides coated with 50 µg/mL fibrinogen for one hour. A 
chemokine gradient was applied from the upper side of the slide (CCL3 200 ng/mL as indicated by the 
arrow) and cells were followed via live cell imaging. For each sample 30 cells were tracked using ImageJ 
manual tracking tool and chemotaxis plots (A-D), y-forward migration (E) and velocity (F) were determined 
using ibidi’s chemotaxis plugin tool in Image J. Error bars depict ± SD, asterisks indicate significant deviation 
compared to the stimulated DMSO control (n.s. = not significant; *** = P< 0.001 determined by student’s t-
test) 
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In immature, murine BmDCs, two-dimensional migration on fibrinogen is hardly affected, when 
cytohesin-1 function is inhibited by Secin 16 or Secin 144, respectively. Neither the track lengths 
nor y-forward migration index or velocity-values are significantly changed by treatment of the 
cells with the small molecule inhibitors Secin 16 and Secin 144. Interestingly, unstimulated cells 
also show a high motility as depicted by the velocity of the cells (cf. figure 30F). Stimulation in this 
context leads to directing the cells towards the chemokine gradient as displayed by the y-forward 
migration index. This index is calculated as the ratio of movement into chemokine-direction (y-
movement) and the length that is covered, and gives information about the degree of 
directionality of the forward locomotion. 
Figure 31 displays the two-dimensional migration of immature BmDCs when they migrate towards 
CCL3 on ICAM-1. CCL3-induced chemotaxis of immature BmDCs on ICAM-1 is abrogated, if cells 
are preincubated with Secin 16 as compared to the CCL3-stimulated vehicle control. The velocity 
of Secin 16 treated cells is strongly reduced, but also the distances that are covered by these cells 
are much lower than in the stimulated control. In contrast, Secin 144 treatment only slightly alters 
path lengths and velocities of immature BmDCs when they migrate towards CCL3 on ICAM-1. 
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Figure 31: Migration on a two-dimensional surface of immature BmDCs on ICAM-1 is abrogated 
if cytohesin is inhibited by Secin 16 treatment, and to lower extend by Secin 144. 
Immature BmDCs were preincubated with 10 µM Secin16 or Secin 144 in 0.5% DMSO or DMSO alone as 
vehicle control, respectively, in minimal medium and seeded on ibidi slides coated with ICAM-1-Fc 
supernatants for one hour. CCL3 (200 ng/mL) was applied to one side of the slide for the induction of a 
chemokine gradient (as indicated by the arrow) and cells were followed via live cell imaging. For each 
sample, 30 cells were tracked using ImageJ manual tracking tool and chemotaxis plots (A-D), y-forward 
migration (E) and velocity (F) were determined using ibidi’s chemotaxis plugin tool in Image J. Error bars 
depict ± SD, asterisks indicate significant deviation compared to the stimulated DMSO control (n.s. = not 
significant; * = P < 0.05; ** = P < 0.01; *** = P< 0.001 determined by student’s t-test) 
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Taken together, these findings indicate that if a specific ligand for LFA-1 is present, e.g. fibronectin 
or ICAM-1, respectively, inhibition of cytohesin-1 and therefore inhibition of LFA-1 activation 
leads to a reduction in chemokine-induced migration of murine immature dendritic cells. This 
reduction however seems to be mainly dependent on the guanine nucleotide exchange function 
of cytohesin-1, since inhibition with Secin 144, which is shown to only influence the regulation of 
LFA-1 activation, only effects chemotaxis to a lower extend.  
This shows on one hand the importance of cytohesin-1 in the migration of immune cells on the 
other hand, it also indicates that not only integrin-dependent processes are responsible for the 
forward locomotion of immune cells in a chemokine gradient, but also intracellular processes 
mediated and regulated by cytohesin-1 seem to be of great importance, which are controlled and 
supported by the GEF-activity of this protein.  
It was furthermore interesting to investigate the role of cytohesin proteins in the two-dimensional 
migration of T cells. To this end, PBL were preincubated with Secin 16 in 0.5% DMSO or DMSO 
alone as control and seeded on fibrinogen and ICAM-1 coated surfaces. 
The influence of cytohesin-1 on the migration of PBL on a two-dimensional fibrinogen substrate is 
displayed in figure 32. Chemokine-induced migration is strongly impaired after application of 
Secin 16 to PBL. Lymphocytes migrate slower and forward locomotion is abrogated. Secin 144 
does not significantly alter CXCL12-induced chemotaxis of PBL  
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Figure 32: Chemotaxis of PBL on two-dimensional fibrinogen is abrogated after inhibiting 
cytohesin-1 functions with Secin 16, but not by Secin 144 treatment. 
Cells were preincubated with 10 µM Secin16 or Secin 144 in 0.5% DMSO or DMSO alone as control, 
respectively, in minimal medium and seeded on ibidi slides coated with 50 µg/mL fibrinogen for one hour. A 
chemokine gradient (arrow) was applied from the upper side of the slide (CXCL12 200 ng/mL) and 
chemotaxis was followed via live cell imaging at 37°C. For each sample 30 cells were tracked using ImageJ 
manual tracking tool and chemotaxis plots. Error bars depict ± SD, asterisks indicate significant deviation 
compared to the stimulated DMSO control (n.s. = not significant; *** = P< 0.001 determined by student’s t-
test) 
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Figure 33: Chemotaxis is reduced after inhibition of cytohesin function in PBL migrating on two-
dimensional ICAM-1.  
Cells were preincubated with 10 µM Secin 16 or Secin 144 in 0.5% DMSO or DMSO alone as vehicle control, 
respectively in minimal medium and seeded on ibidi slides coated with ICAM-1-Fc for one hour. A 
chemokine gradient was applied from the upper side of the slide (CXCL12 200 ng/mL) and cells were 
monitored via live cell imaging. For each sample 30 cells were tracked using ImageJ manual tracking tool 
and chemotaxis plots (A-C), y-forward migration (D) and velocity (E) were determined using ibidi’s 
chemotaxis plugin tool in Image J. Error bars depict ± SD, asterisks indicate significant deviation compared 
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to the stimulated DMSO control (n.s. = not significant; ** = P < 0.01; *** = P< 0.001 determined by 
student’s t-test) 
Two-dimensional migration of PBL is also significantly reduced on ICAM-1 coated surfaces after 
inhibition of cytohesin function by the use of Secin 16. Additionally to decreased track lengths 
also the forward migration ability and velocity are significantly reduced as delineated in figure 33. 
Interestingly, in this setup also the inhibition of cytohesin-1 function by Secin 144, that is only 
limited to regulation of LFA-1 activation, leads to a decrease in chemotaxis of PBL.  
3.3.4.3 Immune cell chemotaxis in three-dimensional environment is dependent on 
cytohesin-GEF activity 
Since immune cells mainly migrate in a three-dimensional tissue environment under natural 
conditions, transwell migration and 2D migration are not completely representative for the in vivo 
situation. Taking that into account, 3D migration experiments were performed in which cells 
migrate through a three-dimensional collagen gel matrix in vitro. Mature BmDCs were mixed with 
collagen and the small molecule inhibitors Secin 16 and Secin 144, respectively, and incubated for 
one hour at 37°C prior to stimulation. 600 ng/mL murine CCL19 were then applied on top of the 
collagen to create a chemokine gradient allowing cells to migrate directionally. The cells were 
observed via live cell microscopy in a climate chamber at 37°C and tracks were monitored by live 
cell imaging over a period of four hours at a frame rate of 2 minutes/frame. 
As it can be seen in figure 34, Secin 16 strongly inhibits the chemotactic migration of murine 
mBmDCs in a 3D environment as compared to the DMSO-treated vehicle control. Not only the 
distance that is covered by the migrating cells is strongly reduced compared to the control but 
also the directionality as depicted by the y-forward migration index and the velocity are 
significantly reduced by at least 50% of the vehicle control. In contrast, treatment of cells with 
Secin 144 does not significantly alter chemotactic migration of mature BmDCs in collagen 
matrices.  
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Figure 34: Migration of mBmDCs in three-dimensional collagen matrices is reduced after Secin 
16 treatment but unaffected by inhibition of cytohesin function with Secin144. 
Mature BmDCs were incubated with 10 µM Secin 16 or Secin 144 in 0.5% DMSO or DMSO alone (vehicle 
control), respectively for one hour prior to stimulation. 600 ng/mL murine CCL 19 was applied on top of the 
collagen to create a chemokine gradient. Results of the quantification of live cell imaging are depicted. For 
each experiment 30 cells tracks were followed over a period of 4 hours in which every two minutes a 
picture was taken. Acquired data were analyzed with chemotaxis and migration plug-in tools (ibidi) in Image 
J and chemotaxis plots, y-forward migration index and velocity were calculated and shown as diagrams. 
Error bars indicate ± SD, asterisks indicate significant deviation from the stimulated control as determined 
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in Student’s t-test (n.s. = not significant; **=P< 0.01; ***=P< 0.001). The data are representative for five 
independent experiments. 
In another experimental setup chemotaxis of PBL in collagen matrices was investigated after 
inhibition of cytohesin-function with the cytohesin-inhibitors Secin 16 and Secin 144. PBL were 
preincubated with 10 µM of the respective small molecule inhibitor in 0.5% DMSO or DMSO alone 
as vehicle control, respectively and mixed with collagen. After one hour 600 ng/mL CXCL12 were 
applied on top of the collagen to evoke a chemokine gradient and cell movement was monitored 
by live cell microscopy in a climate chamber at 37°C. 
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Figure 35: PBL chemotaxis in three-dimensional collagen matrices is only reduced after 
inhibiting cytohesin-function with Secin 16 but not with Secin 144. 
PBL were incubated with 10 µM Secin 16 or Secin 144 in 0.5% DMSO or DMSO alone (vehicle control), 
respectively for one hour prior to stimulation. 600 ng/mL human CXCL12 was applied on top of the collagen 
to create a chemokine gradient. Results of the quantification of live cell imaging are depicted. For each 
experiment 30 cells tracks were followed over a period of 4 hours in which every two minutes a picture was 
taken. Acquired data were analyzed with chemotaxis and migration plug-in tools (ibidi) in Image J and 
chemotaxis, y-forward migration index and velocity were calculated and shown as diagrams. Error bars 
indicate ± SD, asterisks indicate significant deviation from the stimulated control as determined in Student’s 
t-test (n.s. = not significant; *=P< 0.05; ***=P< 0.001). The data are a representative for five independent 
experiments. 
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As displayed in figure 35, the migratory capability of PBL is strongly reduced after inhibiting 
cytohesin-1 function with Secin 16. The overall migration is lower and also directionality as 
represented by the y-forward migration index is abrogated. The velocity is reduced, however to a 
lower extent than compared to velocity reduction in mature BmDCs, which might be due to a 
higher motility of PBL. Thus, even in unstimulated samples the chemotaxis and velocity are higher 
than in mBmDCs. Secin 144 treatment however, does not reduce chemotactic movement of PBL 
in a three-dimensional collagen gel. All measured parameters e.g. track length, y-forward 
migration and velocity do not significantly alter as compared to the CXCL12-stimulated vehicle 
control. 
Taken together, these findings confirm, that in three-dimensional chemotaxis, cytohesin-1 
function is an important factor for the migration of immune cells, e.g. mature BmDCs and PBL. 
Furthermore, for this migration mode, the functions of cytohesin-1 that are related to guanine 
nucleotide exchange are indispensable, whereas cytohesin-1 mediated activation of LFA-1 is 
redundant. These findings are augmented by reports that dendritic cells move integrin-
independently in three-dimensional surroundings (Lämmermann et al. 2008; Quast et al. 2009) 
and further imply that integrins are also dispensable for locomotion of T cells in a three-
dimensional substrate.  
3.3.4.4 Chemokine-induced ex vivo migration of Langerhans Cells is dependent on the 
GEF-function of cytohesin-1 
The inhibition of cytohesin-1 with Secin 16 proved to be a useful tool to investigate the function 
of cytohesin-1 in migration. Furthermore it was shown before that Secin 144 is a partial inhibitor 
of cytohesin-mediated functions that are involved in integrin activation (see chapter 3.2). Neither 
in mature BmDCs nor in T cells, transwell migration and chemotaxis in three-dimensional 
surroundings were altered after inhibition of cytohesin functions by employment of Secin 144. 
However these experiments are limited in mimicking tissue environment and, since no specific 
ligand for LFA-1 was present in the experimental setup, an influence on immune cell migration 
could not be observed. To investigate further impacts of cytohesin-1 on migration in a three-
dimensional situation, and the role of cytohesin-mediated activation of LFA-1 function, ex vivo 
migration experiments, in which the chemotaxis of Langerhans cells migrating from ear tissue 
towards a chemokine, were performed. 
Mouse ears of WT C57BL/6 mice were divided in dorsal and ventral halves and floated on 
medium, containing 10 µM Secin 16 or 10 µM Secin 144 in 0.5% DMSO or DMSO alone as vehicle 
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control, respectively. After one hour of incubation 100 ng/mL CCL19 was added to the medium in 
presence of vehicle and compounds. The ears were cultivated for three days and emigrated 
Langerhans cells (LC) were subsequently quantified.  
 
Figure 36: Migration of Langerhans cells out of ear tissue is not disturbed by the application of 
Secin 144 as inhibitor for cytohesin function however, Secin 16 treatment reduces emigrated 
cell numbers. 
Mouse ears were separated into dorsal and ventral halves and were laid with the dermal site down onto 
growth medium containing 0.5% DMSO (vehicle control) or 10 µM Secin 16 or Secin 144 in 0.5% DMSO, 
respectively. After one hour 100 ng/mL murine CCL19 was added as stimulation where indicated. Ears were 
cultivated for three days and migrated LCs were quantified. Shown is the average migration rate 
determined from five independent experiments. Asterisks indicate significance as determined via Student’s 
t-test (n.s. = not significant; ** = P< 0.01; *** = P<0.001).  
Cytohesin-1 seems to be important for the migration of Langerhans cells. Inhibition of cytohesin-1 
functions with Secin 16 leads to a reduction of over 30% in the number of cells that migrate out of 
the ear in direction towards the chemokine as compared to the stimulated vehicle control. This 
indicates that also in more complex tissue surroundings cytohesin-1 is needed for proper 
migration of immune cells towards a chemokine.  
However, the results depicted in figure 36 also show clearly that the partial inhibition of cytohesin 
function that is related to regulation of integrin activation does not cause a decrease in the 
migration-ability of Langerhans cells towards a chemokine. Thus, chemotaxis in tissue 
environment does not need activated integrins on dendritic cells for locomotion and therefore 
activation via cytohesin-1 is dispensable. These findings indicate that the GEF-function of 
cytohesin-1 is an important factor for the chemokine-induced chemotaxis of many immune cells, 
e.g. T cells and dendritic cells in mice and men. 
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4 Discussion 
4.1 Novel small molecule inhibitors for cytohesin protein function  
This study describes the discovery of novel small molecules that serve as inhibitors for cytohesin 
function, and its implications in the further investigation of GEF–dependent and –independent 
cytohesin function in immune cells.  
Cytohesin proteins were first discovered as regulators of LFA-1 mediated cell adhesion (Kolanus et 
al. 1996). Furthermore they serve as guanine-nucleotide exchange factors for ADP-ribosylation 
factors (ARF) (Chardin et al. 1996). There are four known members of the cytohesin family in 
mammals, namely cytohesin-1, cytohesin-2 (ARNO), cytohesin-3 (Grp1 and steppke in Drosophila) 
and cytohesin-4 (Ogasawara et al. 2000). Except for cytohesin-4, which is only expressed in cells of 
hematopoietic origin (Ogasawara et al. 2000), all other cytohesins are ubiquitously expressed. All 
guanine nucleotide exchange factors for ARF proteins share a common domain, the Sec7 domain 
which harbours the catalytic GEF-activity.  
This function can be inhibited by Brefeldin A, however, the small ARF-GEFs of the cytohesin family 
are insensitive to treatment with this compound. Until very recently, no chemical inhibitor for 
cytohesin proteins was available and hence the investigation of cytohesin function relied on 
overexpression and RNAi-knockdown experiments. The small molecule Secin H3 (Sec7 domain 
inhibitor H3) was discovered in an aptamer displacement assay (Hafner et al. 2006). In this assay, 
Secin H3 was able to replace the aptamer M69 (Mayer et al. 2001), that specifically binds to 
cytohesin proteins. Furthermore, the small molecule specifically inhibited cytohesin function and 
had no influence on other ARF-GEFs, e.g. EFA6. By the use of this inhibitor it was possible to link 
cytohesin function to signaling pathways including insulin signaling and EGFR signaling (Bill et al. 
2010; Hafner et al. 2006).  
Notwithstanding the efficacy of Secin H3 to inhibit cytohesin function in signaling pathways, such 
as insulin signaling and EGFR signaling, in immune cells, this small molecule was only insufficiently 
capable of inhibiting cytohesin functions. Therefore – and because no knockout model is available 
at the moment – it was necessary to find novel small molecules with higher efficacy for the 
inhibition of cytohesin function especially in immune cells.  
This task was addressed by a novel approach combining bioinformatics for in silico identification 
of potential novel small molecule candidates with several in vitro experiments for functional 
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screening, regarding their efficacy in inhibiting known cytohesin functions. The bioinformatic 
strategy included two separate screening methodologies for the identification of small molecules 
that are similar to the lead compound Secin H3 yet divergent enough to display a different 
inhibition profile for cytohesin functions (Stumpfe et al. 2010). 
In the outcome of the virtual in silico screening approach, 145 compounds were selected due to 
their theoretical potential to serve as cytohesin inhibitors and their commercial availability and 
were subjected to further investigation. In three different assays, the inhibitory potential of these 
compounds was tested. These specific assays were chosen, because they are an established 
representation of the reported cytohesin functions. Furthermore, in these initial screenings the 
combination of the assays was selected in such a way, that three members of the cytohesin family 
were involved and a combination of various in vitro experiments was performed with cytohesins 
from different organisms(cf. figure 8).  
One screening experiment was the GDP/GTP-exchange assay, in which the Sec7 domain of 
cytohesin-2 (ARNO) catalyzes the GDP-to-GTP-exchange on ARF1(17N) in vitro (Stumpfe et al. 
2010). GTP-loading onto ARF1 leads to an increase in the intrinsic tryptophan autofluorescence, 
caused by a conformational change in the protein. Inhibition of ARNO would lead to diminished 
incorporation of GTP in ARF1 and therefore less increase in fluorescence.  
The second experiment was based on the reported involvement of the Drosophila cytohesin 
steppke in FOXO1-dependent insulin signaling (Stumpfe et al. 2010; Fuss et al. 2006). Upon 
stimulation of starved S2 cells with insulin, phosphorylation of dFoxo1 by Akt/PKB can be 
observed (Fuss et al. 2006). The transcription factor dFoxo1 is thereby retained in the cytosol and 
unable to regulate the transcription of d4EB-P1. Inhibition of steppke leads to decreased dFoxo1 
phosphorylation, therefore, dFoxo1 can enter the nucleus and can regulate the d4EB-P1 
transcription which in turn leads to elevated d4EB-P1 mRNA levels.  
The third experiment in this study setup exploited the reported function of cytohesin-1 to 
increase adhesive properties of immune cells to ICAM-1 coated surfaces upon TCR engagement or 
stimulation of T cells with the DAG-analog PMA (Stumpfe et al. 2010). Inhibition of cytohesin-1 as 
a direct interaction partner of LFA-1 leads to diminished adhesion of T cells to ICAM-1 (Kolanus et 
al. 1996). Quantification of T cells that are attached to ICAM-1 coated surfaces after treatment 
with the novel small molecules served as readout in this assay. 
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In combination, the outcome of these three different assays can provide valuable information for 
creating holistic inhibition profiles of the putative novel small molecule inhibitors, since all these 
assays address different reported functions of the cytohesin family and furthermore diverse 
cytohesins are involved.  
In this initial screen two novel molecules, namely Secin 16 and Secin 144, were identified amongst 
others, which showed interesting inhibition profiles. These small molecules were further selected 
for the investigation of cytohesin function in the present study. 
Secin 16 was able to inhibit the reported cytohesin functions in all of the three initial screening 
experiments with significantly higher efficacy compared to Secin H3 treatment. Thus, it inhibited 
the in vitro GTP-exchange of ARF1(17N) catalyzed by ARNO, led to elevated d4EB-P1 mRNA 
levels upon stimulation of S2 cells with insulin and abrogated adhesion of Jurkat T cells to ICAM-1 
coated surfaces (cf. figure 10).  
In contrast, Secin 144 was only able to inhibit cytohesin function in one of the three screening 
experiments. Secin 144 could efficiently block adhesion of Jurkat T cells to ICAM-1 coated 
surfaces. However, neither inhibition of ARNO-catalyzed GDP/GTP-exchange nor influence on the 
increase of d4EB-P1 could be observed (cf. figure 13) 
This was an interesting finding and raised more questions concerning the different character of 
these small molecule compounds.  
First of all, it was of great importance to ascertain that the observed inhibitory phenotypes are 
due to a specific interaction of the compounds with its target protein, cytohesin. To address this 
question, SPR experiments were performed with the Sec7 domain of cytohesin-1. Indeed, an 
interaction between the small molecule compounds Secin 16 and Secin 144 and the Sec7 domain 
of cytohesin-1 could be observed (figure 11 and figure 14). The interaction proved to occur in a 
concentration-dependent fashion. Furthermore, application of LY294002, a small molecule 
specific for the inhibition of PI3-kinase, served as a negative control and did not alter SPR curves. 
Unspecific interaction of the small molecules with other proteins was further excluded by 
measuring interaction of the small molecules to covalently linked BSA or ARF1 via SPR. Also in this 
experimental setup, no interaction could be observed. This led to the conclusion that the small 
molecules are able to specifically interact with cytohesin-1 proteins. However, it cannot be fully 
ruled out that these compounds influence other proteins than the family of cytohesin proteins. 
Nevertheless, there are some points that can serve as arguments against this, since on one hand 
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these molecules are structurally derived from the small molecule inhibitor Secin H3 that 
specifically interacts with the Sec7 domain of cytohesin proteins, and therefore, these novel 
compounds are likely to interact in a comparable fashion with the target protein. On the other 
hand, the assays chosen for the functional screening are very divers concerning the signaling 
pathways that are involved and the only protein that is involved in all these pathways is cytohesin. 
Furthermore, in the in vitro GTP-exchange assay only ARF1 and the Sec7 domain of cytohesin are 
present, and since the SPR experiments showed that the compounds do not interact with ARF1, 
cytohesin proteins are the only potential targets in this assay. 
In conclusion, this multi-disciplinary approach of bioinformatics, chemistry and biology was very 
successful in the identification of novel small molecule compounds that can serve as inhibitors for 
cytohesin function (Stumpfe et al. 2010). 
It was then of great interest to characterize the nature of these small molecule compounds, 
especially, since a differential inhibitory profile was observed regarding the compounds Secin 16 
and Secin 144 in the GTP-exchange and drosophila FOXO1 assay.  
Secin 144 treatment solely affected adhesion of Jurkat T cells to ICAM-1 but did not exhibit 
significant alterations in the in vitro GTP-exchange assay or in the expression levels of d4EB-P1 
mRNA in starved S2 cells after insulin stimulation (figure 13). Although all proteins of the 
cytohesin family share a high similarity, which is especially true for their Sec7 domain, it had to be 
investigated whether this discrepancy in inhibitory ability was due to a sole inhibition of 
cytohesin-1 proteins with Secin 144. To rule out this possibility, in vitro GTP-exchange assays with 
the Sec7 domain of cytohesins-1 and ARF1(17N) were performed. Also in this experimental 
setup the use of Secin 144 showed no reduction of cytohesin-catalyzed GTP-exchange towards 
ARF1 (figure 16). In contrast, the use of Secin 16 efficiently decreased GTP-loading onto ARF1 by 
cytohesin-1 Sec7 domain (figure 15). It can therefore not only be concluded that Secin 144 targets 
specifically cytohesin proteins but also that the different inhibition profile compared to Secin 16 is 
due to a separate inhibitory mechanism by which Secin 144 abrogates cytohesin function in T cell 
adhesion. A possible explanation is the alteration in the binding site of the small molecule to the 
Sec7 domain. Binding of the compound to the Sec7 domain seems to exclusively inhibit the 
interaction between the Sec7 domain and LFA-1, although this interaction site has to be in close 
proximity to the position of the catalytic GEF-activity of the cytohesin proteins. This can be 
concluded from the observation that Secin 16 in contrast is able to inhibit both functions, the 
GEF-activity as well as the adhesion of T cells to ICAM-1. To fully understand the nature of 
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inhibition of these two small molecule inhibitors it would be of great importance to identify the 
exact binding sides of Secin 16 and Secin 144, respectively. This could be done by X-ray 
crystallography or binding studies e.g. SPR experiments with point mutants of the cytohesin Sec7 
domain. 
Furthermore, these results clearly show that the influence of cytohesin-1 on the regulation of 
LFA-1 and therefore T cell adhesion is not dependent on its catalytic activity as a GEF for ARF 
proteins.  
In comparison, the E157K mutant affects both, the GTP-exchange ability of cytohesin proteins as 
well as the LFA-1 mediated adhesion of immune cells (Knorr et al. 2000; Geiger et al. 2000). Thus, 
it can be concluded that the mutation at this position and the resulting conformational changes 
affect the interaction with proteins of the ARF family and interaction with other regulatory 
proteins as those of the integrin family. Secin 144 now separates these functions that were 
thought to be inseparable and the use of this compound might provide valuable information 
about the function of this class of proteins. 
Combination of the two novel inhibitors in assays that serve as readout for cytohesin function can 
possibly provide information important to dissect GEF-dependent and -independent regulation of 
cytohesin proteins for the first time.  
 
4.2 GEF-dependent and independent functions of cytohesin in T cell activation 
Cytohesin-1 is reported to be a direct interactor of 2-integrins (Geiger et al. 2000; Kolanus et al. 
1996). In this regard, overexpression of cytohesin-1 regulates the activation of LFA-1 and leads to 
enhanced adhesion of Jurkat T cells to ICAM-1 coated surfaces after TCR engagement (Geiger et 
al. 2000; Kolanus et al. 1996).  
Inhibition of cytohesin function by application of the two novel small molecule compounds 
Secin 16 or Secin 144 indeed leads to abrogated adhesion of T cells to ICAM-1 coated surfaces 
after TCR engagement (cf. figure 5, figure 10 and figure 13). This inhibition of adhesion is most 
probably due to interference with the interaction between 2-integrin and cytohesin-1. The 
molecules inhibit this process with higher efficacy than the earlier described Secin H3 compound 
(Hafner et al. 2006) and can be used in lower concentrations. The exact mode of action was not 
investigated in this study but it would be interesting to investigate where the differences for 
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example in the binding sites of the compounds to the Sec7 domain are. Furthermore, inhibition of 
adhesion is not due to the inhibition of the catalytic GEF-activity of the cytohesin proteins, but can 
be separated by the use of the small molecule Secin 144, which is an exclusive inhibitor for the 
reported cytohesin-1 involvement in the establishment of T cell adhesion to ICAM-1. 
However, inhibition of T cell adhesion does not only occur on ICAM-1 coated surfaces but can be 
also observed for lymphocyte adhesion on VCAM-1, a ligand for VLA-4 (very late antigen-4; 41) 
(figure 17). It was reported that cytohesin-1 only interacts with 2-integrins directly, but not with 
1-integrins (Kolanus et al. 1996). In contrast, cytohesin-2 and -3 are reported to be responsible 
for the regulation of integrins of the 1-family and treatment of HeLa cells with Secin H3 or 
transfection of these cells with siRNA targeting ARNO led to diminished adhesion to fibronectin, 
another 1-integrin ligand (Oh and Santy 2010). It can therefore be concluded that the novel small 
molecule inhibitors for cytohesin function are able to diminish the interaction between proteins 
of the cytohesin family and proteins of the integrin 1-and 2-family. Although cytohesin-3 seems 
to have an opposing effect on adhesion and migration in comparison to cytohesin-2 in HeLa cells, 
chemical inhibition of both proteins at the same time seems to have only an influence on 
cytohesin-2. The situation in PBL is slightly different, since the expression levels of cytohesin-3 are 
marginal (Korthauer et al. 2000). Moreover, cytohesin-1 and -2 seem to act in the same direction 
in the adhesion pathway.  
Adhesion under static conditions is mainly dependent on the presence of a suitable ligand. In 
contrast, the formation of adhesive contacts between T cells and the endothelium in the blood 
stream relies on the fast development of the integrin high-affinity conformation. In earlier studies 
it was shown that cytohesin-1 and the dominant negative cytohesin-1 E157K mutant directly 
interact with the cytoplasmic tail of CD18 and that overexpression of cytohesin-1 wildtype and the 
cytohesin-1 E157K mutant positively regulate the accessibility of the intermediate LFA-1 
conformation mAB24-epitope (Geiger et al. 2000). In contrast, cytohesin-1, but not the 
cytohesin-1 E157K mutant could increase the number of adherent T cells to endothelium under 
flow conditions (Weber et al. 2001). The employment of the novel small molecule compounds 
corroborates the findings of Geiger et al., that it is not the GEF-activity of cytohesins that 
regulates the LFA-1 conformational change (Geiger et al. 2000), since Secin 144 which is unable to 
inhibit the catalytic GEF-activity of cytohesin-1 decreases adhesion of PBL to endothelium under 
flow conditions. In contrast, Secin 16 which is an inhibitor for both, LFA-1 mediated adhesion and 
GEF-activity, fails to inhibit the fast conformational change in LFA-1 in this context (cf. figure 18). 
This interesting finding indicates that the catalytic GEF-function of cytohesin-1 is dispensable in 
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this process. Furthermore, it implicates that the dominant-negative cytohesin-1 E157K mutant 
acts in a yet undefined mechanism that does not only rely on catalytic GEF-activity. Variations in 
the target interaction sites of the two compounds Secin 16 and Secin 144 with the Sec7 domain of 
cytohesin-1 seem to be a possible explanation for differences in the inhibition of T cell adhesion 
to endothelium under flow. For example, the binding of Secin 144 could abrogate the interaction 
between LFA-1 and cytohesin-1 leading to a reduction in T cell adhesion to endothelium, whereas 
inhibition of T cells with Secin 16 only insufficiently interferes in this process but nevertheless 
inhibits long-term establishment of T cell adhesion to ICAM-1.  
It is reported for cytohesin-1 to be part of the outside-in signaling in which cytohesin-1 signs 
responsible for the signal transduction in the MAPK cascade, especially ERK1/2, (Paul 2007; Perez 
et al. 2003) leading to the production of cytokines and proliferation signals. These proliferation 
signals are dependent on the production of IL-2, as a hallmark of T cell activation (Serfling et al. 
1995). IL-2 reporter activity is positively regulated when cytohesin-1 was overexpressed (Paul 
2007). Inhibition of cytohesin-function with the novel small molecule compounds reduces the 
levels of produced IL-2 in murine and human T cells (figure 19 and figure 20). The reduction of IL-2 
production by inhibition of cytohesin-1 corroborates findings of Grell and Paul who could report 
reduction in the IL-2 reporter gene assay after downregulation of cytohesin-1 and upregulation 
following overexpression in T cells. Interestingly, the employment of Secin 144 only leads to a 
partial IL-2 decrease, whereas the use of Secin 16 almost abrogates IL-2 production in murine and 
human T cells. This observation indicates that the activation of LFA-1 is not the main factor for 
initiation of IL-2 production. In contrast, the GEF-function of cytohesin-1 appears to be 
indispensable in this process. The fact, that a slight reduction in the cytokine production after 
application of Secin 144 can be observed, might be explained by a minor impact of LFA-1. 
Although the aAPCs are not coated with a specific ligand for LFA-1, T cell – T cell contacts could 
provide the respective ICAM-1 as ligand in the course of LFA-1 activation and these intercellular 
interactions are then also inhibited by the small molecule compounds. Taken together, the 
catalytic GTP-exchange function of cytohesin-1 and its involvement in the positive regulation of 
integrin activation seem to work synergistically in the process of cytokine production. Comparable 
results are also achieved when the levels of other cytokines where analyzed. Also for IL-4, TNF- 
and Interferon- a slight decrease in cytokine production could be noted, when primary T cells 
were inhibited by the use of Secin 144. In contrast, the employment of Secin 16 led to a strong 
reduction of effector cytokine production.  
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As a result of reduced IL-2 production, inhibition of cytohesin function should also lead to reduced 
proliferation of T cells after TCR engagement. Indeed, the inhibition of cytohesin proteins with 
Secin 16 almost abrogates T cell proliferation (figure 21). In contrast, Secin 144 employment 
inhibits T cell proliferation only marginally (figure 22). Although ICAM-1 as specific LFA-1 ligand is 
not present on the beads, intercellular contacts to other T cells could provide LFA-1 activation and 
therefore subsequent signaling needed for full cytohesin-mediated T cell proliferation. Secin 144 
would also inhibit these activation events, resulting in a minor decrease in proliferation levels. 
Taken together, diminished proliferation as a result of cytohesin inhibition is fully in line with the 
previous findings of reduced cytokine production.  
It can be concluded, that cytohesin-1 is an important factor for the establishment of T cell 
activation. Clonal T cell expansion depends on cytokine production and is regulated in parts by 
signals derived from the MAP kinase cascade. It was shown, that ERK1/2 phosphorylation is 
positively regulated by cytohesin-1 as part of the outside-in signaling after activation of LFA-1 
(Perez et al. 2003). With the help of the novel small molecule inhibitors for cytohesin function it 
was now not only possible to investigate the role of cytohesin in ERK1/2 phosphorylation. 
Additionally, by the combination of the two inhibitors Secin 16 and Secin 144 it was furthermore 
feasible to investigate the influence of LFA-1 in this context. Since Secin 144 seems to solely 
inhibit the LFA-1 activation of cytohesin-1 proteins, the use of this compound should give further 
insides into the question, if LFA-1 activation is an indispensable prerequisite for cytohesin-
mediated ERK phosphorylation. Inhibition of the cytohesin GTP-exchange activity by the use of 
Secin 16 abrogates phosphorylation events of the MAP kinase ERK1/2, whereas sole inhibition of 
cytohesin-mediated LFA-1 activation by Secin 144 employment does not lead to decreased 
phosphorylation levels (figure 26). In contrast, an increase in MAPK ERK1/2 phosphorylation can 
be observed. This puzzling finding might be explained by a slightly enhanced GTP-exchange 
activity of cytohesins after Secin 144 employment that could be observed in vitro, but since this 
effect was very small it is more likely that another, yet unknown factor leads to this enhancement 
of phosphorylation.   
Since no specific ligand for LFA-1 was present in this experimental setup and the stimulation of 
the T cells was achieved by aAPCs that only provide CD3 and CD28 stimulation, it can be 
concluded that the role of cytohesin-1 in the phosphorylation of ERK1/2 during T cell activation is 
not only dependent on LFA-1 induced cytohesin function in primary T cells. This finding 
strengthens previous results of Paul, who could observe a reduction in the ERK1/2 target protein 
phosphorylation of Elk1 after the use of siRNA targeting cytohesin-1 in Jurkat T cells. 
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To further address the question, whether the novel small molecule cytohesin inhibitors show 
undesired side effects in T cell activation associated signaling pathways, intracellular calcium-flux 
after TCR ligation was investigated. Intracellular calcium is released as a consequence of PLC 
activation after TCR engagement. Secin 16 leaves the calcium-levels in T cells unaltered as 
compared to the vehicle control (figure 25). This finding corroborates findings that 
downregulation of cytohesins (Paul 2007) and chemical inhibition of cytohesin proteins by 
Secin H3 (El Azreq et al. 2010) have no influence on the mobilization of intracellular calcium ions. 
Toxicity of the inhibitors could cause reduced cytokine production and lower proliferation rates. 
Therefore, viability studies had to ascertain, that no toxic side effects of the chemical compounds 
influence the outcome of the in vitro experiments. As depicted in figure 23 and figure 24 the use 
of the chemical inhibitors does not impair T cell viability in the course of the experiment. Thus, it 
can be concluded, that the observed effects on proliferation and cytokine production in T cells are 
a result of cytohesin inhibition. Moreover, loss of GTP-exchange activity has the highest impact in 
this context and can only be observed if Secin 16 is used to inhibit cytohesin function. 
 
4.3 GEF-dependent and -independent cytohesin functions in immune cell 
migration  
Immune cell migration is one fundamental component for establishment and maintenance of 
immunity. Immature APCs cross the blood vessels and migrate into tissues, where they mature 
after encountering an antigen. During maturation, dendritic cells leave the residual tissue and 
enter lymphatic vessels that direct them chemotactically to draining lymph nodes. In the lymph 
node, antigens are presented to the lymphocytes. They undergo activation and further 
differentiation and migrate, guided by chemokines, through the blood stream to inflamed tissues, 
where they fulfill pathogen clearance. Without the chemokinetic information provided by 
inflamed tissue or persistent secretion of chemokines by the lymph nodes, no directed movement 
would be possible. This in turn, would lead to prolonged response time, in which pathogenic 
threats could cause severe damage to the organism. Investigation of migration events in immune 
cells therefore is an important task in understanding the nature of the pathogen-host 
homeostasis.  
In this study, two novel molecules were characterized that serve as differential inhibitors for 
cytohesin function, Secin 16 and Secin 144, respectively. Secin 16 application leads to strong 
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inhibition of all reported cytohesin functions in immune cells at a concentration of 10 µM 
including GEF-activity towards ARF proteins and LFA-1 activation. In contrast, Secin 144 occurs to 
be a bonafide inhibitor exclusively affecting cytohesin-mediated integrin activation. 
Overexpression of the dominant negative cytohesin-1 E157K mutant in dendritic cells and primary 
T cells results in low transfection rates and hence, is insufficient for the investigation of the impact 
of cytohesin GEF-activity on immune cell migration. Furthermore, Secin H3, a recently discovered 
cytohesin inhibitor, does not allow for discrimination between GEF-dependent and –independent 
cytohesin functions. The novel small molecule inhibitors described in this study could overcome 
this hurdle and moreover appear to be more potent in inhibition of cytohesin-mediated events as 
compared to inhibition of cytohesin function with Secin H3.  
It was therefore interesting to inhibit cytohesin function in different immune cells and subject 
them to a variety of migration experiments. Transwell migration assays were first used to validate 
the inhibitory potential of Secin 16 and Secin 144. Application of the inhibitors to migrating 
mature BmDCs resulted in a reduction of migration, when Secin 16 was used to inhibit cytohesin 
function. However, employment of Secin 144 for this purpose did not alter the number of 
migrating mature BmDCs after chemokine stimulation compared to vehicle treated cells (Figure 
1figure 27). This indicates, that migration of mature BmDCs is cytohesin dependent and 
furthermore, that the catalytic GEF-function of this protein is indispensable. This finding is in full 
accordance with earlier results of Quast et al., who reported that dendritic cells transfected with 
siRNA targeting cytohesin-1 or overexpressing the dominant negative E157K mutant show a 
reduction in chemotaxis (Quast et al. 2009). Since no specific ligand for LFA-1 was present, the 
influence of cytohesin-mediated LFA-1 regulation was expected to be marginal. In agreement with 
the observations for mature BmDCs, also Jurkat T cells migrate in a GEF-dependent fashion and 
migration could only be inhibited by the use of Secin 16, but not by application of Secin 144 (cf. 
figure 28).  
Transwell assays represent a rather simple model for the investigation of chemotaxis. 
Furthermore, integrins are employed by the cell to generate forward locomotion for chemotaxis 
on two-dimensional substrates (Alon and Dustin 2007; Johnson et al. 2006), but are dispensable 
for immune cells migrating in three-dimensional surroundings (Lämmermann et al. 2008). Hence, 
more complex experiments had to be performed for the investigation of cytohesin-involvement in 
immune cell chemotaxis.  
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Chemotaxis of immature BmDCs on two-dimensional substrates seems to be mainly dependent 
on cytohesin GEF activity. In the presence of ligands for 1- or 2-integrins, inhibition of cytohesin 
protein function with Secin 16 leads to reduced chemotaxis (cf. figure 29 and figure 31). This is 
especially true for surfaces that are coated with fibronectin and ICAM-1. In contrast, inhibition of 
cytohesin-1 mediated LFA-1 activation by Secin 144 has only a minor impact on the migratory 
capacity of immature BmDCs. These observations hint to a role for cytohesin proteins in the 
activation of GTPases rather than in the mediation of integrin binding in this process. In fact, it 
was reported for mature dendritic cells that overexpression of the GEF-inactive cytohesin-1 E157K 
mutant reduced chemotaxis in transwell assays (Quast et al. 2009) 
In comparison, chemotaxis of PBL appears to be stronger dependent on cytohesin-mediated LFA-1 
activation during chemotaxis. Chemotaxis on fibrinogen as a substrate is only impaired when the 
GEF-activity of cytohesin proteins is inhibited by the use of Secin 16 (figure 32). This is an 
interesting finding since fibrinogen is not a specific ligand for integrins expressed by lymphocytes 
and chemotaxis of BmDCs is unaffected by cytohesin-1 inhibition in this context. However, the 
main influence of cytohesin function on migration can be observed when the GTP-exchange 
ability of the protein is inhibited by Secin 16 inhibition (figure 33). Nevertheless, with ICAM-1 as 
substrate for two-dimensional chemotaxis and the employment of Secin 144 as an inhibitor of 
cytohesin-1 mediated LFA-1 activation, migration of T cells is more severely reduced as compared 
to the same situation in immature BmDCs. ICAM-1 is the specific ligand for the 2-integrin LFA-1. 
Presumably this is the reason for the impairment of forward locomotion of PBL, because PBL 
cannot use attachment sites to generate traction for chemotaxis.  
This might indicate that the migration mode of lymphocytes on two-dimensional surfaces slightly 
differs from the one in dendritic cells hinting to a movement that is stronger dependent on the 
involvement of LFA-1. This finding is also underlined by work of Alon and coworkers in which they 
show that the stimulation of lymphocytes with chemokines leads to the clustering of LFA-1 
molecules (Woolf et al. 2007), suggesting that the distribution of active LFA-1 molecules on the 
surface has a stronger impact in PBL. 
In three-dimensional surroundings, inhibition of the GEF-activity of cytohesins by Secin 16 
application leads to a strong reduction of chemotaxis in mature BmDCs as well as in PBL (cf. figure 
34 and figure 35). Utilization of Secin 144 to inhibit cytohesin-mediated LFA-1 activation has no 
impact on the migratory behavior of the examined immune cells. Although collagen is not a 
specific ligand for LFA-1, the same influence of cytohesin proteins can be observed in an in vivo 
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situation. Langerhans cells (LC) that are incubated with the respective compounds also show an 
impairment in chemotaxis only when the cytohesin GEF-activity is inhibited by the use of Secin 16. 
Preincubation with Secin 144 has no influence on LC chemotaxis (figure 36). Lämmermann et al. 
reported that immune cells do not rely on integrin-dependent movement in a three-dimensional 
surrounding (Lämmermann et al. 2008). They migrate mainly by using the environmental traction 
to generate forward locomotion by squeezing. Changes in chemotaxis by inhibition of integrin-
activation is therefore likely not observable.  
Taken together, all chemotactic events in the examined cell types and experimental setups lead to 
the conclusion, that the main function of cytohesin proteins during chemotaxis is the activation of 
GTPases. Cytohesin-mediated integrin activation plays a minor role in immune cell chemotaxis as 
it can be concluded by employment of Secin 144, which solely inhibits this cytohesin function and 
only has a slight influence in chemotactic immune cell movement. The effector molecules that are 
targeted by cytohesin-regulation remain unclear and need to be further investigated. However, it 
is very likely that cells use comparable signaling pathways to provide spatio-temporal information 
for chemotaxis. Therefore it can be assumed, that -as reported for mature DCs and HeLa cells- 
also in immature DCs and lymphocytes cytohesin-1 mediates signals by regulation of RhoA (Quast 
et al. 2009). Other targets for cytohesin proteins during chemotaxis are possible, e.g. it was 
reported that ARL4D is able to interact with the PH-domain of all four members of the cytohesin 
family and recruits them to the plasma membrane. 
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Figure 37: Overview of the effects of Secin 16 and Secin 144 as differential inhibitors for 
cytohesin function. 
Secin 16 inhibits the cytohesin-regulated activation of ARF proteins and LFA-1 in immune cells. Secin 144 
exclusively inhibits cytohesin-mediated LFA-1 activation, leading to reduced T cell adhesion and integrin-
dependent migration.  
 
Figure 37 summarizes and illustrates the role of cytohesin function as investigated by the 
inhibition of cytohesin function with Secin 16 or Secin 144, respectively. Inhibition of cytohesin by 
application of Secin 16 leads to diminished LFA-1 activation. This negatively influences adhesion of 
T cells to ICAM-1 and VCAM-1, respectively, and the integrin-dependent migration of T cells and 
mature and immature BmDCs. Furthermore inhibition of cytohesin with Secin 16 strongly reduces 
the catalytic GEF-activity of cytohesin proteins, resulting in decreased GTP- loading to ARF1 in 
vitro and diminished insulin signaling in drosophila S2 cells. Moreover, it inhibits T cell activation 
through reduced cytokine production and proliferation, T cell signaling via the MAPK pathway and 
chemotaxis in immune cells during integrin-dependent and -independent migration.  
In contrast, Secin 144 only inhibits the cytohesin-mediated activation of LFA-1, resulting in a 
strong reduction in T cell adhesion to ICAM-1 and VCAM-1 and a diminished development of the 
active, high affinity LFA-1 conformational state during adhesion under flow conditions. 
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Chemotaxis in this context only is inhibited, when integrins are indispensable for forward 
locomotion, e.g. in two-dimensional migration on ICAM-1 as a substrate. The influence of 
cytohesin-mediated LFA-1 activation in the course of T cell activation is of minor importance, 
since observed effects in T cell proliferation and cytokine production as well as in T cell signaling 
are marginal. 
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5 Summary 
Cytohesins are guanine nucleotide exchange factors (GEFs) for the small GTPases of the ARF 
family. They play important roles in immune cell signaling, immune cell adhesion and migration 
and furthermore in non-immune insulin signaling and regulation of Erb activation. Cytohesin-1 
was first discovered as an interactor with the L/2-integrin LFA-1 and later as important regulator 
of T cell signaling in the course of T cell activation.  
Investigation of cytohesin function relied on overexpression and downregulation of the protein in 
a cellular context until recently the small molecule inhibitor Secin H3 was discovered. However, in 
immune cells Secin H3 was only insufficiently capable of inhibiting cytohesin-mediated processes. 
In a multidisciplinary approach, bioinformatic in silico predictions for novel molecules derived 
from the structurally similar Secin H3 were examined for their ability to serve as inhibitors for 
cytohesin functions in various screening assays. These assays were selected, because they 
involved different cytohesin functions and cytohesin family members, respectively.  
In the outcome of these functional screening assays, two novel small molecules, namely Secin 16 
and Secin 144, showed interesting inhibition profiles. With the use of Secin 16, it was possible to 
inhibit GTP-exchange of ARNO towards ARF1, steppke-dependent insulin signaling and T cell 
adhesion to ICAM-1 with significantly more potency compared to Secin H3. In contrast, Secin 144 
employment abrogated cytohesin-1 mediated T cell adhesion to ICAM-1, whereas GTP-exchange 
activity or drosophila insulin signaling was left unaffected. Further characterization of these two 
small molecule inhibitors revealed that they are able to inhibit reported functions of all cytohesin 
family members without toxic side effects and that they specifically interact with the Sec7 domain 
of cytohesin-1 in vitro. However, Secin 144 was a specific inhibitor for cytohesin-mediated integrin 
activation and did not interfere with cytohesin functions related to its GEF-activity. In contrast, 
Secin 16 was able to inhibit both, adhesion- and GEF-related processes that are linked to 
cytohesin activity.  
The combination of these two novel inhibitors was then further exploited for the investigation of 
cytohesin-mediated processes and their dependency on catalytic cytohesin GEF-activity. It is 
shown here, that cytohesin-mediated leukocyte adhesion on endothelial cells is mainly achieved 
by the interaction between cytohesin-1 and LFA-1 and independent of the catalytic GEF-activity of 
cytohesin proteins. Furthermore, cytohesin-mediated signaling in T cell activation is mainly 
dependent on the ability of cytohesin GTP-exchange. Hence, cytokine production, T cell 
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proliferation and ERK1/2 phosphorylation are abrogated, when the pan-cytohesin inhibitor Secin 
16 was used. In contrast, the employment of Secin 144 had no significant impact on the inhibition 
of cytohesin-mediated T cell activation. 
Furthermore, immune cell migration is dependent on both, cytohesin GTP-exchange activity and 
cytohesin-mediated activation of LFA-1. Immune cells are able to switch between integrin-
dependent and –independent modes of migration. In integrin-dependent migration the GEF-
activity as well as the LFA-1 activation mediated by cytohesin proteins is indispensable for proper 
forward locomotion in various immune cells. However, in three-dimensional environment 
integrins are not required for immune cell migration. In this context, only inhibition of the 
catalytic GEF-activity of cytohesin proteins is impairing migration. In contrast, inhibition of 
cytohesin-mediated LFA-1 activation does not impair three-dimensional chemotaxis. 
In conclusion, the novel small molecule inhibitors for cytohesin function are potent tools for the 
dissection of GEF-dependent and -independent cytohesin functions. 
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Zusammenfassung 
Cytohesine sind Guaninnukleotid-Austausch Faktoren für die kleinen GTPasen der ARF-Protein-
Familie. Sie spielen sowohl in der Signaltransduktion, der Adhäsion und der Migration von 
Immunzellen als auch in der Insulinsignalkaskade und der ErbB Regulation in Nicht-Immunzellen 
eine entscheidende Rolle. Cytohesin-1 wurde zunächst als Interaktionspartner des L/2-Integrins 
LFA-1 entdeckt und später als wichtiger Regulator der T Zell-Aktivierungskaskade und Aktivator 
von RhoA in der Migration dendritischer Zellen identifiziert. 
Die Untersuchung der Cytohesin Funktion in Immunzellen basierte vornehmlich auf 
Überexpressionsstudien und Herunterregulierung des Proteins auf mRNA-Ebene mit Hilfe von 
RNAi bis der organische Molekülinhibitor Secin H3 entdeckt wurde, mit dessen Hilfe eine effektive 
Inhibition der Cytohesin-Aktivität erreicht werden konnte. Im immunologischen Kontext allerdings 
zeigte der Inhibitor eine unzureichende Effizienz in der Inhibition von Cytohesin-vermittelten 
Funktionen. In einem interdisziplinären Ansatz aus Bioinformatik, Chemie und Biologie wurden 
deshalb neue Moleküle identifiziert, die als Cytohesin Inhibitoren mit verbesserter Wirkeffizienz 
fungieren sollten. Ausgehend von Secin H3 als Leitstruktur wurden zu diesem Zweck in silico 
Vorhersagen für kleine organische Moleküle getroffen, die im Folgenden auf ihre Fähigkeit zur 
Inhibition von Cytohesin Proteinen funktionell untersucht wurden. Hierzu wurden Screening-
Assays benutzt, in denen sowohl unterschiedliche Cytohesine als auch unterschiedliche Cytohesin 
Funktionen betroffen waren. 
Mit Hilfe der funktionellen Screening-Assays wurden zwei neuartige Moleküle, Secin 16 und 
Secin 144 identifiziert, die interessante Inhibitionsprofile zeigten. Der Einsatz von Secin 16 in 
diesen Assays ermöglichte die Inhibition sowohl des GTP-Austauschs an ARF1 von Cytohesin-2, als 
auch steppke-vermittelte Insulin-Signaltransduktion in der Fruchtfliege und T-Zell-Adhäsion an 
ICAM-1 durch Cytohesin-1. Verglichen mit Secin H3 konnte eine signifikant stärkere Inhibition in 
allen Assays beobachtet werden. Im Gegensatz dazu konnte durch die Verwendung von Secin 144 
ausschließlich die T-Zell Adhäsion auf ICAM-1-Untergrund inhibiert werden, während sowohl die 
GTP-Austausch-Aktivität von Cytohesin-2 an ARF1 als auch die Insulin-Signaltransduktion in 
D. melanogaster unverändert blieben. Durch die weitere Charakterisierung dieser kleinen 
organischen Moleküle konnte gezeigt werden, dass diese Inhibitoren spezifisch an die Sec7 
Domäne von Cytohesin-1 binden. Des Weiteren zeigten Secin 16 und Secin 144 in kultivierten 
Zellen keine toxischen Nebeneffekte. Allerdings konnte mit Hilfe von Secin 144 ausschließlich die 
Cytohesin-vermittelte Integrinaktivierung unterbunden werden, nicht aber Cytohesin-Funktionen, 
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die durch die GEF-Aktivität der Proteine bedingt waren. Im Gegensatz dazu war es möglich durch 
den Gebrauch von Secin 16 beide bekannten Cytohesin-1 Funktionen, nämlich LFA-1 Aktivierung 
und GTP-Austausch an ARF-GTPasen mit großer Effizienz zu inhibieren. 
Im Folgenden wurden deshalb beide neuen Inhibitoren in Kombination eingesetzt, um Cytohesin-
regulierte Prozesse auf ihre GEF-Abhängigkeit zu untersuchen. Es konnte hier gezeigt werden, 
dass Cytohesin-vermittelte Leukozyten-Adhäsion an Endothelzellen hauptsächlich, wenn nicht 
ausschließlich auf der Interaktion zwischen Cytohesin-1 und LFA-1 beruht und unabhängig von der 
katalytischen GEF-Aktivität von Cytohesin-Proteinen ist. Weiterhin ist die T-Zell Aktivierung in 
weiten Teilen abhängig von der GEF-Funktion der Cytohesine, weshalb Zytokin-Produktion, T-Zell 
Proliferation und ERK1/2 Phosphorylierung stark reduziert waren, wenn Secin 16 als Cytohesin-
Inhibitor eingesetzt wurde, nicht aber wenn Secin 144 benutzt wurde.  
Immunzell-Migration ist hingegen sowohl abhängig von der vollständigen Aktivierung von 
Integrinen durch Cytohesine als auch von der katalytischen GEF-Aktivität derselben. Immunzellen 
können zwischen Integrin-abhängiger und –unabhängiger Chemotaxis wechseln, abhängig von der 
Umgebung. Während der Integrin-abhängigen Migration sind sowohl die Cytohesin-vermittelte 
Integrinativierung als auch die GEF-Aktivität vonnöten, um gerichtete Vorwärtsbewegungen 
verschiedener Immunzellen zu gewährleisten. Im Gegensatz dazu werden Integrine in 
dreidimensionalen Umgebungen nicht für die Immunzellmigration benötigt. In diesem 
Zusammenhang kann eine Verminderung der Chemotaxis ausschließlich beobachtet werden, 
wenn die katalytische GEF-Aktivität der Cytohesine durch Secin 16 inhibiert ist. Der Gebrauch von 
Secin 144 führte zu keiner negativen Beeinflussung der Migrationsfähigkeit in einer 
dreidimensionalen Collagenmatrix. 
Zusammenfassend stellen die neuartigen, kleinen organischen Moleküle zur Inhibition von 
Cytohesin Funktionen ein wertvolles Werkzeug dar, mit dem sich GEF-abhängige 
und -unabhängige Cytohesin Funktionen unterscheiden und weiter untersuchen lassen. 
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Abbreviations 
aAPC    artificial antigen presenting cell, bead 
ARF1    ADP ribosylation factor 1 
ARNO    Cytohesin-2, ARF nucleotide-binding site opener 
ATP    Adenosine-5’-triphospate 
CD    Cluster of Differentiation 
cf.    latin: confer, compare 
DC    dendritic cell 
DMSO    dimethyl sulfoxide 
ELISA    enzyme linked immuno sorbent assay 
ERK    extracellular signal-related kinase 
et al.     et alii, and others 
FCS    fetal calf serum 
GDP    Guanosine-5’-diphosphate 
GEF    Guanine nucleotide exchange factor 
GFP    green fluorescent protein 
GTP    Guanosine-5’-triphosphate 
HUVEC    Human Umbilical Vein Endothelial Cells 
IFN    Interferon 
IL    Interleukin 
immBmDC   immature bone marrow derived dendritic cells 
LC    Langerhans cell 
MAPK    Mitogen-activated protein kinase 
mBmDC   mature bone marrow derived dendritic cells 
MHC I    major histocompatibility complex I 
PBL    peripheral blood lymphocytes 
PI3K    Phosphoinositide 3-kinase 
SD    standard deviation 
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SD    Standard deviation 
Secin    Sec7-inhibitor 
TCR    T cell receptor 
TH1 cells   T Helper cells type 1 
TH2 cells   T Helper cells type 2 
TNF    Tumor necrosis factor 
VS    virtual similarity 
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